Barely three months into the new year and we are happy to announce a monumental milestone reached - 150 million downloads.
\n\n
This achievement solidifies IntechOpen’s place as a pioneer in Open Access publishing and the home to some of the most relevant scientific research available through Open Access.
\n\n
We are so proud to have worked with so many bright minds throughout the years who have helped us spread knowledge through the power of Open Access and we look forward to continuing to support some of the greatest thinkers of our day.
\n\n
Thank you for making IntechOpen your place of learning, sharing, and discovery, and here’s to 150 million more!
\n\n\n\n
\n'}],latestNews:[{slug:"intechopen-supports-asapbio-s-new-initiative-publish-your-reviews-20220729",title:"IntechOpen Supports ASAPbio’s New Initiative Publish Your Reviews"},{slug:"webinar-introduction-to-open-science-wednesday-18-may-1-pm-cest-20220518",title:"Webinar: Introduction to Open Science | Wednesday 18 May, 1 PM CEST"},{slug:"step-in-the-right-direction-intechopen-launches-a-portfolio-of-open-science-journals-20220414",title:"Step in the Right Direction: IntechOpen Launches a Portfolio of Open Science Journals"},{slug:"let-s-meet-at-london-book-fair-5-7-april-2022-olympia-london-20220321",title:"Let’s meet at London Book Fair, 5-7 April 2022, Olympia London"},{slug:"50-books-published-as-part-of-intechopen-and-knowledge-unlatched-ku-collaboration-20220316",title:"50 Books published as part of IntechOpen and Knowledge Unlatched (KU) Collaboration"},{slug:"intechopen-joins-the-united-nations-sustainable-development-goals-publishers-compact-20221702",title:"IntechOpen joins the United Nations Sustainable Development Goals Publishers Compact"},{slug:"intechopen-signs-exclusive-representation-agreement-with-lsr-libros-servicios-y-representaciones-s-a-de-c-v-20211123",title:"IntechOpen Signs Exclusive Representation Agreement with LSR Libros Servicios y Representaciones S.A. de C.V"},{slug:"intechopen-expands-partnership-with-research4life-20211110",title:"IntechOpen Expands Partnership with Research4Life"}]},book:{item:{type:"book",id:"5431",leadTitle:null,fullTitle:"Breast Cancer - From Biology to Medicine",title:"Breast Cancer",subtitle:"From Biology to Medicine",reviewType:"peer-reviewed",abstract:"Breast Cancer - From Biology to Medicine thoroughly examines breast cancer from basic definitions, to cellular and molecular biology, to diagnosis and treatment. This book also has some additional focus on preclinical and clinical results in diagnosis and treatment of breast cancer. The book begins with introduction on epidemiology and pathophysiology of breast cancer in Section 1. In Section 2, the subsequent chapters introduce molecular and cellular biology of breast cancer with some particular signaling pathways, the gene expression, as well as the gene methylation and genomic imprinting, especially the existence of breast cancer stem cells. In Section 3, some new diagnostic methods and updated therapies from surgery, chemotherapy, hormone therapy, immunotherapy, radiotherapy, and some complementary therapies are discussed. This book provides a succinct yet comprehensive overview of breast cancer for advanced students, graduate students, and researchers as well as those working with breast cancer in a clinical setting.",isbn:"978-953-51-3000-0",printIsbn:"978-953-51-2999-8",pdfIsbn:"978-953-51-4882-1",doi:"10.5772/62922",price:159,priceEur:175,priceUsd:205,slug:"breast-cancer-from-biology-to-medicine",numberOfPages:568,isOpenForSubmission:!1,isInWos:null,isInBkci:!1,hash:"d90527637742a2483c1d96d5a5f7cc02",bookSignature:"Phuc Van Pham",publishedDate:"April 5th 2017",coverURL:"https://cdn.intechopen.com/books/images_new/5431.jpg",numberOfDownloads:44449,numberOfWosCitations:27,numberOfCrossrefCitations:33,numberOfCrossrefCitationsByBook:0,numberOfDimensionsCitations:58,numberOfDimensionsCitationsByBook:0,hasAltmetrics:1,numberOfTotalCitations:118,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"April 11th 2016",dateEndSecondStepPublish:"May 2nd 2016",dateEndThirdStepPublish:"July 29th 2016",dateEndFourthStepPublish:"October 27th 2016",dateEndFifthStepPublish:"December 26th 2016",currentStepOfPublishingProcess:5,indexedIn:"1,2,3,4,5,6",editedByType:"Edited by",kuFlag:!1,featuredMarkup:null,editors:[{id:"28799",title:"Ph.D.",name:"Phuc Van",middleName:"Van",surname:"Pham",slug:"phuc-van-pham",fullName:"Phuc Van Pham",profilePictureURL:"https://mts.intechopen.com/storage/users/28799/images/system/28799.png",biography:"Phuc Van Pham received his Ph.D. in Human Physiology from Vietnam National University, Ho Chi Minh City, Vietnam. He is currently an Associate Professor of Biology at Vietnam National University; Direct of Stem Cell Institute; Director of the Laboratory of Stem Cell Research and Application; and Vice-Director of the Laboratory of Cancer Research. He is a longstanding lecturer and translational scientist at the University, and is a member of several societies and journal editorial boards focused on stem cells as well as cellular therapy.",institutionString:"VNU-HCM University of Science",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"2",totalChapterViews:"0",totalEditedBooks:"2",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"1075",title:"Breast Oncology",slug:"breast-oncology"}],chapters:[{id:"53860",title:"Epidemiology, Pathology, Management and Open Challenges of Breast Cancer in Central Sudan: A Prototypical Limited Resource African Setting",doi:"10.5772/67175",slug:"epidemiology-pathology-management-and-open-challenges-of-breast-cancer-in-central-sudan-a-prototypic",totalDownloads:2030,totalCrossrefCites:3,totalDimensionsCites:5,hasAltmetrics:0,abstract:"Little is known about breast cancer in Sudan. According to the recent data published by the Khartoum Cancer Registry, breast cancer was the most common cancer among Sudanese women. Generally, breast cancer in native African women is characterized by young age at onset, occurrence in multiparous premenopausal patients, advanced stage at diagnosis, large tumor size, high‐grade and triple‐negative phenotype, with correspondingly poor prognosis. In Sudan, it was reported that about 70% of the women diagnosed with breast cancer were younger than 50 years old. We present here data from local and international publications as well as primary information from the National Cancer Institute in Wad Medani (one of the only two cancer hospitals of the country, both located in Central Sudan in Khartoum and Wad Medani). We provide an up‐to‐date situation analysis of breast cancer in Central Sudan as an example for an African reality and the various open challenges of breast cancer in a limited resource setting. A better understanding of breast cancer in black African women is of global relevance, as there is an alarming increase in breast cancer among young black women worldwide, and these patients have the lowest survival rates.",signatures:"Renato Mariani-Costantini, Moawia Mohammed Ali Elhassan,\nGitana Maria Aceto, Ahmed Abdalla Mohamedani and Khalid\nDafaallah Awadelkarim",downloadPdfUrl:"/chapter/pdf-download/53860",previewPdfUrl:"/chapter/pdf-preview/53860",authors:[{id:"34845",title:"Prof.",name:"Renato",surname:"Mariani Costantini",slug:"renato-mariani-costantini",fullName:"Renato Mariani Costantini"},{id:"43821",title:"Dr.",name:"Khalid",surname:"Awadelkarim",slug:"khalid-awadelkarim",fullName:"Khalid Awadelkarim"},{id:"190476",title:"Dr.",name:"Moawia",surname:"Elhassan",slug:"moawia-elhassan",fullName:"Moawia Elhassan"},{id:"190485",title:"Dr.",name:"Gitana",surname:"Aceto",slug:"gitana-aceto",fullName:"Gitana Aceto"},{id:"194585",title:"Prof.",name:"Ahmed Abdalla",surname:"Mohamedani",slug:"ahmed-abdalla-mohamedani",fullName:"Ahmed Abdalla Mohamedani"}],corrections:null},{id:"52969",title:"Histopathological Characteristics: Clinical Course of Breast Cancer Subtypes Depending on the ER(+) (−)/PR(+) (−) Receptor Status",doi:"10.5772/66176",slug:"histopathological-characteristics-clinical-course-of-breast-cancer-subtypes-depending-on-the-er-pr-r",totalDownloads:1909,totalCrossrefCites:0,totalDimensionsCites:1,hasAltmetrics:0,abstract:"Breast cancer patients were divided into separate groups, which were the estrogen receptor (ER)+/progesterone receptor (PR)+ HER2−, the ER or PR+ HER2−, the ER+/PR+ HER2+, the ER or PR+ HER2+, the ER−/PR− HER2−, and the ER−/PR− HER2+ groups. Patients with the ER/PR(+)/HER2− subtype breast cancers show better clinical prognosis compared to the hormone-negative, triple-negative (TN), and HER2+ subtypes. TN, HER2+ tumors in postmenopausal women were of higher grade, showing lymph node and lymphovascular invasion with poor prognosis in all case series. However, the ER+/PR−/HER2+ subgroup had the lowest survival rates in 2- and 5-year follow-ups. Comparison between the ER+PR+HER2+ and ER+PR−HER2− subgroups showed that HER2− status is an indicator of improved prognosis in long-term follow-up. Single hormone receptor (HR)(+) status, particularly HER2(−) cases, was in between the favorable and poor survival subgroups. The ER−, PR−, and HER2+ properties were found to be risk factors for frequent recurrences. In this chapter, breast cancer subtypes are compared with each other. Results from different studies highlight the importance of ER/PR/HER2 receptor variations in the choice of treatment and prognosis of breast cancer.",signatures:"Nilufer Bulut",downloadPdfUrl:"/chapter/pdf-download/52969",previewPdfUrl:"/chapter/pdf-preview/52969",authors:[{id:"189255",title:"Associate Prof.",name:"Nilufer",surname:"Bulut",slug:"nilufer-bulut",fullName:"Nilufer Bulut"}],corrections:null},{id:"54191",title:"Breast Cancer as an Epstein-Barr Virus (EBV)-Associated Malignancy",doi:"10.5772/66988",slug:"breast-cancer-as-an-epstein-barr-virus-ebv-associated-malignancy",totalDownloads:1479,totalCrossrefCites:0,totalDimensionsCites:1,hasAltmetrics:0,abstract:"The Epstein Barr Virus is among the very first oncogenic viruses to be identified as culprits of human malignancies. Its role as an etiologic agent of breast cancer however remains debated despite mounting molecular evidence. In this chapter we address the challenge of multiple molecular etiologies of breast cancer (BC) with emphasis on the Epstein Barr Virus (EBV) as a potential causative agent within a frame work of gene/environment interaction. We also hope to contribute to a critique of the a concept of universal single agent or gene in cancer etiology. In addition to reviewing further reasons of why EBV should be considered a tumor virus, coupling molecular targets at the initiation stage, we examine evidence for the culpability of EBV as oncogenic virus in relation to the genetic and epigenetic events that leads to carcinogenesis of cancer; and the subsequent downstream interaction including genetic and epigenetic modifiers of signaling and molecular function underlying the cancerous phenotype. The TNF family is taken as an example of how the epigenetic reprogramming process, impacts molecular targets and how these combined interplay of molecular events impinges on pathogenesis and malignancy of breast cancer in humans.",signatures:"Ghimja Fessahaye and Muntaser E. Ibrahim",downloadPdfUrl:"/chapter/pdf-download/54191",previewPdfUrl:"/chapter/pdf-preview/54191",authors:[{id:"69817",title:"Prof.",name:"Muntaser",surname:"Ibrahim",slug:"muntaser-ibrahim",fullName:"Muntaser Ibrahim"}],corrections:null},{id:"53856",title:"Early-Stage Progression of Breast Cancer",doi:"10.5772/65633",slug:"early-stage-progression-of-breast-cancer",totalDownloads:1713,totalCrossrefCites:4,totalDimensionsCites:4,hasAltmetrics:0,abstract:"Breast cancer can be defined as a group of diseases with heterogeneous origins, molecular profiles and behaviors characterized by uncontrolled proliferation of cells within the mammary tissue. Around one in eight women in the US will develop breast cancer in their lifetime, making it the second most frequently diagnosed cancer behind skin cancer [1]. In 2015, an estimated 231,840 cases of invasive carcinoma were diagnosed, and over 40,000 deaths were caused by breast cancer which accounts for almost 7% of all cancer mortality each year. In 2015, 60,290 cases of in situ breast cancer were diagnosed, representing over 14% of all new cancer cases among women and men. The steep increase in diagnosis of early‐stage breast cancer over the past 10 years is believed to be a result of more frequent mammography. However, since over half of these in situ lesions will not progress to invasive breast cancer, controversies have arisen about approaches to treatment and prevention of progression of early‐stage in situ breast cancer. Understanding the mechanisms of transition of normal breast to in situ pre‐neoplastic lesions and invasive breast cancer is currently a major focus of breast cancer research with implications for preventive and clinical management of breast cancer. In this review, we give an overview of current knowledge on the molecular and pathological changes that occur during early‐stage progression of breast cancer and describe some of the current models that are used to study this process.",signatures:"William Kietzman, Anna T. Riegel and Virginie Ory",downloadPdfUrl:"/chapter/pdf-download/53856",previewPdfUrl:"/chapter/pdf-preview/53856",authors:[{id:"190578",title:"Prof.",name:"Anna",surname:"Riegel",slug:"anna-riegel",fullName:"Anna Riegel"},{id:"190580",title:"Dr.",name:"Virginie",surname:"Ory",slug:"virginie-ory",fullName:"Virginie Ory"},{id:"190583",title:"MSc.",name:"William",surname:"Kietzman",slug:"william-kietzman",fullName:"William Kietzman"}],corrections:null},{id:"54190",title:"GWAS in Breast Cancer",doi:"10.5772/67223",slug:"gwas-in-breast-cancer",totalDownloads:2005,totalCrossrefCites:0,totalDimensionsCites:2,hasAltmetrics:0,abstract:"Breast cancer is the most diagnosed cancer in women, and the second cause of cancer-related deaths among women worldwide. It is expected that more than 240,000 new cases and 40,450 deaths related to the disease will occur in 2016. It is well known that inherited genetic variants are drivers for breast cancer development. There are many mechanisms through which germline genetic variation affects prognosis, such as BRCA1 and BRCA2 genes, which account for approximately 20% of the increased hereditary risks. Therefore, it is evident that the genetic pathways that underlie cancer development are complex in which networks of multiple alleles confer disease susceptibility and risks. Global analyses through genome-wide association studies (GWAS) have revealed several loci across the genome are associated with the breast cancer. This chapter compiles all breast GWAS released since 2007, year of the first article published in this area, and discuss the future directions of this field. Currently, hundreds of genetic markers are linked to breast cancer, and understanding the underlying mechanisms of these variants might lead to the discover of biomarkers and targets for therapy in patients.",signatures:"Paulo C.M. Lyra‐Junior, Nayara G. Tessarollo, Isabella S. Guimarães,\nTaciane B. Henriques, Diandra Z. dos Santos, Marcele L.M. de Souza,\nVictor Hugo M. Marques, Laura F.R.L. de Oliveira, Krislayne V.\nSiqueira, Ian V. Silva, Leticia B.A. Rangel and Alan T. Branco",downloadPdfUrl:"/chapter/pdf-download/54190",previewPdfUrl:"/chapter/pdf-preview/54190",authors:[{id:"60359",title:"Dr.",name:"Letícia",surname:"Rangel",slug:"leticia-rangel",fullName:"Letícia Rangel"}],corrections:null},{id:"54294",title:"Circulating Tumor Cells in Breast Cancer: A Potential Liquid Biopsy",doi:"10.5772/66439",slug:"circulating-tumor-cells-in-breast-cancer-a-potential-liquid-biopsy",totalDownloads:2040,totalCrossrefCites:1,totalDimensionsCites:2,hasAltmetrics:0,abstract:"Circulating tumor cells (CTCs) have emerged as a new generation of liquid biomarker that allows for noninvasive longitudinal disease monitoring. CTCs represent a rare cell population in the blood, surrounded by billions of hematopoietic cells. Due to the rarity of CTCs in the blood, the isolation of pure CTCs’ populations has proven to be challenging. However, a number of new technologies have emerged using CTCs cytometric/immunological and physical characteristics. Currently, patients with greater than 5 CTCs have a shorter progression-free survival, as compared with those with less than 5 CTCs per 7.5 ml of whole blood. Although the CTC count itself is an independent prognostic marker, the field is shifting toward understanding metastasis-relevant marker expression on CTCs for the improvement of the prognostic significance of CTCs. This chapter first introduces the principles of CTC isolation and detection methods, then the clinical utility of CTCs for prediction of prognosis and therapy response. Lastly, the heterogeneity of CTCs will be discussed.",signatures:"Mohamed Kamal, Wajeeha Razaq, Macall Leslie, Smita Adhikari and\nTakemi Tanaka",downloadPdfUrl:"/chapter/pdf-download/54294",previewPdfUrl:"/chapter/pdf-preview/54294",authors:[{id:"188855",title:"Dr.",name:"Takemi",surname:"Tanaka",slug:"takemi-tanaka",fullName:"Takemi Tanaka"},{id:"196565",title:"Dr.",name:"Mohamed",surname:"Kamal",slug:"mohamed-kamal",fullName:"Mohamed Kamal"},{id:"196566",title:"Dr.",name:"Wajeeha",surname:"Razaq",slug:"wajeeha-razaq",fullName:"Wajeeha Razaq"},{id:"196568",title:"BSc.",name:"Macall",surname:"Leslie",slug:"macall-leslie",fullName:"Macall Leslie"}],corrections:null},{id:"53849",title:"DNA Hypermethylation in Breast Cancer",doi:"10.5772/66900",slug:"dna-hypermethylation-in-breast-cancer",totalDownloads:1805,totalCrossrefCites:1,totalDimensionsCites:2,hasAltmetrics:0,abstract:"Cancer development is a complex process with multiple steps. Many factors, including radiation, chemicals, viruses, genetic and epigenetic changes, lead to abnormal proliferation of a single cell, which results in the outgrowth of a population of clonal-derived tumour cells. It has established that DNA hypermethylation, an epigenetic mechanism that occurred by the addition of a methyl group at 5′ position of the pyrimidine ring of cytosine residues at CpG islands through the action of DNA methyltransferase enzymes, has been considered as the cause of human tumorigenesis, including breast cancer development. Moreover, DNA hypermethylation holds a promising application as a potential biomarker for the early detection, prognosis and prediction of drug sensitivity in cancer. Therefore, this chapter focuses on the description and exemplification of the DNA hypermethylation changes, particularly, highlight the DNA hypermethylation as a potential biomarker applied in predictive, diagnostic, prognostic and therapeutic monitoring of breast cancer.",signatures:"Le Huyen Ai Thuy, Lao Duc Thuan and Truong Kim Phuong",downloadPdfUrl:"/chapter/pdf-download/53849",previewPdfUrl:"/chapter/pdf-preview/53849",authors:[{id:"188780",title:"Dr.",name:"Huyen Ai Thuy",surname:"Le",slug:"huyen-ai-thuy-le",fullName:"Huyen Ai Thuy Le"},{id:"190443",title:"Ph.D. Student",name:"Thuan Duc",surname:"Lao",slug:"thuan-duc-lao",fullName:"Thuan Duc Lao"},{id:"201479",title:"MSc.",name:"Phuong",surname:"Kim Truong",slug:"phuong-kim-truong",fullName:"Phuong Kim Truong"}],corrections:null},{id:"53690",title:"ErbB2 Receptor in Breast Cancer: Implications in Cancer Cell Migration, Invasion and Resistance to Targeted Therapy",doi:"10.5772/66902",slug:"erbb2-receptor-in-breast-cancer-implications-in-cancer-cell-migration-invasion-and-resistance-to-tar",totalDownloads:1587,totalCrossrefCites:3,totalDimensionsCites:4,hasAltmetrics:0,abstract:"Overexpression of ErbB2 is found in several types of human carcinomas. In breast tumors, ErbB2 overexpression is detected in up to 20% of patients. Breast cancers in with amplification of ErbB2 are characterized by rapid tumor growth, lower survival rate and increased disease progression. The molecular mechanisms underlying the oncogenic action of ErbB2 involve a complex signaling network that tightly regulates malignant cell migration and invasion and hence metastatic potential. Recent efforts have been made to identify gene expression signatures of ErbB2-positive invasive breast cancers that may represent important mediators of ErbB2-induced tumorigenesis and metastatic progression.\nIn this chapter, we will discuss the canonical ErbB2 signaling pathways responsible for tumor growth and dissemination along with newly identified mediators such as adaptor protein p130Cas and miRNAs. From a therapeutic point of view, the treatment with anti-ErbB2 monoclonal antibody trastuzumab has greatly improved the outcomes of patients with ErbB2 aggressive cancer. Nevertheless, de novo and acquired resistance to trastuzumab therapy still represent a major clinical problem. In the second part of the chapter, we will provide an overview of the mechanisms so far implicated in the onset of resistance to targeted therapy and of the new strategies to overcome resistance.",signatures:"Maria del Pilar Camacho-Leal, Marianna Sciortino and Sara Cabodi",downloadPdfUrl:"/chapter/pdf-download/53690",previewPdfUrl:"/chapter/pdf-preview/53690",authors:[{id:"189004",title:"Ph.D.",name:"Maria Del Pilar",surname:"Camacho Leal",slug:"maria-del-pilar-camacho-leal",fullName:"Maria Del Pilar Camacho Leal"}],corrections:null},{id:"52973",title:"Analysis of 10086 Microarray Gene Expression Data Uncovers Genes that Subclassify Breast Cancer Intrinsic Subtypes",doi:"10.5772/66161",slug:"analysis-of-10086-microarray-gene-expression-data-uncovers-genes-that-subclassify-breast-cancer-intr",totalDownloads:1644,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Breast cancer is a complex disease comprising molecularly distinct subtypes. The prognosis and treatment differ between subtypes; thus, it is important to distinguish one subtype from another. In this chapter, we make use of high-throughput microarray dataset to perform breast cancer subtyping of 10086 samples. Aside from the four major subtypes, that is, Basal-like, HER2-enriched, luminal A, and luminal B, we defined a normal-like subtype that has a gene expression profile similar to that found in normal and adjacent normal breast samples. Also, a group of luminal B-like samples with better prognosis was distinguished from the high-risk luminal B breast cancer. We additionally identified 33 surface-protein encoding genes whose gene expression profiles were associated with survival outcomes. We believe these genes are potential therapeutic targets and diagnostic biomarkers for breast cancer.",signatures:"I-Hsuan Lin and Ming-Ta Hsu",downloadPdfUrl:"/chapter/pdf-download/52973",previewPdfUrl:"/chapter/pdf-preview/52973",authors:[{id:"49774",title:"Prof.",name:"Ming-Ta",surname:"Hsu",slug:"ming-ta-hsu",fullName:"Ming-Ta Hsu"},{id:"172713",title:"Dr.",name:"I-Hsuan",surname:"Lin",slug:"i-hsuan-lin",fullName:"I-Hsuan Lin"}],corrections:null},{id:"52901",title:"Jab1/Csn5 Signaling in Breast Cancer",doi:"10.5772/66174",slug:"jab1-csn5-signaling-in-breast-cancer",totalDownloads:1329,totalCrossrefCites:1,totalDimensionsCites:1,hasAltmetrics:0,abstract:"c-Jun activation domain-binding protein1 (Jab1), also known as a monomer or the fifth component of the constitutive photomorphogenesis 9 signalosome (Csn5) complex, regulates cell proliferation, cell-cycle progression, and apoptosis and affects a series of pathways. Jab1/Csn5 also promotes cell transformation and tumorigenesis, and its overexpression in many tumor types suggests it is involved in cancer progression and closely associated with poor cancer prognosis. Jab1/Csn5 dysregulation contributes to oncogenesis by deactivating several tumor suppressors. Increasing evidence of the role of Jab1/Csn5 overexpression in breast and other cancers has spurred interest in Jab1/Csn5 inhibitors for cancer therapy. In this chapter, we summarize the evidence demonstrating the importance of Jab1/Csn5 expression in breast and other cancers and review recent advances in dissecting the Jab1/Csn5 signaling pathway along with its potential as a therapeutic target for cancer.",signatures:"Yunbao Pan and Francois X. Claret",downloadPdfUrl:"/chapter/pdf-download/52901",previewPdfUrl:"/chapter/pdf-preview/52901",authors:[{id:"108913",title:"Dr.",name:"Francois",surname:"Claret",slug:"francois-claret",fullName:"Francois Claret"},{id:"190726",title:"Dr.",name:"Yunbao",surname:"Pan",slug:"yunbao-pan",fullName:"Yunbao Pan"}],corrections:null},{id:"52920",title:"Splicing Factors in Breast Cancer: Drivers of the Breast Tumor Fate",doi:"10.5772/66162",slug:"splicing-factors-in-breast-cancer-drivers-of-the-breast-tumor-fate",totalDownloads:1586,totalCrossrefCites:0,totalDimensionsCites:1,hasAltmetrics:0,abstract:"Splicing is a critical step in gene expression, responsible for the excision of introns, producing the mature form of mRNA. Also, the possible arrangements of exons enlarge the proteome in 80%, enabling one gene to encode more than one protein isoform, thus increasing proteome. Growing data show deregulation of splicing events in cancer, being breast cancer the most studied. This aberrant pattern of splicing has an important role in breast tumor progression. These alterations are mainly caused by misexpression of some critical alternative splicing factors. The behavior of these splicing factors is implicated with important clinical features, such as chemoresistance, aggressiveness, and also metastases. In this chapter, the role of five splicing factors is discussed in the light of relevant data about in vitro, in vivo, and ex vivo studies to construct a representative scheme of their behavior in breast cancer progression. Although the presented five splicing factors have important role in breast cancer, only three of them (ESRP1, RBFOX2, and SRSF1) have a more prominent role in tumorigenesis and tumor progression. These concepts will elucidate their role in tumorigenesis and a prospective use as biomarkers in breast cancer.",signatures:"Felipe A. C. da Luz, Paula C. Brígido, Alberto S. Moraes, Rogério A.\nAraújo and Marcelo J. B. Silva",downloadPdfUrl:"/chapter/pdf-download/52920",previewPdfUrl:"/chapter/pdf-preview/52920",authors:[{id:"190065",title:"Prof.",name:"Marcelo",surname:"Silva",slug:"marcelo-silva",fullName:"Marcelo Silva"},{id:"190214",title:"MSc.",name:"Felipe",surname:"Da Luz",slug:"felipe-da-luz",fullName:"Felipe Da Luz"},{id:"190215",title:"Prof.",name:"Rogério",surname:"De Araújo",slug:"rogerio-de-araujo",fullName:"Rogério De Araújo"},{id:"190216",title:"Dr.",name:"Alberto",surname:"Moraes",slug:"alberto-moraes",fullName:"Alberto Moraes"}],corrections:null},{id:"53577",title:"The Role of Stem Cells in Breast Cancer",doi:"10.5772/66904",slug:"the-role-of-stem-cells-in-breast-cancer",totalDownloads:1815,totalCrossrefCites:1,totalDimensionsCites:1,hasAltmetrics:0,abstract:"A significant progress has been made in describing cellular hierarchy and the stem cell niche in the human mammary gland. Mammary stem and progenitor cells exist in two different states: epithelial-like and mesenchymal-like. Several features of the mammary stem cells predispose them to play a critical role in breast cancer initiation, progression and metastasis. Signaling pathways contributing to the self-renewal, such as Wnt, Notch, Hh and BMP, have been shown to be linked with breast cancer stem cells. Furthermore, biomarkers connected with stemness, such as CD44, CD24, EpCAM and ALDH1, have been identified and used to characterize these cells. Additionally, many different miRNA families and microenvironmental factors were shown to regulate a lot of cancer stem cells properties and maintain their stemness. All these findings have started a new era of breast cancer research. In present breast cancer, stem cells have become the targets of breast cancer therapy, although the tests are mainly on the basic stage level. Since the cancer stem cells are able to escape chemotherapy and are resistant to drugs, radiotherapy and apoptotic processes, the therapeutic targeting is mostly concentrated on the disruption of survival signaling pathways and the use of modern technology, like nanotechnology.",signatures:"Joanna Magdalena Zarzynska",downloadPdfUrl:"/chapter/pdf-download/53577",previewPdfUrl:"/chapter/pdf-preview/53577",authors:[{id:"175016",title:"Dr.",name:"Joanna",surname:"Zarzynska",slug:"joanna-zarzynska",fullName:"Joanna Zarzynska"}],corrections:null},{id:"54049",title:"Ion Channels in Breast Cancer: From Signaling to Therapy",doi:"10.5772/66172",slug:"ion-channels-in-breast-cancer-from-signaling-to-therapy",totalDownloads:2041,totalCrossrefCites:3,totalDimensionsCites:6,hasAltmetrics:1,abstract:"Breast cancer consists of an assortment of illness and therapeutic failure is mostly due to the complex and heterogeneous phenotype of the disease. Recently, changes in expression of several ion channels have been associated with malignancy including breast cancers. This suggests that breast cancer cells might gain a selective advantage by controlling ion channel expression/activity and that ion channels can contribute to the hallmarks of cancer. Due to the growing body of research demonstrating that ion channels are key factors in breast cancer biology. In this chapter, we discuss the role of specific ion channels in contributing to hallmarks of breast and whether these ion channels can be used as potential pharmacologic targets for breast cancer.",signatures:"Dowd Jonathan, Hendin Josh, Daniela F. Fukushiro-Lopes, David\nLaczynski and Saverio Gentile",downloadPdfUrl:"/chapter/pdf-download/54049",previewPdfUrl:"/chapter/pdf-preview/54049",authors:[{id:"185692",title:"Prof.",name:"Saverio",surname:"Gentile",slug:"saverio-gentile",fullName:"Saverio Gentile"}],corrections:null},{id:"53531",title:"Modern Radiotherapy Era in Breast Cancer",doi:"10.5772/66906",slug:"modern-radiotherapy-era-in-breast-cancer",totalDownloads:1852,totalCrossrefCites:0,totalDimensionsCites:1,hasAltmetrics:0,abstract:"Radiation therapy (RT) is one of the major treatment modalities that are used in breast cancer treatment, and depending on the chest-wall anatomy, RT fields have to be customized. Techniques used in planning have been evolving since last two decades from two dimensional (2D) to three-dimensional (3D), while intensity modulated radiotherapy (IMRT), volumetric modulated arc therapy (VMAT) and even proton therapy have been an option in daily approach. In addition, technological hardware and software advances in delivery and planning systems, total treatment duration of breast RT have been shortened in last decades along with recent hypofractionated radiotherapy schemes or emerging partial-breast irradiation protocols. The other attractive approach—accelerated partial breast irradiation (APBI) could be a reasonable option for highly selected subpopulation of early-stage breast cancer patients out of a clinical trial. Long-term follow-up results have emerged heart and coronary sparing with maximum safety and efficacy. The most important advance could be named as cardiac sparing—deep breath-hold approach—in all the modern technique improvement. Although most advanced techniques in management of breast cancer have not been verified to increase survival, we suggest recommending resource stratified advanced in order to provide best technical and clinical care in this long-term survivor candidates.",signatures:"Yasemin Bolukbasi and Ugur Selek",downloadPdfUrl:"/chapter/pdf-download/53531",previewPdfUrl:"/chapter/pdf-preview/53531",authors:[{id:"189528",title:"Dr.",name:"Ugur",surname:"Selek",slug:"ugur-selek",fullName:"Ugur Selek"},{id:"190551",title:"Dr.",name:"Yasemin",surname:"Bolukbasi",slug:"yasemin-bolukbasi",fullName:"Yasemin Bolukbasi"}],corrections:null},{id:"53892",title:"Breast Cancer and Flavonoids as Treatment Strategy",doi:"10.5772/66169",slug:"breast-cancer-and-flavonoids-as-treatment-strategy",totalDownloads:2065,totalCrossrefCites:4,totalDimensionsCites:7,hasAltmetrics:1,abstract:"Breast cancer is the most prevalent cancer type among women. Despite recent progress in early detection and therapeutic strategies, the rate of mortality is increasing. Anti-estrogens or aromatase inhibitors are preferred to treat the women diagnosed with estrogen-receptor (ER) positive tumors. However, breast tumors usually show intra-tumoral heterogeneity with ER-positive and -negative cells. The advanced breast cancer cells lose the estrogen responsiveness and become aggressive by developing new strategies for rapid proliferation such as mutations in cell cycle machinery. New promising drugs are still being investigating against these types of tumors especially to overcome acquired resistance against chemotherapeutic drugs; however, a successful treatment for metastatic tumors is still unclear. Flavonoids, with various pharmacological activities, are plant or fungus secondary metabolites present in human diet. In plants, beside their role in pigmentation, they may also act as messengers, regulators and cell cycle inhibitors. Therefore, they are being tested in ovarian, cervical as well as breast cancer. Due to the positive correlation between flavonoids-rich diet and lower risk of cancer, flavonoids are referred as chemopreventive agents. The current chapter emphasizes the therapeutic potential of flavonoids and their synthetic analogues as anti-cancer agents in breast cancer providing new insights into the molecular mechanisms.",signatures:"Pinar Obakan-Yerlikaya, Elif Damla Arisan, Ajda Coker-Gurkan and\nNarcin Palavan-Unsal",downloadPdfUrl:"/chapter/pdf-download/53892",previewPdfUrl:"/chapter/pdf-preview/53892",authors:[{id:"183217",title:"Dr.",name:"Damla",surname:"Arisan",slug:"damla-arisan",fullName:"Damla Arisan"},{id:"183665",title:"Dr.",name:"Ajda",surname:"Coker-Gurkan",slug:"ajda-coker-gurkan",fullName:"Ajda Coker-Gurkan"},{id:"183666",title:"Prof.",name:"Pinar",surname:"Obakan-Yerlikaya",slug:"pinar-obakan-yerlikaya",fullName:"Pinar Obakan-Yerlikaya"},{id:"183669",title:"Prof.",name:"Narcin",surname:"Palavan-Unsal",slug:"narcin-palavan-unsal",fullName:"Narcin Palavan-Unsal"}],corrections:null},{id:"52931",title:"Translational Challenges and Therapeutic Opportunities in BRCA1-Related Breast Cancer",doi:"10.5772/66168",slug:"translational-challenges-and-therapeutic-opportunities-in-brca1-related-breast-cancer",totalDownloads:1242,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Although significant progress has been made in the management of the hereditary cancer syndrome related to mutations of BRCA1, two fundamental and clinically relevant questions regarding BRCA1-related cancer syndrome remain unresolved: (1) What factors account for the tissue specificity of the BRCA1-related cancer risk? (2) How does a mutation or loss of BRCA1 lead to the basal-like phenotype of breast cancer? This review focuses on recent studies in BRCA1-related pathways that lead to specific characteristics of the hereditary cancer syndrome and discusses the current translational evidence for exploiting these pathways in new therapeutic strategies. Mounting evidence suggests that estrogen signaling and metabolism, oxidative stress, specific secondary mutations, and regulation of specific progenitor cells and transcriptional programs are critical in BRCA1-associated breast cancer. Strategies geared toward estrogen reduction may play a role in treatment and prevention. Therapies aimed at mitigating oxidative stress may be a strategy for risk reduction, while cancer-cell-specific sensitivity to oxidative stress may also be an opportunity for specific targeting. BRCA1-related transcriptional regulation and signaling provide a number of therapeutic targets, including the PI3-AKT and Notch pathways. Thus, significant opportunities exist in translational and clinical research for developing the treatment strategies for the management of BRCA1-related breast cancer.",signatures:"Jeffrey Johnson, William Audeh, Hisashi Tanaka, Farin Amersi,\nArmando E. Giuliano and Xiaojiang Cui",downloadPdfUrl:"/chapter/pdf-download/52931",previewPdfUrl:"/chapter/pdf-preview/52931",authors:[{id:"188836",title:"Dr.",name:"Xiaojiang",surname:"Cui",slug:"xiaojiang-cui",fullName:"Xiaojiang Cui"},{id:"194416",title:"Dr.",name:"Jeffrey",surname:"Johnson",slug:"jeffrey-johnson",fullName:"Jeffrey Johnson"},{id:"194417",title:"Dr.",name:"William",surname:"Audeh",slug:"william-audeh",fullName:"William Audeh"},{id:"194418",title:"Dr.",name:"Hisashi",surname:"Tanaka",slug:"hisashi-tanaka",fullName:"Hisashi Tanaka"},{id:"194419",title:"Dr.",name:"Farin",surname:"Amersi",slug:"farin-amersi",fullName:"Farin Amersi"},{id:"194420",title:"Dr.",name:"Armando",surname:"Giuliano",slug:"armando-giuliano",fullName:"Armando Giuliano"}],corrections:null},{id:"53631",title:"Molecular Fingerprints and Biomarkers of Breast Cancer",doi:"10.5772/66899",slug:"molecular-fingerprints-and-biomarkers-of-breast-cancer",totalDownloads:1691,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Substantial progress has been made over the past three decades in understanding breast cancer (BC) molecular biology, genomics, and targeted therapy. The recent comprehensive molecular and pathological diversity observed in BC patients indicates that BC is not a homogeneous disease; It may be appropriately defined as a myriad of diseases. The explosion of molecular information in the past 10 years has led to a better understanding of the biologic diversity of breast cancers (BCs), and clues to the different etiologic pathways to BC development. It will be useful to study the epigenetics of BC cells and define the mechanisms of both genetic and epigenetic driving alterations beside the mutations. Identifying the oncogenes and tumor suppressor genes is the purpose cancer diagnostics and therapeutics. Oncogenes as well as novel ones involved in the significantly altered regions would enable researchers to identify new causes and molecular pathways that may be targeted at BC treatment. Our main goal is to provide comprehensive understanding of underlying molecular mechanisms and hallmarks of BC, focusing on the identification of fingerprints and novel molecular targets that will greatly improve the cancer predictive, prognostic, and diagnostic biomarkers and, in addition, the possible targets for novel therapies.",signatures:"Hala Fawzy Mohamed Kamel, Hiba Saeed Bagader Al-Amodi and\nHanan Mohamed AbdElmoneim",downloadPdfUrl:"/chapter/pdf-download/53631",previewPdfUrl:"/chapter/pdf-preview/53631",authors:[{id:"179315",title:"Dr.",name:"Hala",surname:"Fawzy Mohamed Kamel",slug:"hala-fawzy-mohamed-kamel",fullName:"Hala Fawzy Mohamed Kamel"},{id:"184928",title:"Dr.",name:"Hiba",surname:"Al-Amodi",slug:"hiba-al-amodi",fullName:"Hiba Al-Amodi"},{id:"190459",title:"Prof.",name:"Hanan",surname:"Mohamed AbdElmoneim",slug:"hanan-mohamed-abdelmoneim",fullName:"Hanan Mohamed AbdElmoneim"}],corrections:null},{id:"53942",title:"Cardiac Toxicity of HER2-Directed Therapy in Women with Breast Cancer: Epidemiology, Etiology, Risk Factors, and Management",doi:"10.5772/66437",slug:"cardiac-toxicity-of-her2-directed-therapy-in-women-with-breast-cancer-epidemiology-etiology-risk-fac",totalDownloads:1578,totalCrossrefCites:1,totalDimensionsCites:1,hasAltmetrics:0,abstract:"The HER2-targeted therapy have profoundly changed the outcomes of women with HER2-positive breast cancers. Trastuzumab and pertuzumab, HER2-targeting monoclonal antibodies, lapatinib and Neratinib, small molecule inhibitors of HER2 and the epidermal growth factor receptor, and ado-trastuzumab emtansine, a HER2-positive directed antibody drug conjugate, are approved for the treatment of HER2-positive breast cancer.",signatures:"Shahid Ahmed, Arooba Talat, Nayyer Iqbal, Mohamed Emara, Duc\nLe, Amir Sami and Jim Xiang",downloadPdfUrl:"/chapter/pdf-download/53942",previewPdfUrl:"/chapter/pdf-preview/53942",authors:[{id:"178507",title:"Dr.",name:"Shahid",surname:"Ahmed",slug:"shahid-ahmed",fullName:"Shahid Ahmed"}],corrections:null},{id:"53499",title:"Aspects of Immediate and Delayed Alloplastic Breast Reconstruction After Mastectomy",doi:"10.5772/66876",slug:"aspects-of-immediate-and-delayed-alloplastic-breast-reconstruction-after-mastectomy",totalDownloads:1409,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Seventy percent of patients with early breast cancer can be treated by breast-conserving surgery, while the remaining 30% are forced to receive mastectomy. Nearly 30% of these patients choose breast reconstruction. In the last decade, new alternative techniques and improved surgical devices have significantly improved techniques for breast reconstruction that especially include immediate or delayed breast reconstruction with silicone implants as an excellent option. In general, implant reconstruction may be single- or two-stage procedures. Single-stage reconstruction is the preferred technique for patients with small breasts and minimal ptosis, while large breasts with ptosis require reduction mastopexy either combined with dermoglandular flap or with titane net for covering the caudal pole of the implant. Thus, excellent cosmetic results can be achieved. Recent studies showed a significant survival benefit for postmastectomy irradiation in nodal-positive patients, so that many candidates for breast reconstruction are irradiated with a higher probability of wound-healing complications after breast reconstruction and increased rates of other complications like capsular fibrosis.",signatures:"Michael Friedrich and Stefan Kraemer",downloadPdfUrl:"/chapter/pdf-download/53499",previewPdfUrl:"/chapter/pdf-preview/53499",authors:[{id:"189408",title:"Prof.",name:"Michael",surname:"Friedrich",slug:"michael-friedrich",fullName:"Michael Friedrich"},{id:"189826",title:"Prof.",name:"Stefan",surname:"Krämer",slug:"stefan-kramer",fullName:"Stefan Krämer"}],corrections:null},{id:"52933",title:"Internal Mammary Sentinel Lymph Node Biopsy",doi:"10.5772/66158",slug:"internal-mammary-sentinel-lymph-node-biopsy",totalDownloads:1393,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"The conception of internal mammary sentinel lymph node biopsy (IM‐SLNB) has been added to the 2009 American Joint Committee on Cancer breast cancer staging manual. However, there has still been slight variation in the surgical treatment model owing to the low visualization rate of internal mammary sentinel lymph nodes (IM‐SLN) with the traditional radiotracer injection technique. According to the hypothesis of IM‐SLN, a modified injection technique (periareolar intraparenchymal, high volume, and ultrasound guidance) was established, which could significantly improve the IM‐SLN visualization rate, and make the IM‐SLNB procedure possible in routine practice. IM‐SLNB could provide minimally invasive staging, prognosis, and decision‐making individually, especially for the patients with clinically positive axilla lymph nodes. Moreover, radiotherapy targeting on internal mammary lymph nodes (IMLN) should be tailored and balanced between the potential benefit and toxicity, and radiotherapy guided by IM‐SLNB could achieve this goal. In the era of emphasizing the effective adjuvant therapy, within the changing therapy approach—more systemic treatment, less loco‐regional treatment—oncologist should reconsider the application of regional IMLN therapy.",signatures:"Yong‐Sheng Wang, Peng‐Fei Qiu and Bin‐Bin Cong",downloadPdfUrl:"/chapter/pdf-download/52933",previewPdfUrl:"/chapter/pdf-preview/52933",authors:[{id:"189822",title:"Prof.",name:"Yong-Sheng",surname:"Wang",slug:"yong-sheng-wang",fullName:"Yong-Sheng Wang"},{id:"190524",title:"Dr.",name:"Peng-Fei",surname:"Qiu",slug:"peng-fei-qiu",fullName:"Peng-Fei Qiu"},{id:"190526",title:"Dr.",name:"Bin-Bin",surname:"Cong",slug:"bin-bin-cong",fullName:"Bin-Bin Cong"}],corrections:null},{id:"53532",title:"Nanobiotechnology for Breast Cancer Treatment",doi:"10.5772/66989",slug:"nanobiotechnology-for-breast-cancer-treatment",totalDownloads:2804,totalCrossrefCites:7,totalDimensionsCites:11,hasAltmetrics:0,abstract:"Despite many technological breakthroughs, even the best breast cancer treatments available today are not 100% effective. Chemotherapy has improved, but many drugs still do not reach the tumor site at effective doses and are often associated with high systemic toxicity and poor pharmacokinetics. Moreover, for many malignancies, diagnosis is obtainable only in metastatic stages of development, reducing the overall effectiveness of treatment. The choice of available treatments depends on tumor characteristics such as biomarkers, tumor size, metastatic disease, ligands, and antigen or endocrine receptor expression. Combined with surgical resection, chemotherapy and radiation remain the first line of treatment for patients with cancer. Even with these treatments, however, cancer continues to have high fatality rates and current therapeutic modalities have yet to significantly improve the often dismal prognosis of this disease. Nanotechnology is a highly focused approach, which may provide more effective and less toxic treatment when compared to chemotherapy. This area of research has emerged as cancer treatment in the form of new drugs and has reached promising results in preclinical and clinical trials proving its value as a potential tumor therapy.",signatures:"Márcia Rocha, Natalia Chaves and Sônia Báo",downloadPdfUrl:"/chapter/pdf-download/53532",previewPdfUrl:"/chapter/pdf-preview/53532",authors:[{id:"147895",title:"Dr.",name:"Sônia Nair",surname:"Báo",slug:"sonia-nair-bao",fullName:"Sônia Nair Báo"},{id:"190527",title:"MSc.",name:"Natalia",surname:"Chaves",slug:"natalia-chaves",fullName:"Natalia Chaves"},{id:"190529",title:"MSc.",name:"Marcia",surname:"Oliveira Da Rocha",slug:"marcia-oliveira-da-rocha",fullName:"Marcia Oliveira Da Rocha"}],corrections:null},{id:"53910",title:"Immunotherapeutic and Preventive Role of Purified Extract Rich in Beta-Glucans Derived from D-Fraction of Grifola frondosa Mushroom in Experimental Mice Biomodel of Mammary Carcinogenesis",doi:"10.5772/66890",slug:"immunotherapeutic-and-preventive-role-of-purified-extract-rich-in-beta-glucans-derived-from-d-fracti",totalDownloads:1402,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:1,abstract:"The overall vision of the modern science needs to change to a revalorization of the natural compounds and their beneficial effects on human diseases, such as cancer. Medicinal mushrooms have been used since thousands of years due to its healing properties. Maitake (Grifola frondosa) is presented as one of the most interesting medicinal mushrooms that have been studied. Until now, Maitake D-Fraction may have anticarcinogenic activity, preventing oncogenesis and metastasis in certain tumor types. However, the exact molecular mechanism by which D-Fraction acts are yet unknown. The results shown in this chapter suggest that Maitake D-Fraction Pro4X, administered intraperitoneally, prevents significantly the development of mammary tumorigenesis, increases survival, and reduces the process of angiogenesis in BALBc mice. Although yet to determine the active component of the extract and the molecular mechanism by which it operates in the breast carcinogenesis process. The socioeconomic impact of this research project could be important, considering that in Argentina similar studies using natural compounds derived from medicinal mushrooms for cancer therapy have not yet been performed. The beneficial effects of Maitake, if proven, could be useful for the treatment of cancer patients who are undergoing chemotherapy or radiation or for breast cancer prevention in high-risk population.",signatures:"Aguilera Braico, Diego Máximo and Gabriela Andrea Balogh",downloadPdfUrl:"/chapter/pdf-download/53910",previewPdfUrl:"/chapter/pdf-preview/53910",authors:[{id:"190412",title:"MSc.",name:"Diego",surname:"Aguilera Braico",slug:"diego-aguilera-braico",fullName:"Diego Aguilera Braico"},{id:"190413",title:"Dr.",name:"Gabriela",surname:"Balogh",slug:"gabriela-balogh",fullName:"Gabriela Balogh"}],corrections:null},{id:"53993",title:"Breast Cancer: From Transcriptional Control to Clinical Outcome",doi:"10.5772/66888",slug:"breast-cancer-from-transcriptional-control-to-clinical-outcome",totalDownloads:1608,totalCrossrefCites:0,totalDimensionsCites:1,hasAltmetrics:0,abstract:"Breast cancer is the most common malignancy in women worldwide. The risk of breast cancer in women increases with age, and this is partly attributable to the accumulation of genetic lesions. Growing evidence demonstrates the role played by epigenetic modifiers and the tumor microenvironment in contributing to the increased risk of breast cancer. This chapter provides a comprehensive overview of the epigenetic regulatory signatures that impact the well-studied signaling pathways in breast tissues. Additionally, we will also delve into the therapeutic and diagnostic potential of noncoding RNAs in breast cancer.",signatures:"Sudhakar Jha, Deepa Rajagopalan, Shainan Hora and Shweta\nPradip Jadhav",downloadPdfUrl:"/chapter/pdf-download/53993",previewPdfUrl:"/chapter/pdf-preview/53993",authors:[{id:"190426",title:"Dr.",name:"Sudhakar",surname:"Jha",slug:"sudhakar-jha",fullName:"Sudhakar Jha"}],corrections:null},{id:"54012",title:"Immune Regulation in Breast Cancer Metastasis and Immunotherapy",doi:"10.5772/66991",slug:"immune-regulation-in-breast-cancer-metastasis-and-immunotherapy",totalDownloads:1445,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"There are significant alterations in the tumor surrounding stromal cells in addition to the cancer cells in tumor microenvironment. Tumor cells can metastasize by acquiring the ability to escape immune control and surveillance. A decline in the ability of the immune cells to recognize and kill the tumor leads to tumor relapse or metastasis after primary treatment. Comprehensive review in this chapter will be conducted to further investigate into the mechanism of immune evasion in metastatic tumor microenvironment. The immune cells, stromal cells, extracellular matrix protein/component, and their interaction will be reviewed and summarized. Breast cancer has not been previously viewed as a particularly immunogenic type of tumor. Nevertheless, immune parameters have been increasingly studied in breast cancer, and accumulating data show that they are relevant for the development and progression of this tumor type. Consequently, immunotherapies of breast cancer are now tested in different clinical trials. The prospect of immunotherapy in metastatic breast cancer will be introduced. The importance of host‐targeted modulation/therapy will be increased in addition to cancer‐targeted strategies. We have to better define subpopulations of breast cancer patients to optimize the immunological way to overcome the cancer metastasis.",signatures:"Ming-Shen Dai",downloadPdfUrl:"/chapter/pdf-download/54012",previewPdfUrl:"/chapter/pdf-preview/54012",authors:[{id:"190480",title:"Dr.",name:"Ming-Shen",surname:"Dai",slug:"ming-shen-dai",fullName:"Ming-Shen Dai"}],corrections:null},{id:"53440",title:"Felt Needs for Rehabilitation After Breast Cancer Treatment in Mexico",doi:"10.5772/66436",slug:"felt-needs-for-rehabilitation-after-breast-cancer-treatment-in-mexico",totalDownloads:1448,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Breast cancer (BC) is the most frequent type of malignancy among women worldwide and the most common cause of mortality, particularly in low and middle‐income countries. As detection and treatment have improved, a larger number of surviving women need adequate rehabilitation after treatment. However, awareness among affected patients remains low. Thus, the aim of this study was to explore the needs and expectations concerning rehabilitation among Mexican women after breast surgery. An ethnographic approach was used. Eight focus groups were conducted in the north‐central state of San Luis Potosí, Mexico, in 2014, in which women under treatment and survivors participated. Results showed that women had insufficient and misleading information concerning the need for rehabilitation from health care authorities. Women seemed to focus more on survival than on quality of life after treatment even though impairments limiting their daily life activities caused frustration and feelings of uselessness. In conclusion, many women perceived the need for rehabilitation, but information was largely lacking. Public health services fail to provide rehabilitation services, which are now partially covered by private organizations. Treatment for breast cancer should be accompanied by rehabilitation. Awareness, availability and access to physiotherapy services need to be put in place.",signatures:"Viveka Hammelin, Luz María Tejada‐Tayabas, Dulce María Galarza‐\nTejada and Joel Monárrez‐Espino",downloadPdfUrl:"/chapter/pdf-download/53440",previewPdfUrl:"/chapter/pdf-preview/53440",authors:[{id:"190554",title:"Associate Prof.",name:"Joel",surname:"Monárrez-Espino",slug:"joel-monarrez-espino",fullName:"Joel Monárrez-Espino"}],corrections:null},{id:"53341",title:"Naringenin Inhibits Proliferation and Survival of Tamoxifen‐ Resistant Breast Cancer Cells",doi:"10.5772/66698",slug:"naringenin-inhibits-proliferation-and-survival-of-tamoxifen-resistant-breast-cancer-cells",totalDownloads:1529,totalCrossrefCites:4,totalDimensionsCites:7,hasAltmetrics:0,abstract:"The majority of breast cancers are estrogen receptor positive (ER+) and utilize estrogen to promote cell proliferation. Thus, the ER has been the target of many therapies. While this strategy has been successful, the long‐term use of antiestrogen therapies, such as tamoxifen (Tam), frequently results in Tam resistance (Tam‐R). Tam‐R cells may proliferate due to the activation of the phosphatidylinositol‐3 kinase (PI3K) and the mitogen‐activated protein kinase (MAPK) pathways. Targeting these proliferation and survival pathways after the development of resistance is critical for the treatment of drug‐resistant cancers. We have identified the flavanone Naringenin (Nar) as an inhibitor of both the PI3K and MAPK pathways. Here, we show that Nar impairs cell proliferation and induces apoptosis of Tam‐R MCF‐7 breast cancer cells. We also demonstrate that Nar treatment reduced the levels of both ERK and AKT in Tam‐R cells. Furthermore, Nar treatment localized ERα to a perinuclear region in Tam‐R cells. Nar may function by inhibiting both the PI3K and MAPK pathways as well as localizing ERα to the cytoplasm to impair cell proliferation of Tam‐R MCF‐7 cells. These studies provide insight into the molecular mechanisms involved in cell proliferation of Tam‐R breast cancer cells.",signatures:"Joseph Ramos, Talia Hatkevich, Lauren Eanes, Idalys Santos‐Sanchez\nand Yashomati M. Patel",downloadPdfUrl:"/chapter/pdf-download/53341",previewPdfUrl:"/chapter/pdf-preview/53341",authors:[{id:"192549",title:"Dr.",name:"Yashomati",surname:"Patel",slug:"yashomati-patel",fullName:"Yashomati Patel"}],corrections:null}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},subseries:null,tags:null},relatedBooks:[{type:"book",id:"5770",title:"Mesenchymal Stem Cells",subtitle:"Isolation, Characterization and Applications",isOpenForSubmission:!1,hash:"8d2f6e69167ad835f02cf8848065c202",slug:"mesenchymal-stem-cells-isolation-characterization-and-applications",bookSignature:"Phuc Van Pham",coverURL:"https://cdn.intechopen.com/books/images_new/5770.jpg",editedByType:"Edited by",editors:[{id:"28799",title:"Ph.D.",name:"Phuc Van",surname:"Pham",slug:"phuc-van-pham",fullName:"Phuc Van Pham"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"329",title:"Breast Cancer",subtitle:"Carcinogenesis, Cell Growth and Signalling Pathways",isOpenForSubmission:!1,hash:"ebf7902b7672e9142e56de2289bcaa5a",slug:"breast-cancer-carcinogenesis-cell-growth-and-signalling-pathways",bookSignature:"Mehmet Gunduz and Esra Gunduz",coverURL:"https://cdn.intechopen.com/books/images_new/329.jpg",editedByType:"Edited by",editors:[{id:"46056",title:"Prof.",name:"Mehmet",surname:"Gunduz",slug:"mehmet-gunduz",fullName:"Mehmet Gunduz"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1278",title:"Breast Cancer",subtitle:"Focusing Tumor Microenvironment, Stem cells and Metastasis",isOpenForSubmission:!1,hash:"bd2df7c338f309db645c7c183571f6a8",slug:"breast-cancer-focusing-tumor-microenvironment-stem-cells-and-metastasis",bookSignature:"Mehmet Gunduz and Esra Gunduz",coverURL:"https://cdn.intechopen.com/books/images_new/1278.jpg",editedByType:"Edited by",editors:[{id:"46056",title:"Prof.",name:"Mehmet",surname:"Gunduz",slug:"mehmet-gunduz",fullName:"Mehmet Gunduz"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1277",title:"Breast Cancer",subtitle:"Current and Alternative Therapeutic Modalities",isOpenForSubmission:!1,hash:"9c0bc3b171254b2a3f7d52bee5c559aa",slug:"breast-cancer-current-and-alternative-therapeutic-modalities",bookSignature:"Esra Gunduz and Mehmet Gunduz",coverURL:"https://cdn.intechopen.com/books/images_new/1277.jpg",editedByType:"Edited by",editors:[{id:"61074",title:"Dr.",name:"Esra",surname:"Gunduz",slug:"esra-gunduz",fullName:"Esra Gunduz"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2883",title:"Oncogene and Cancer",subtitle:"From Bench to Clinic",isOpenForSubmission:!1,hash:"ba08b50f799acf44d8d2f0f0c6c2e768",slug:"oncogene-and-cancer-from-bench-to-clinic",bookSignature:"Yahwardiah Siregar",coverURL:"https://cdn.intechopen.com/books/images_new/2883.jpg",editedByType:"Edited by",editors:[{id:"137622",title:"Dr.",name:"Yahwardiah",surname:"Siregar",slug:"yahwardiah-siregar",fullName:"Yahwardiah Siregar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1276",title:"Targeting New Pathways and Cell Death in Breast Cancer",subtitle:null,isOpenForSubmission:!1,hash:"e1541edf35e439e637938657d6ac482b",slug:"targeting-new-pathways-and-cell-death-in-breast-cancer",bookSignature:"Rebecca L. Aft",coverURL:"https://cdn.intechopen.com/books/images_new/1276.jpg",editedByType:"Edited by",editors:[{id:"45492",title:"Dr.",name:"Rebecca",surname:"Aft",slug:"rebecca-aft",fullName:"Rebecca Aft"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1310",title:"Topics in Cancer Survivorship",subtitle:null,isOpenForSubmission:!1,hash:"6ea3485c7d116f29327e36b78c5e9e6f",slug:"topics-in-cancer-survivorship",bookSignature:"Ravinder Mohan",coverURL:"https://cdn.intechopen.com/books/images_new/1310.jpg",editedByType:"Edited by",editors:[{id:"58197",title:"Prof.",name:"Ravinder",surname:"Mohan",slug:"ravinder-mohan",fullName:"Ravinder Mohan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1279",title:"Breast Cancer",subtitle:"Recent Advances in Biology, Imaging and Therapeutics",isOpenForSubmission:!1,hash:"eb213b69670bbf5c4c6ab643bb13c4d4",slug:"breast-cancer-recent-advances-in-biology-imaging-and-therapeutics",bookSignature:"Susan J. Done",coverURL:"https://cdn.intechopen.com/books/images_new/1279.jpg",editedByType:"Edited by",editors:[{id:"51859",title:"Dr.",name:"Susan",surname:"Done",slug:"susan-done",fullName:"Susan Done"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"4549",title:"A Concise Review of Molecular Pathology of Breast Cancer",subtitle:null,isOpenForSubmission:!1,hash:"defcba71c9acb69a0f9c99264c4856c5",slug:"a-concise-review-of-molecular-pathology-of-breast-cancer",bookSignature:"Mehmet Gunduz",coverURL:"https://cdn.intechopen.com/books/images_new/4549.jpg",editedByType:"Edited by",editors:[{id:"38384",title:"Prof.",name:"Mehmet",surname:"Gunduz",slug:"mehmet-gunduz",fullName:"Mehmet Gunduz"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6633",title:"Breast Cancer and Surgery",subtitle:null,isOpenForSubmission:!1,hash:"05f2f1a893b64cb77385aed5dd184fa1",slug:"breast-cancer-and-surgery",bookSignature:"Nilufer Bulut",coverURL:"https://cdn.intechopen.com/books/images_new/6633.jpg",editedByType:"Edited by",editors:[{id:"189255",title:"Associate Prof.",name:"Nilufer",surname:"Bulut",slug:"nilufer-bulut",fullName:"Nilufer Bulut"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],ofsBooks:[]},correction:{item:{id:"79356",slug:"corrigendum-to-aspects-regarding-thermal-mechanical-fatigue-of-shape-memory-alloys",title:"Corrigendum To: Aspects Regarding Thermal-Mechanical Fatigue of Shape Memory Alloys",doi:null,correctionPDFUrl:"https://cdn.intechopen.com/pdfs/80207.pdf",downloadPdfUrl:"/chapter/pdf-download/80207",previewPdfUrl:"/chapter/pdf-preview/80207",totalDownloads:null,totalCrossrefCites:null,bibtexUrl:"/chapter/bibtex/80207",risUrl:"/chapter/ris/80207",chapter:{id:"62954",slug:"aspects-regarding-thermal-mechanical-fatigue-of-shape-memory-alloys",signatures:"Petrică Vizureanu and Dragoș-Cristian Achiței",dateSubmitted:"April 12th 2018",dateReviewed:"April 25th 2018",datePrePublished:null,datePublished:"September 26th 2018",book:{id:"7213",title:"Shape-Memory Materials",subtitle:null,fullTitle:"Shape-Memory Materials",slug:"shape-memory-materials",publishedDate:"September 26th 2018",bookSignature:"Alicia Esther Ares",coverURL:"https://cdn.intechopen.com/books/images_new/7213.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"91095",title:"Dr.",name:"Alicia Esther",middleName:null,surname:"Ares",slug:"alicia-esther-ares",fullName:"Alicia Esther Ares"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"12354",title:"Prof.",name:"Petrică",middleName:null,surname:"Vizureanu",fullName:"Petrică Vizureanu",slug:"petrica-vizureanu",email:"peviz2002@yahoo.com",position:null,institution:{name:"Gheorghe Asachi Technical University of Iași",institutionURL:null,country:{name:"Romania"}}},{id:"209329",title:"Dr.",name:"Mirabela Georgiana",middleName:null,surname:"Minciuna",fullName:"Mirabela Georgiana Minciuna",slug:"mirabela-georgiana-minciuna",email:"mirabela.minciuna@yahoo.ro",position:null,institution:{name:"Gheorghe Asachi Technical University of Iași",institutionURL:null,country:{name:"Romania"}}},{id:"245668",title:"Dr.",name:"Dragos Cristian",middleName:null,surname:"Achitei",fullName:"Dragos Cristian Achitei",slug:"dragos-cristian-achitei",email:"dragos_adc@tuiasi.ro",position:null,institution:{name:"Gheorghe Asachi Technical University of Iași",institutionURL:null,country:{name:"Romania"}}},{id:"245669",title:"Dr.",name:"Manuela Cristina",middleName:null,surname:"Perju",fullName:"Manuela Cristina Perju",slug:"manuela-cristina-perju",email:"cryss_ela@yahoo.com",position:null,institution:null}]}},chapter:{id:"62954",slug:"aspects-regarding-thermal-mechanical-fatigue-of-shape-memory-alloys",signatures:"Petrică Vizureanu and Dragoș-Cristian Achiței",dateSubmitted:"April 12th 2018",dateReviewed:"April 25th 2018",datePrePublished:null,datePublished:"September 26th 2018",book:{id:"7213",title:"Shape-Memory Materials",subtitle:null,fullTitle:"Shape-Memory Materials",slug:"shape-memory-materials",publishedDate:"September 26th 2018",bookSignature:"Alicia Esther Ares",coverURL:"https://cdn.intechopen.com/books/images_new/7213.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"91095",title:"Dr.",name:"Alicia Esther",middleName:null,surname:"Ares",slug:"alicia-esther-ares",fullName:"Alicia Esther Ares"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"12354",title:"Prof.",name:"Petrică",middleName:null,surname:"Vizureanu",fullName:"Petrică Vizureanu",slug:"petrica-vizureanu",email:"peviz2002@yahoo.com",position:null,institution:{name:"Gheorghe Asachi Technical University of Iași",institutionURL:null,country:{name:"Romania"}}},{id:"209329",title:"Dr.",name:"Mirabela Georgiana",middleName:null,surname:"Minciuna",fullName:"Mirabela Georgiana Minciuna",slug:"mirabela-georgiana-minciuna",email:"mirabela.minciuna@yahoo.ro",position:null,institution:{name:"Gheorghe Asachi Technical University of Iași",institutionURL:null,country:{name:"Romania"}}},{id:"245668",title:"Dr.",name:"Dragos Cristian",middleName:null,surname:"Achitei",fullName:"Dragos Cristian Achitei",slug:"dragos-cristian-achitei",email:"dragos_adc@tuiasi.ro",position:null,institution:{name:"Gheorghe Asachi Technical University of Iași",institutionURL:null,country:{name:"Romania"}}},{id:"245669",title:"Dr.",name:"Manuela Cristina",middleName:null,surname:"Perju",fullName:"Manuela Cristina Perju",slug:"manuela-cristina-perju",email:"cryss_ela@yahoo.com",position:null,institution:null}]},book:{id:"7213",title:"Shape-Memory Materials",subtitle:null,fullTitle:"Shape-Memory Materials",slug:"shape-memory-materials",publishedDate:"September 26th 2018",bookSignature:"Alicia Esther Ares",coverURL:"https://cdn.intechopen.com/books/images_new/7213.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"91095",title:"Dr.",name:"Alicia Esther",middleName:null,surname:"Ares",slug:"alicia-esther-ares",fullName:"Alicia Esther Ares"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},ofsBook:{item:{type:"book",id:"1940",leadTitle:null,title:"Bio-Inspired Computational Algorithms and Their Applications",subtitle:null,reviewType:"peer-reviewed",abstract:"Bio-inspired computational algorithms are always hot research topics in artificial intelligence communities. Biology is a bewildering source of inspiration for the design of intelligent artifacts that are capable of efficient and autonomous operation in unknown and changing environments. It is difficult to resist the fascination of creating artifacts that display elements of lifelike intelligence, thus needing techniques for control, optimization, prediction, security, design, and so on. Bio-Inspired Computational Algorithms and Their Applications is a compendium that addresses this need. It integrates contrasting techniques of genetic algorithms, artificial immune systems, particle swarm optimization, and hybrid models to solve many real-world problems. The works presented in this book give insights into the creation of innovative improvements over algorithm performance, potential applications on various practical tasks, and combination of different techniques. The book provides a reference to researchers, practitioners, and students in both artificial intelligence and engineering communities, forming a foundation for the development of the field.",isbn:null,printIsbn:"978-953-51-0214-4",pdfIsbn:"978-953-51-5638-3",doi:"10.5772/2358",price:139,priceEur:155,priceUsd:179,slug:"bio-inspired-computational-algorithms-and-their-applications",numberOfPages:434,isOpenForSubmission:!1,isSalesforceBook:!1,isNomenclature:!1,hash:"9025a709550b508f98bdb47a9a856d89",bookSignature:"Shangce Gao",publishedDate:"March 7th 2012",coverURL:"https://cdn.intechopen.com/books/images_new/1940.jpg",keywords:null,numberOfDownloads:53746,numberOfWosCitations:41,numberOfCrossrefCitations:42,numberOfDimensionsCitations:63,numberOfTotalCitations:146,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"May 18th 2011",dateEndSecondStepPublish:"June 15th 2011",dateEndThirdStepPublish:"October 20th 2011",dateEndFourthStepPublish:"November 19th 2011",dateEndFifthStepPublish:"March 18th 2012",dateConfirmationOfParticipation:null,remainingDaysToSecondStep:"11 years",secondStepPassed:!0,areRegistrationsClosed:!0,currentStepOfPublishingProcess:5,editedByType:"Edited by",kuFlag:!1,biosketch:null,coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"111444",title:"Dr.",name:"Shangce",middleName:null,surname:"Gao",slug:"shangce-gao",fullName:"Shangce Gao",profilePictureURL:"https://mts.intechopen.com/storage/users/111444/images/2292_n.jpg",biography:"Shangce Gao received the B.S. degree from Southeast University, Nanjing, China in 2005, and the M.S. and Ph. D. degrees in intellectual information systems and Innovative life science from University of Toyama, Toyama, Japan in 2008 and 2011, respectively. From 2005 to 2006, he was a technical support engineer in Wicrosoft Co. Ltd., Shanghai, China. He has received the Outstanding Academic Performance Award of IEICE Hokuriku Branch in 2008, the Outstanding Self-financed Students Abroad Award of Chinese Government from China Scholarship Council in 2009, the Outstanding Academic Achievement Award of IPSJ Hokuriku Branch in 2011, and the Outstanding Doctoral Award of University of Toyama in 2011. He is currently an associate research fellow at the Key Laboratory of Embedded System and Service Computing, Ministry of Education, Tongji University, Shanghai 200092, China. His main research interests are intelligent computing and brain cognition.",institutionString:null,position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"0",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"University of Toyama",institutionURL:null,country:{name:"Japan"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"590",title:"Algorithm Analysis",slug:"numerical-analysis-and-scientific-computing-algorithm-analysis"}],chapters:[{id:"30226",title:"The Successive Zooming Genetic Algorithm and Its Applications",slug:"the-successive-zooming-genetic-algorithm-and-its-applications",totalDownloads:2619,totalCrossrefCites:0,authors:[{id:"108216",title:"Dr.",name:"Young-Doo",surname:"Kwon",slug:"young-doo-kwon",fullName:"Young-Doo Kwon"},{id:"108217",title:"Prof.",name:"Dae-Suep",surname:"Lee",slug:"dae-suep-lee",fullName:"Dae-Suep Lee"}]},{id:"30227",title:"The Network Operator Method for Search of the Most Suitable Mathematical Equation",slug:"the-network-operator-method-for-search-of-the-most-suitable-mathematical-equation",totalDownloads:2077,totalCrossrefCites:12,authors:[{id:"106991",title:"Prof.",name:"Askhat",surname:"Diveev",slug:"askhat-diveev",fullName:"Askhat Diveev"},{id:"136965",title:"Prof.",name:"Elena",surname:"Sofronova",slug:"elena-sofronova",fullName:"Elena Sofronova"}]},{id:"30228",title:"Performance of Simple Genetic Algorithm Inserting Forced Inheritance Mechanism and Parameters Relaxation",slug:"performance-of-simple-genetic-algorithm-inserting-forced-inheritance-mechanism-and-parameters-relaxa",totalDownloads:2324,totalCrossrefCites:0,authors:[{id:"107496",title:"Dr.",name:"Esther",surname:"Lugo-Gonzalez",slug:"esther-lugo-gonzalez",fullName:"Esther Lugo-Gonzalez"},{id:"138521",title:"Dr.",name:"Emmanuel Alejandro",surname:"Merchán-Cruz",slug:"emmanuel-alejandro-merchan-cruz",fullName:"Emmanuel Alejandro Merchán-Cruz"},{id:"138954",title:"Dr.",name:"Luis H",surname:"Hernandez-Gomez",slug:"luis-h-hernandez-gomez",fullName:"Luis H Hernandez-Gomez"},{id:"138955",title:"Dr.",name:"Christopher Rene",surname:"Torres-San Miguel",slug:"christopher-rene-torres-san-miguel",fullName:"Christopher Rene Torres-San Miguel"},{id:"138956",title:"Dr.",name:"Javier",surname:"Ramírez-Gordillo",slug:"javier-ramirez-gordillo",fullName:"Javier Ramírez-Gordillo"},{id:"138990",title:"Dr.",name:"Luis Héctor",surname:"Hernández-Gómez",slug:"luis-hector-hernandez-gomez",fullName:"Luis Héctor Hernández-Gómez"}]},{id:"30229",title:"The Roles of Crossover and Mutation in Real-Coded Genetic Algorithms",slug:"the-roles-of-crossover-and-mutation-in-real-coded-genetic-algorithms",totalDownloads:4135,totalCrossrefCites:9,authors:[{id:"116162",title:"Ms.",name:"Yourim",surname:"Yoon",slug:"yourim-yoon",fullName:"Yourim Yoon"},{id:"116167",title:"Prof.",name:"Yong-Hyuk",surname:"Kim",slug:"yong-hyuk-kim",fullName:"Yong-Hyuk Kim"}]},{id:"30230",title:"A Splicing/Decomposable Binary Encoding and Its Novel Operators for Genetic and Evolutionary Algorithms",slug:"a-splicing-decomposable-binary-encoding-and-its-novel-operators-for-genetic-and-evolutionary-algorit",totalDownloads:2510,totalCrossrefCites:0,authors:[{id:"117124",title:"Dr.",name:null,surname:"Liang",slug:"liang",fullName:"Liang"}]},{id:"30231",title:"Genetic Algorithms: An Overview with Applications in Evolvable Hardware",slug:"genetic-algorithms-an-overview",totalDownloads:3643,totalCrossrefCites:2,authors:[{id:"112519",title:"Dr.",name:"Rustem",surname:"Popa",slug:"rustem-popa",fullName:"Rustem Popa"}]},{id:"30232",title:"Tune Up of a Genetic Algorithm to Group Documentary Collections",slug:"tune-up-of-a-genetic-algorithm-to-group-documentary-collections",totalDownloads:2092,totalCrossrefCites:0,authors:[{id:"107049",title:"Dr.",name:"José Luis",surname:"Castillo Sequera",slug:"jose-luis-castillo-sequera",fullName:"José Luis Castillo Sequera"}]},{id:"30233",title:"Public Portfolio Selection Combining Genetic Algorithms and Mathematical Decision Analysis",slug:"public-portfolio-selection-combining-genetic-algorithms-and-mathematical-decision-analysis",totalDownloads:1921,totalCrossrefCites:2,authors:[{id:"115654",title:"Dr.",name:"Ines Fernando",surname:"Vega-Lopez",slug:"ines-fernando-vega-lopez",fullName:"Ines Fernando Vega-Lopez"},{id:"116331",title:"Dr.",name:"Eduardo",surname:"Fernandez-Gonzalez",slug:"eduardo-fernandez-gonzalez",fullName:"Eduardo Fernandez-Gonzalez"},{id:"136914",title:"Dr.",name:"Jorge A.",surname:"Navarro-Castillo",slug:"jorge-a.-navarro-castillo",fullName:"Jorge A. Navarro-Castillo"}]},{id:"30234",title:"The Search for Parameters and Solutions: Applying Genetic Algorithms on Astronomy and Engineering",slug:"the-search-for-parameters-and-solutions-applying-genetic-algorithms-on-astronomy-and-engineering",totalDownloads:2475,totalCrossrefCites:0,authors:[{id:"115139",title:"Dr",name:"Annibal",surname:"Hetem Jr.",slug:"annibal-hetem-jr.",fullName:"Annibal Hetem Jr."}]},{id:"30235",title:"Fusion of Visual and Thermal Images Using Genetic Algorithms",slug:"fusion-of-visual-and-thermal-images-using-genetic-algorithms",totalDownloads:2780,totalCrossrefCites:4,authors:[{id:"107239",title:"Dr.",name:"Sertan",surname:"Erkanli",slug:"sertan-erkanli",fullName:"Sertan Erkanli"},{id:"115693",title:"Mr.",name:"Ender",surname:"Oguslu",slug:"ender-oguslu",fullName:"Ender Oguslu"},{id:"115703",title:"Dr.",name:"Jiang",surname:"Li",slug:"jiang-li",fullName:"Jiang Li"}]},{id:"30236",title:"Self Adaptive Genetic Algorithms for Automated Linear Modelling of Time Series",slug:"self-adaptive-genetic-algorithms-for-automated-linear-modelling-of-time-series",totalDownloads:2432,totalCrossrefCites:0,authors:[{id:"11073",title:"Dr.",name:"Larysa",surname:"Burtseva",slug:"larysa-burtseva",fullName:"Larysa Burtseva"},{id:"108502",title:"Dr.",name:"Pedro",surname:"Flores",slug:"pedro-flores",fullName:"Pedro Flores"}]},{id:"30237",title:"Optimal Feature Generation with Genetic Algorithms and FLDR in a Restricted-Vocabulary Speech Recognition System",slug:"optimal-feature-generation-with-genetic-algorithms-and-fldr-in-a-restricted-vocabulary-speech-recogn",totalDownloads:2697,totalCrossrefCites:1,authors:[{id:"40993",title:"Dr.",name:"Miguel",surname:"Mora-González",slug:"miguel-mora-gonzalez",fullName:"Miguel Mora-González"},{id:"107230",title:"Dr",name:"Julio",surname:"Martinez-Romo",slug:"julio-martinez-romo",fullName:"Julio Martinez-Romo"},{id:"143075",title:"Dr.",name:"Francisco Javier",surname:"Luna-Rosas",slug:"francisco-javier-luna-rosas",fullName:"Francisco Javier Luna-Rosas"},{id:"143077",title:"Dr.",name:"Carlos Alejandro",surname:"De Luna-Ortega",slug:"carlos-alejandro-de-luna-ortega",fullName:"Carlos Alejandro De Luna-Ortega"},{id:"143078",title:"MSc.",name:"Valentin",surname:"López-Rivas",slug:"valentin-lopez-rivas",fullName:"Valentin López-Rivas"}]},{id:"30238",title:"Performance of Varying Genetic Algorithm Techniques in Online Auction",slug:"performance-of-varying-genetic-algorithm-techniques-in-online-auction",totalDownloads:2535,totalCrossrefCites:0,authors:[{id:"109656",title:"MSc.",name:"Kim Soon",surname:"Gan",slug:"kim-soon-gan",fullName:"Kim Soon Gan"}]},{id:"30239",title:"Mining Frequent Itemsets over Recent Data Stream Based on Genetic Algorithm",slug:"mining-frequent-itemsets-over-recent-data-stream-based-on-genetic-algorithm",totalDownloads:2789,totalCrossrefCites:2,authors:[{id:"117268",title:"Prof.",name:"Yong",surname:"Zhou",slug:"yong-zhou",fullName:"Yong Zhou"},{id:"152013",title:"Dr.",name:"Han",surname:"Jun",slug:"han-jun",fullName:"Han Jun"},{id:"152014",title:"Dr.",name:"Guo",surname:"He",slug:"guo-he",fullName:"Guo He"}]},{id:"30240",title:"Optimal Design of Power System Controller Using Breeder Genetic Algorithm",slug:"optimal-design-of-power-system-controller-using-breeder-genetic-algorithm",totalDownloads:2381,totalCrossrefCites:1,authors:[{id:"117273",title:"Prof.",name:"Komla",surname:"Folly",slug:"komla-folly",fullName:"Komla Folly"}]},{id:"30241",title:"On the Application of Optimal PWM of Induction Motor in Synchronous Machines at High Power Ratings",slug:"on-the-application-of-optimal-pwm-of-induction-motor-in-synchronous-machines-at-high-power-ratings",totalDownloads:1983,totalCrossrefCites:1,authors:[{id:"110031",title:"Mr.",name:"Arash",surname:"Sayyah",slug:"arash-sayyah",fullName:"Arash Sayyah"},{id:"115770",title:"Prof.",name:"Alireza",surname:"Rezazade",slug:"alireza-rezazade",fullName:"Alireza Rezazade"}]},{id:"30274",title:"Artificial Immune Systems, Dynamic Fitness Landscapes, and the Change Detection Problem",slug:"artificial-immune-systems-dynamic-fitness-landscapes-and-the-change-detection-problem",totalDownloads:1863,totalCrossrefCites:1,authors:[{id:"111200",title:"Prof.",name:"Hendrik",surname:"Richter",slug:"hendrik-richter",fullName:"Hendrik Richter"}]},{id:"30275",title:"Modelling the Innate Immune System",slug:"modelling-the-innate-immune-system",totalDownloads:2410,totalCrossrefCites:4,authors:[{id:"118743",title:"Prof.",name:"Marcelo",surname:"Lobosco",slug:"marcelo-lobosco",fullName:"Marcelo Lobosco"},{id:"118744",title:"Prof.",name:"Rodrigo",surname:"Weber Dos Santos",slug:"rodrigo-weber-dos-santos",fullName:"Rodrigo Weber Dos Santos"},{id:"118745",title:"MSc.",name:"Bárbara",surname:"De Melo Quintela",slug:"barbara-de-melo-quintela",fullName:"Bárbara De Melo Quintela"},{id:"118746",title:"MSc.",name:"Alexandre",surname:"Bittencourt Pigozzo",slug:"alexandre-bittencourt-pigozzo",fullName:"Alexandre Bittencourt Pigozzo"},{id:"118747",title:"Prof.",name:"Gilson",surname:"Macedo",slug:"gilson-macedo",fullName:"Gilson Macedo"},{id:"118748",title:"BSc.",name:"Pedro",surname:"Augusto Ferreira Rocha",slug:"pedro-augusto-ferreira-rocha",fullName:"Pedro Augusto Ferreira Rocha"}]},{id:"30276",title:"A Stochastically Perturbed Particle Swarm Optimization for Identical Parallel Machine Scheduling Problems",slug:"a-stochastically-perturbed-particle-swarm-optimization-for-identical-parallel-machine-scheduling-pro",totalDownloads:2225,totalCrossrefCites:1,authors:[{id:"109818",title:"Dr.",name:"Mehmet",surname:"Sevkli",slug:"mehmet-sevkli",fullName:"Mehmet Sevkli"},{id:"111077",title:"Dr.",name:"Zulal",surname:"Sevkli",slug:"zulal-sevkli",fullName:"Zulal Sevkli"}]},{id:"30277",title:"Performance Study of Cultural Algorithms Based on Genetic Algorithm with Single and Multi Population for the MKP",slug:"performance-study-of-cultural-algorithms-based-on-genetic-algorithm-with-single-and-multi-population",totalDownloads:3350,totalCrossrefCites:1,authors:[{id:"104669",title:"Dr.",name:"Otavio",surname:"Teixeira",slug:"otavio-teixeira",fullName:"Otavio Teixeira"},{id:"104698",title:"Mr.",name:"Roberto",surname:"Oliveira",slug:"roberto-oliveira",fullName:"Roberto Oliveira"},{id:"108034",title:"M.Sc.",name:"Deam",surname:"Da Silva",slug:"deam-da-silva",fullName:"Deam Da Silva"}]},{id:"30278",title:"Using a Genetic Algorithm to Solve the Benders’ Master Problem for Capacitated Plant Location",slug:"using-a-genetic-algorithm-to-solve-the-benders-master-problem-for-capacitated-plant-location",totalDownloads:2505,totalCrossrefCites:1,authors:[{id:"106984",title:"Prof.",name:"Hansuk",surname:"Sohn",slug:"hansuk-sohn",fullName:"Hansuk Sohn"}]}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:null},relatedBooks:[{type:"book",id:"14",title:"Traveling Salesman Problem",subtitle:"Theory and Applications",isOpenForSubmission:!1,hash:null,slug:"traveling-salesman-problem-theory-and-applications",bookSignature:"Donald Davendra",coverURL:"https://cdn.intechopen.com/books/images_new/14.jpg",editedByType:"Edited by",editors:[{id:"2961",title:"Prof.",name:"Donald",surname:"Davendra",slug:"donald-davendra",fullName:"Donald Davendra"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"98",title:"Evolutionary Algorithms",subtitle:null,isOpenForSubmission:!1,hash:"6816724ee9d4c10832441d90fd28a485",slug:"evolutionary-algorithms",bookSignature:"Eisuke Kita",coverURL:"https://cdn.intechopen.com/books/images_new/98.jpg",editedByType:"Edited by",editors:[{id:"22506",title:"Prof.",name:"Eisuke",surname:"Kita",slug:"eisuke-kita",fullName:"Eisuke Kita"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6119",title:"Advances in Evolutionary Algorithms",subtitle:null,isOpenForSubmission:!1,hash:"49e46daf06834416b65ddf059cae29f6",slug:"advances_in_evolutionary_algorithms",bookSignature:"Witold Kosinski",coverURL:"https://cdn.intechopen.com/books/images_new/6119.jpg",editedByType:"Edited by",editors:[{id:"6162",title:"Prof.",name:"Witold",surname:"Kosinski",slug:"witold-kosinski",fullName:"Witold Kosinski"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6121",title:"Greedy Algorithms",subtitle:null,isOpenForSubmission:!1,hash:"a7b8354916df79ba38188bafe59e3a89",slug:"greedy_algorithms",bookSignature:"Witold Bednorz",coverURL:"https://cdn.intechopen.com/books/images_new/6121.jpg",editedByType:"Edited by",editors:[{id:"130302",title:"PhD.",name:"Witold",surname:"Bednorz",slug:"witold-bednorz",fullName:"Witold Bednorz"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"89",title:"Search Algorithms and Applications",subtitle:null,isOpenForSubmission:!1,hash:"724aa705bd006317eaa0062212fd8b05",slug:"search-algorithms-and-applications",bookSignature:"Nashat Mansour",coverURL:"https://cdn.intechopen.com/books/images_new/89.jpg",editedByType:"Edited by",editors:[{id:"22053",title:"Prof.",name:"Nashat",surname:"Mansour",slug:"nashat-mansour",fullName:"Nashat Mansour"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6114",title:"Tabu Search",subtitle:null,isOpenForSubmission:!1,hash:"73a2322552a6c99a6dca22e9c604aff2",slug:"tabu_search",bookSignature:"Wassim Jaziri",coverURL:"https://cdn.intechopen.com/books/images_new/6114.jpg",editedByType:"Edited by",editors:[{id:"132091",title:"Prof.",name:"Jaziri",surname:"Wassim",slug:"jaziri-wassim",fullName:"Jaziri Wassim"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophile",surname:"Theophanides",slug:"theophile-theophanides",fullName:"Theophile Theophanides"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"56394",title:"Omental Flap in Breast Reconstruction",doi:"10.5772/intechopen.70115",slug:"omental-flap-in-breast-reconstruction",body:'
1. Historical background
The omentum is not just an abdominal structure, it is an unique organ with a peculiar location, shape, attachments, supply, and function. The omentum has a mechanical function as a barrier or sealant. It has an immune function and an endocrinal function through secreting many cytokines, growth factors, and hormones [1, 2]. Surgeons aimed to use this organ in many reconstructive procedures. The first use of a pedicled omental flap was reported by Senn in 1888 when he used it for protection of intestinal anastomosis [3]. More recently, the omentum was revisited by Knazozovicky in 1929 when he used the pedicled omentum after arthroplasty [4]. Due to its immune function, it was used for coverage of deep sternal and infected wounds as well as to protect anastomoses [5, 6]. The Romanian surgeon, Kiricuta described the use of the pedicled omental flap for repair of vesicovaginal fistula and for breast reconstruction after mastectomy [7, 8]. He reported on 10 cases of breast reconstruction after subcutaneous mastectomy with 40% pure omental reconstruction without any need for implants. This opened the gate for use of pedicled omental flap in breast reconstruction. The main two problems with this flap were the unpredictable volume [9, 10] and the requirement of laparotomy for retrieval. The latter was associated with potential morbidity especially in regards to the occurrence of incisional hernia [11]. Some researchers tried to extract this flap through a minilaparotomy; yet incisional hernia still remained a complication [12]. For this reason Saltz described omental flap retrieval through a laparoscopic approach [13]. Later on, there was a shift toward the laparoscopic retrieval with great success. The largest series was reported by Hisamitsu Zaha who performed around 200 cases of laparoscopically harvested omental flap (LHOF) with minimal complications and satisfactory aesthetic results [14]. Subsequently, to avoid any traction over the pedicle with added length of the pedicle to the total flap volume, a trend emerged toward usage of free omental flaps extracted through a small abdominal incision to avoid any traction over the pedicle with added length of the pedicle to the total flap volume [15, 16]. The first free omental flap was performed in an emergent basis to cover a large defect in the scalp after avulsion [15]. After that, its indications were widened and it was applied to several locations [17]. In this work, we shall try to answer the following question: is there a role for omental flap in breast reconstruction in the era of oncoplastic surgery?
2. Advantages of the omental flap
We can list several advantages of the omental flap [11, 12, 18]:
Easy harvest which is not technically demanding, and that is characterized by a short learning curve.
Minimal donor site morbidity especially with the use of laparoscopic harvesting.
Minimal blood loss.
Can be retrieved simultaneously with mastectomy by two teams with neither need for extra time nor for changing patient′s position for staged operations.
Fast recovery with early discharge especially with laparoscopic harvesting.
This flap is fatty in nature, so it mimics the normal breast and you can hardly differentiate in between even with the use of mammography (Figure 1).
Reliability of its axial blood supply with less common ischemic complications transverse rectus abdominis myocutaneous flap (TRAM) is a perforator flap with common ischemic complications and fat necrosis.
Great adaptability to any cavities.
Great malleability with ease in reshaping to mimic the breast mound.
It is a good reconstructive tool in obese women (its volume increases with weight gain) and can be retrieved with the laparoscope without major complications. On the other hand, obesity is a relative contraindication for TRAM flap and its ischemic complications increases in obese women.
Long pedicle which can be transferred easily to the mastectomy bed through an epigastric incision.
The flap is bipedicled and can be divided to work for both breasts simultaneously.
It has a characteristic absorptive power, so seroma is less evident and drain output is usually of lesser amount.
It is the only flap that shows a unique phenomenon of size gain, which is completed by the end of the sixth month. Other flaps (or lipofilling) usually undergo size decrease with progress of time due to either muscle atrophy or adipose tissue loss [19].
It has an immune function and good tissue adherence, so it can cover ischemic areas.
It is suitable for all ages, stages, body weights, and controllable comorbidities.
It has a very good tolerance for postoperative radiotherapy.
Surprisingly, if it is used as a cover for the silicone implants, capsular contracture, and rupture are rare [12].
Figure 1.
Mammographic view of the right breast reconstructed with an omental flap.
3. Limitations
The main drawback of this flap is the unpredictable volume, however if volume is insufficient [9, 11], it can be used safely as a cover for an implant.
It is not suitable for cases in which the whole breast with its skin is removed.
It may be deficient in thin women (implant can be used as an adjunct).
It is considered an abdominal operation with all hazards of laparoscopic use as bleeding, visceral injuries, and complications of laparoscopy.
Presence of adhesions may be a limiting factor.
Presence of peritoneal metastases or omental deposits may preclude flap retrieval.
3.1. Contraindications
The main contraindication is the presence of omental malignant nodules, omental cake, or malignant ascites [11].
If omentectomy was done for any reason.
Presence of marked abdominal adhesions that make retrieval difficult.
Contraindications of laparoscopy.
4. Anatomic considerations
The greater omentum is attached inferiorly to the transverse colon after making a loop over itself forming a four layer loop. Superiorly, it is attached to the greater curve of the stomach (Figure 2) [20, 21, 22].
Figure 2.
Layers and attachment of the greater omentum.
It has the advantage of having a dual blood supply from both gastroepiploic arteries (right epiploic from gastroduodenal and left from the splenic). Both form anterior and posterior epiploic arcades (Figure 3) and gives rise to anterior, posterior, and accessory epiploic arteries.
Figure 3.
Arterial supply of the greater omentum.
The flap pedicle can be based on either the right or the left gastroepiploic arteries (commonly the right) after dividing the contralateral artery (Figure 4). However, if a free flap is used, both vascular pedicles can be anastomosed to the branches of the axillary artery through a microvascular anastomosis.
Figure 4.
Pedicled omental flap based on the right gastroepiploic artery.
Moreover, the flap can be lengthened by dividing the anterior epiploic arteries keeping the anterior and posterior omental arcades (Figure 5).
Figure 5.
Lengthened omental flap (dotted division line).
5. Technique
The omentum may be retrieved through a small epigastric minilaparotomy (Figure 6) or through laparoscopy. Laparoscopic ports are usually infra‐umbilical; a 12 mm port just below the umbilicus for the camera and two 5 mm lateral ports for handling and dissection. Optional one or two 5 mm ports may be used in the upper right or left hypochondrium for omental retraction if it has a large volume (Figure 7).
Figure 6.
Omental flap retrieved through a small epigastric minilaparotmy.
Figure 7.
Laparoscopically retrieved omental flap with port sites demonstrated.
In laparoscopic harvest, it is preferable to start dissection with separation of the omentum from the colonic attachment to preserve the flap suspended from the greater curve (Figure 8).
Figure 8.
Separation of the greater omentum from the colonic attachment.
Then working in a counterclockwise direction, dissection is extended toward the left gastroepiploic artery which is sealed and divided either by harmonic scalpel or preferably by Ligasure as this device can control sizable vessels (Figure 9).
Figure 9.
Division of the left gastroepiploic artery.
Then, we start dividing the attachment to the greater curvature of the stomach up to the visualization of the right gastroepiploic artery within a fold (Figure 10).
Figure 10.
Division of attachments to the greater curvature.
The last step is a creation of an epigastric incision through the lower mastectomy flap, then a 12 mm trocar is introduced to grasp the distal tip of the freed omentum which is widened to 2–3 fingers width to allow transmission of the flap to the mastectomy bed (Figure 11).
Figure 11.
Grasping of the flap distal end to be transmitted into the mastectomy bed.
When the flap is transferred to the bed, it could be molded to fit to the breast envelope, then the flap should be fixed by few nonabsorbable sutures to the underlying muscles to avoid flap retraction into the abdomen. Care should be exercised to avoid injury of the vascular pedicle by these sutures. We prefer carrying mastectomy through a hidden inframammary incision close to the epigastrium. This allows delivery of the flap through the subcutaneous tunnel and enables us to obtain a very good cosmetic outcome “scarless procedure” (Figure 12). The problem with this incision is the relative higher ischemic complications, these can be avoided by testing its vascularity by either simple pricking, peripheral cutting or through dye techniques. However, any ischemia could be easily managed in the outpatient clinic with a very satisfactory cosmetic outcome.
Figure 12.
Inframammary incision to make a scarless procedure and to ease flap retrieval through the epigastric incision.
6. Volume insufficiency
In the largest reported series by the Japanese surgeon Hisamitsu Zaha that included 200 cases, volume insufficiency was around 30%; in such case, a silicone implant could be used as an adjunct with a very good aesthetic outcome (Figure 13) [14].
Figure 13.
Silicone implant as an adjunct with omental flap.
7. Pedicled versus free flaps
A free omental flap is recommended if remote coverage is required such as scalp avulsion, however there are advantages for free omental flap transfer in breast reconstruction, such as making benefit of the length of pedicle when added to the flap [16], ridding the patient of epigastric discomfort or pain due to passage of the pedicle through the tunnel, and finally minimal incidence of epigastric hernia consequent upon avoidance of the epigastric wound. This is especially so, if the omental flap is retrieved through a small Pfannenstiel incision or even through an epigastric wound which is completely closed.
8. Evaluation of flap integrity
Some authors leave a small window for this purpose, however the best way is to perform an intraoperative Doppler study and postoperative Duplex assessment (Figure 14).
Figure 14.
Duplex assessment showing an intact vascularity.
9. The aesthetic outcome
As reported by many authors, more than 80% of patients express an excellent aesthetic outcome [14]. Figures 15 and 16 show cases of skin sparing mastectomy (SSM) reconstructed with a pedicled omental flap. In Figure 15, retrieval was done through a minlaparotomy and in Figure 16 it was through a laparoscopic harvesting (LHOF) with a nearly scarless procedure.
Figure 15.
SSM which is reconstructed with pedicled omental flap through minilaparotomy.
Figure 16.
SSM which is reconstructed with laparoscopically harvested omental flap (LHOF).
10. Complications
10.1. General
Those of laparoscopy, as complications of the access, visceral injury, gas embolism, etc.
Chest complications.
Deep venous thrombosis (DVT) and pulmonary embolism.
10.2. Specific
Flap loss which may be either total or partial (partial loss may be minor or major that mandates surgical resection).
Traumatic fat necrosis.
Local sepsis that may end up with necrotizing fasciitis especially in poorly controlled diabetics; this may be another cause of flap loss.
Hemorrhage, either in the mastectomy bed or intra‐abdominal after flap retrieval. The most common abdominal sources are, the sealed left gastroepiploic vessels, short gastric vessels, or sealed vessels along the greater curve.
Epigastric discomfort or hernia due to passage of the pedicle through the epigastric tunnel.
Port site hernia after laparoscopic retrieval.
Seroma which is less common than with mastectomy alone due to the absorptive power of this flap.
11. Place of the omental flap in the era of oncoplastic surgery
This flap is ideal to solve the problem of volume replacement of medial quadrant volume replacement in cases of partial mastectomy for tumors in the medial quadrant. Moreover, it is a very good choice for total breast reconstruction after skin sparing mastectomy (SSM) especially in women with body mass index above the age of 30 years. This is particularly so, even if the volume is not adequate, because in such case it can be used to cover a silicone implant to avoid the capsular contracture and implant rupture.
12. Conclusion
Omental flap is a strong working horse in breast reconstruction after partial or skin sparing mastectomy. It can be free or pedicled. It could be retrieved by a minilaparotomy or preferably by laparoscopic harvesting (LHOF). It is a simple, safe, and reliable flap that mimics the natural contour of the breast. In about 30% of cases with volume insufficiency, it can be used with an implant as a cover with low complication rate and good aesthetic outcome.
\n',keywords:"breast, reconstruction, omental flap, mastectomy",chapterPDFUrl:"https://cdn.intechopen.com/pdfs/56394.pdf",chapterXML:"https://mts.intechopen.com/source/xml/56394.xml",downloadPdfUrl:"/chapter/pdf-download/56394",previewPdfUrl:"/chapter/pdf-preview/56394",totalDownloads:1258,totalViews:282,totalCrossrefCites:0,totalDimensionsCites:1,totalAltmetricsMentions:0,introChapter:null,impactScore:1,impactScorePercentile:67,impactScoreQuartile:3,hasAltmetrics:0,dateSubmitted:"October 31st 2016",dateReviewed:"June 13th 2017",datePrePublished:"December 20th 2017",datePublished:"April 18th 2018",dateFinished:"July 11th 2017",readingETA:"0",abstract:"Objectives: The use of omental flap for breast reconstruction was reported by the Romanian surgeon Kiricuta in 1963, since that time some surgeons tried to use the omentum either pedicled or free for breast reconstruction. It can be used after partial or total mastectomy.",reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/56394",risUrl:"/chapter/ris/56394",book:{id:"5927",slug:"issues-in-flap-surgery"},signatures:"Ashraf Khater, Adel Fathi and Hosam Ghazy",authors:[{id:"200042",title:"Ph.D.",name:"Ashraf",middleName:null,surname:"Khater",fullName:"Ashraf Khater",slug:"ashraf-khater",email:"dr.ashrafkhater@yahoo.com",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:{name:"Mansoura University",institutionURL:null,country:{name:"Egypt"}}},{id:"205795",title:"Dr.",name:"Adel",middleName:null,surname:"Fathi",fullName:"Adel Fathi",slug:"adel-fathi",email:"dr_adel_fathe@hotmail.com",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:{name:"Mansoura University",institutionURL:null,country:{name:"Egypt"}}},{id:"205796",title:"Dr.",name:"Hosam",middleName:null,surname:"Ghazy",fullName:"Hosam Ghazy",slug:"hosam-ghazy",email:"hosamelbanna@hotmail.com",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:{name:"Mansoura University",institutionURL:null,country:{name:"Egypt"}}}],sections:[{id:"sec_1",title:"1. Historical background",level:"1"},{id:"sec_2",title:"2. Advantages of the omental flap",level:"1"},{id:"sec_3",title:"3. Limitations",level:"1"},{id:"sec_3_2",title:"3.1. Contraindications",level:"2"},{id:"sec_5",title:"4. Anatomic considerations",level:"1"},{id:"sec_6",title:"5. Technique",level:"1"},{id:"sec_7",title:"6. Volume insufficiency",level:"1"},{id:"sec_8",title:"7. Pedicled versus free flaps",level:"1"},{id:"sec_9",title:"8. Evaluation of flap integrity",level:"1"},{id:"sec_10",title:"9. The aesthetic outcome",level:"1"},{id:"sec_11",title:"10. Complications",level:"1"},{id:"sec_11_2",title:"10.1. General",level:"2"},{id:"sec_12_2",title:"10.2. Specific",level:"2"},{id:"sec_14",title:"11. Place of the omental flap in the era of oncoplastic surgery",level:"1"},{id:"sec_15",title:"12. Conclusion",level:"1"}],chapterReferences:[{id:"B1",body:'Smitka K, Marešová D. Adipose tissue as an endocrine organ: An update on pro‐inflammatory and anti‐inflammatory microenvironment. Prague Medical Report. 2015;116:(2):87‐111'},{id:"B2",body:'Fonseca‐Alaniz MH. Takada J. Alonso‐Vale MI, Lima FB. The adipose tissue as a regulatory center of the metabolism. Arquivos Brasileiros de Endocrinologia & Metabologia. 2006;50:216‐229'},{id:"B3",body:'Senn N. An experimental contribution to intestinal surgery, with special reference to the treatment of intestinal obstruction (concluded). Annals of Surgery. 1888;7:421‐430'},{id:"B4",body:'Lieberman‐Meffert D, White H. The Greater Omentum: Anatomy, Physiology, Pathology, Surgery, with a Historical Survey. New York: Springer; 1983'},{id:"B5",body:'Irons GB, Witzke DJ, Arnold PG, Wood MB. Use of the omental free flap for soft‐tissue reconstruction. Annals of Plastic Surgery. 1983;11(6):501‐507'},{id:"B6",body:'Parissis H, Al‐Alao B, Soo A, Orr D, Young V. Risk analysis and outcome of mediastinal wound and deep mediastinal wound infections with specific emphasis to omental transposition. Journal of Cardiothoracic Surgery. Sep 2011;6:111'},{id:"B7",body:'Kiricuta I. The use of the great omentum in the surgery of breast cancer. La Presse Médicale. 1963;5:15‐17'},{id:"B8",body:'Kiricuta I, Goldstein AM. The repair of extensive vesicovaginal fistulas with pedicled omentum: A review of 27 cases. The Journal of Urology. 1972;108:724‐727'},{id:"B9",body:'Cothier‐Savey I, Tamtawi B, Franck D, et al. Immediate breast reconstruction using laparoscopically harvested omental flap. Plastic and Reconstructive Surgery. 2001;107:1156‐1163'},{id:"B10",body:'Zaha H, Inamine S, Naito T, Nomura H. Laparoscopically harvested omental flap for immediate breast reconstruction. The American Journal of Surgery. Oct 2006;192(4):556‐558'},{id:"B11",body:'Zaha H, Inamine S. Laparoscopically harvested omental flap: Results for 96 patients. Surgical Endoscopy. 2010;24:103‐107'},{id:"B12",body:'Khater A. Erratum to: Evaluation of pedicled omental flap delivered through a minilaparotomy for immediate breast reconstruction in obese patients. Aesthetic Plastic Surgery. 2014;38:482'},{id:"B13",body:'Saltz R, Stowers R, Smith M, Gadacz TR. Laparoscopically harvested omental free flap to cover a large soft tissue defect. Annals of Surgery. 1993;217(5):542‐546; discussion 6‐7'},{id:"B14",body:'Zaha H, Abe N, Sagawa N, Unesoko M. Oncoplastic surgery with omental flap reconstruction: A study of 200 cases. Breast Cancer Research and Treatment. Jan 24, 2017;162(2):267‐274. DOI: 10.1007/s10549‐017‐4124‐9. [Epub ahead of print]'},{id:"B15",body:'McLean DH, Buncke HJ. Autotransplant of omentum to a large scalp defect, with microsurgical revascularization. Plastic and Reconstructive Surgery. 1972;49(3):268‐274'},{id:"B16",body:'Gomez JA, Pascal SG, Michel S, Mitchel H, Richard L. Free omental flap for skin‐sparing breast reconstruction harvested laparoscopically. Plastic & Reconstructive Surgery. 2002;110(2):545‐551'},{id:"B17",body:'Losken A, Carlson GW, Culbertson JH, Scott Hultman C, Kumar AV, Jones GE, Bostwick 3rd J, Jurkiewicz MJ. Omental free flap reconstruction in complex head and neck deformities. Head & Neck. Apr 2002;24(4):326‐331'},{id:"B18",body:'Costa SS, Blotta RM, Mariano MB, Meurer L, Edelweiss MIA. Laparoscopic treatment of Poland’s syndrome using the omentum flap technique. Clinics Sao Paulo. 2010;65(4):401‐406'},{id:"B19",body:'Costa SS, Blotta RM, Meurer L, Edelweiss MIA. Adipocyte morphometric evaluation and angiogenesis in the omentum transposed to the breast: A preliminary study. Clinics Sao Paulo. Feb 2011;66(2):307‐312'},{id:"B20",body:'Skandalakis JE, Colborn GL, Weidman TA, Foster Jr RS, Kingsnorth AN, et al. Surgical Anatomy: The Embryologic and Anatomic Basis of Modern Surgery. Chapter 10. Peritoneum, Omenta, and Internal Hernias. Athens, Greece: Paschalidis Medical Publications; 2004'},{id:"B21",body:'Nakao K, Miyata M, Ito T, et al. Omental transposition and skin graft in patients for advanced or recurrent breast cancer. The Japanese Journal of Surgery. 1986;16:112'},{id:"B22",body:'Samson R, Pasternak BM. Current status of surgery of the omentum. Surgery, Gynecology & Obstetrics. 1979;149:437'}],footnotes:[],contributors:[{corresp:"yes",contributorFullName:"Ashraf Khater",address:"dr.ashrafkhater@yahoo.com",affiliation:'
Department of Surgical Oncology, Faculty of Medicine, Mansoura Oncology Center (OCMU), Mansoura University, Egypt
General Surgery Department, Mansoura University Hospital, Mansoura University, Egypt
'}],corrections:null},book:{id:"5927",type:"book",title:"Issues in Flap Surgery",subtitle:null,fullTitle:"Issues in Flap Surgery",slug:"issues-in-flap-surgery",publishedDate:"April 18th 2018",bookSignature:"Sherif Amr",coverURL:"https://cdn.intechopen.com/books/images_new/5927.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",isbn:"978-1-78923-013-0",printIsbn:"978-1-78923-012-3",pdfIsbn:"978-1-83881-258-4",reviewType:"peer-reviewed",numberOfWosCitations:3,isAvailableForWebshopOrdering:!0,editors:[{id:"179930",title:"Prof.",name:"Sherif",middleName:null,surname:"Amr",slug:"sherif-amr",fullName:"Sherif Amr"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"1149"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"56356",type:"chapter",title:"Plasma Cytokine and Growth Factor Profiling during Free Flap Transplantation",slug:"plasma-cytokine-and-growth-factor-profiling-during-free-flap-transplantation",totalDownloads:923,totalCrossrefCites:0,signatures:"Juliane C. Finke, Jingzhi Yang, Marius Bredell, Uwe von Fritschen\nand Michael O. Glocker",reviewType:"peer-reviewed",authors:[{id:"205811",title:"Dr.",name:"Michael",middleName:null,surname:"O. Glocker",fullName:"Michael O. Glocker",slug:"michael-o.-glocker"},{id:"205812",title:"Dr.",name:"Juliane C.",middleName:null,surname:"Finke",fullName:"Juliane C. Finke",slug:"juliane-c.-finke"},{id:"205813",title:"MSc.",name:"Jingzhi",middleName:null,surname:"Yang",fullName:"Jingzhi Yang",slug:"jingzhi-yang"},{id:"205814",title:"Dr.",name:"Marius",middleName:null,surname:"Bredell",fullName:"Marius Bredell",slug:"marius-bredell"},{id:"205815",title:"Dr.",name:"Uwe",middleName:null,surname:"Von Fritschen",fullName:"Uwe Von Fritschen",slug:"uwe-von-fritschen"}]},{id:"56213",type:"chapter",title:"Experimental Rat Flap Models",slug:"experimental-rat-flap-models",totalDownloads:1129,totalCrossrefCites:0,signatures:"Merdan Serin and Mehmet Bayramicli",reviewType:"peer-reviewed",authors:[{id:"199977",title:"Dr.",name:"Merdan",middleName:null,surname:"Serin",fullName:"Merdan Serin",slug:"merdan-serin"}]},{id:"57249",type:"chapter",title:"Perforator Flaps: Principles and Techniques",slug:"perforator-flaps-principles-and-techniques",totalDownloads:1780,totalCrossrefCites:1,signatures:"Goktekin Tenekeci",reviewType:"peer-reviewed",authors:[{id:"200651",title:"M.D.",name:"Goktekin",middleName:null,surname:"Tenekeci",fullName:"Goktekin Tenekeci",slug:"goktekin-tenekeci"}]},{id:"55847",type:"chapter",title:"Application of Free Flow‐Through Anterolateral Thigh Flap for the Reconstruction of an Extremity Soft Tissue Defect Requiring Vascularization",slug:"application-of-free-flow-through-anterolateral-thigh-flap-for-the-reconstruction-of-an-extremity-sof",totalDownloads:1343,totalCrossrefCites:2,signatures:"Masaki Fujioka",reviewType:"peer-reviewed",authors:[{id:"53197",title:"Prof.",name:"Masaki",middleName:null,surname:"Fujioka",fullName:"Masaki Fujioka",slug:"masaki-fujioka"}]},{id:"56466",type:"chapter",title:"Emergent or Early Flap Resurfacing Is Required for Bone- Exposing Wounds of Gustilo-Anderson IIIB and IIIC Fractures",slug:"emergent-or-early-flap-resurfacing-is-required-for-bone-exposing-wounds-of-gustilo-anderson-iiib-and",totalDownloads:1046,totalCrossrefCites:1,signatures:"Masaki Fujioka",reviewType:"peer-reviewed",authors:[{id:"53197",title:"Prof.",name:"Masaki",middleName:null,surname:"Fujioka",fullName:"Masaki Fujioka",slug:"masaki-fujioka"}]},{id:"56555",type:"chapter",title:"Reconstruction for Mandibular Implant Failure",slug:"reconstruction-for-mandibular-implant-failure",totalDownloads:984,totalCrossrefCites:1,signatures:"Shih-Heng Chen, Hao-Chih Tai, Tai-Ju Cheng, Hung-Chi Chen, An-Ta\nKo, Tyng-Luan Roan, Yo-Shen Chen and Yueh-Bih Tang",reviewType:"peer-reviewed",authors:[{id:"202122",title:"Prof.",name:"Yueh-Bih",middleName:null,surname:"Tang",fullName:"Yueh-Bih Tang",slug:"yueh-bih-tang"}]},{id:"60418",type:"chapter",title:"Hand Coverage",slug:"hand-coverage",totalDownloads:1648,totalCrossrefCites:1,signatures:"Francisco Martinez Martinez, M. Llanos Guerrero Navarro, Juan\nGarcia Navarro, Alberto Gimenez Ros and Alba Izquierdo\nRobledano",reviewType:"peer-reviewed",authors:[{id:"219563",title:"Dr.",name:"Francisco",middleName:null,surname:"Martinez Martinez",fullName:"Francisco Martinez Martinez",slug:"francisco-martinez-martinez"},{id:"222714",title:"Dr.",name:"Maria Llanos",middleName:null,surname:"Guerrero Navarro",fullName:"Maria Llanos Guerrero Navarro",slug:"maria-llanos-guerrero-navarro"},{id:"222914",title:"Dr.",name:"Juan",middleName:null,surname:"García Navarro",fullName:"Juan García Navarro",slug:"juan-garcia-navarro"},{id:"222915",title:"Dr.",name:"Alberto",middleName:null,surname:"Gimenez Ros",fullName:"Alberto Gimenez Ros",slug:"alberto-gimenez-ros"},{id:"222916",title:"Dr.",name:"Alba",middleName:null,surname:"Izquierdo Robledano",fullName:"Alba Izquierdo Robledano",slug:"alba-izquierdo-robledano"}]},{id:"56394",type:"chapter",title:"Omental Flap in Breast Reconstruction",slug:"omental-flap-in-breast-reconstruction",totalDownloads:1258,totalCrossrefCites:0,signatures:"Ashraf Khater, Adel Fathi and Hosam Ghazy",reviewType:"peer-reviewed",authors:[{id:"200042",title:"Ph.D.",name:"Ashraf",middleName:null,surname:"Khater",fullName:"Ashraf Khater",slug:"ashraf-khater"},{id:"205795",title:"Dr.",name:"Adel",middleName:null,surname:"Fathi",fullName:"Adel Fathi",slug:"adel-fathi"},{id:"205796",title:"Dr.",name:"Hosam",middleName:null,surname:"Ghazy",fullName:"Hosam Ghazy",slug:"hosam-ghazy"}]},{id:"56236",type:"chapter",title:"An Overview of Hypospadias Surgery",slug:"an-overview-of-hypospadias-surgery",totalDownloads:1513,totalCrossrefCites:1,signatures:"Wenceslao M. Calonge and Gianluca Sapino",reviewType:"peer-reviewed",authors:[{id:"202013",title:"M.D.",name:"Wenceslao M",middleName:null,surname:"Calonge",fullName:"Wenceslao M Calonge",slug:"wenceslao-m-calonge"},{id:"205276",title:"Dr.",name:"Gianluca",middleName:null,surname:"Sapino",fullName:"Gianluca Sapino",slug:"gianluca-sapino"}]}]},relatedBooks:[{type:"book",id:"2988",title:"A Textbook of Advanced Oral and Maxillofacial Surgery",subtitle:null,isOpenForSubmission:!1,hash:"b5d9f2be309d43646fca5ce2cd1e3d19",slug:"a-textbook-of-advanced-oral-and-maxillofacial-surgery",bookSignature:"Mohammad Hosein Kalantar Motamedi",coverURL:"https://cdn.intechopen.com/books/images_new/2988.jpg",editedByType:"Edited by",editors:[{id:"90148",title:"Dr.",name:"Mohammad Hosein",surname:"Motamedi",slug:"mohammad-hosein-motamedi",fullName:"Mohammad Hosein Motamedi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"44949",title:"Complications Following Surgery of Impacted Teeth and Their Management",slug:"complications-following-surgery-of-impacted-teeth-and-their-management",signatures:"Çetin Kasapoğlu, Amila Brkić, Banu Gürkan-Köseoğlu and Hülya\nKoçak-Berberoğlu",authors:[{id:"111192",title:"Ph.D.",name:"Amila",middleName:null,surname:"Brkic",fullName:"Amila Brkic",slug:"amila-brkic"},{id:"160519",title:"Prof.",name:"Banu",middleName:null,surname:"Gürkan-Köseoğlu",fullName:"Banu Gürkan-Köseoğlu",slug:"banu-gurkan-koseoglu"},{id:"160520",title:"Prof.",name:"Hülya",middleName:null,surname:"Koçak-Berberoğlu",fullName:"Hülya Koçak-Berberoğlu",slug:"hulya-kocak-berberoglu"},{id:"160522",title:"Prof.",name:"Çetin",middleName:null,surname:"Kasapoğlu",fullName:"Çetin Kasapoğlu",slug:"cetin-kasapoglu"}]},{id:"44967",title:"New Concepts in Impacted Third Molar Surgery",slug:"new-concepts-in-impacted-third-molar-surgery",signatures:"Mohammad Hosein Kalantar Motamedi and Farshid Kavandi",authors:[{id:"166975",title:"Dr.",name:"Farshid",middleName:null,surname:"Kavandi",fullName:"Farshid Kavandi",slug:"farshid-kavandi"}]},{id:"44950",title:"Odontogenic Infections",slug:"odontogenic-infections",signatures:"Onur Gonul, Sertac Aktop, Tulin Satilmis, Hasan Garip and Kamil\nGoker",authors:[{id:"86656",title:"Dr.",name:"Hasan",middleName:null,surname:"Garip",fullName:"Hasan Garip",slug:"hasan-garip"},{id:"87174",title:"Dr.",name:"Tülin",middleName:null,surname:"Satılmış",fullName:"Tülin Satılmış",slug:"tulin-satilmis"},{id:"87224",title:"Prof.",name:"Kamil",middleName:null,surname:"Göker",fullName:"Kamil Göker",slug:"kamil-goker"},{id:"166953",title:"Dr.",name:"Sertac",middleName:null,surname:"Aktop",fullName:"Sertac Aktop",slug:"sertac-aktop"},{id:"166970",title:"Dr.",name:"Onur",middleName:null,surname:"Gonul",fullName:"Onur Gonul",slug:"onur-gonul"}]},{id:"41009",title:"Non-Odontogenic Oral and Maxillofacial Infections",slug:"non-odontogenic-oral-and-maxillofacial-infections",signatures:"Petr Schütz and Hussein Hassan Hamed Ibrahim",authors:[{id:"154334",title:"Dr.",name:"Petr",middleName:null,surname:"Schütz",fullName:"Petr Schütz",slug:"petr-schutz"},{id:"166898",title:"Dr.",name:"Hussein Hassan Hamed",middleName:null,surname:"Ibrahim",fullName:"Hussein Hassan Hamed Ibrahim",slug:"hussein-hassan-hamed-ibrahim"}]},{id:"44249",title:"Diagnosis and Management of Common Oral and Maxillofacial Lesions",slug:"diagnosis-and-management-of-common-oral-and-maxillofacial-lesions",signatures:"Taghi Azizi",authors:[{id:"166841",title:"Dr.",name:"Taghi",middleName:null,surname:"Azizi",fullName:"Taghi Azizi",slug:"taghi-azizi"}]},{id:"44992",title:"Treatment of Large Cysts of the Mandible with Autografts of Cancellous Bone from the Tibia",slug:"treatment-of-large-cysts-of-the-mandible-with-autografts-of-cancellous-bone-from-the-tibia",signatures:"Piotr Malara",authors:[{id:"152421",title:"Prof.",name:"Piotr",middleName:null,surname:"Malara",fullName:"Piotr Malara",slug:"piotr-malara"}]},{id:"44277",title:"Keratocystic Odontogenic Tumors – Clinical and Molecular Features",slug:"keratocystic-odontogenic-tumors-clinical-and-molecular-features",signatures:"Miroslav Andrić, Božidar Brković, Vladimir Jurišić, Milan Jurišić and\nJelena Milašin",authors:[{id:"49081",title:"Dr.",name:"Miroslav",middleName:null,surname:"Andric",fullName:"Miroslav Andric",slug:"miroslav-andric"},{id:"64273",title:"Dr.",name:"Jelena",middleName:null,surname:"Milašin",fullName:"Jelena Milašin",slug:"jelena-milasin"},{id:"84391",title:"Prof.",name:"Vladimir",middleName:null,surname:"Jurisic",fullName:"Vladimir Jurisic",slug:"vladimir-jurisic"},{id:"162943",title:"Dr.",name:"Bozidar",middleName:null,surname:"Brkovic",fullName:"Bozidar Brkovic",slug:"bozidar-brkovic"},{id:"162944",title:"Prof.",name:"Milan",middleName:null,surname:"Jurisic",fullName:"Milan Jurisic",slug:"milan-jurisic"}]},{id:"44951",title:"Marsupialization of Keratocystic Odontogenic Tumors of the Mandible: Longitudinal Image Analysis of Tumor Size via 3D Visualized CT Scans",slug:"marsupialization-of-keratocystic-odontogenic-tumors-of-the-mandible-longitudinal-image-analysis-of-t",signatures:"Hajime Shudou, Masanori Sasaki, Takahiro Yamashiro, Shizuo\nTsunomachi, Yasuharu Takenoshita, Yasutaka Kubota, Tomohiro\nNinomiya, Toshiyuki Kawazu and Yoshihide Mori",authors:[{id:"160624",title:"Dr.",name:"Hajime",middleName:null,surname:"Shudou",fullName:"Hajime Shudou",slug:"hajime-shudou"}]},{id:"44968",title:"Radiation and Chemotherapy in Oral and Maxillofacial Surgery",slug:"radiation-and-chemotherapy-in-oral-and-maxillofacial-surgery",signatures:"Orett E. Ogle and Levon Nikoyan",authors:[{id:"154754",title:"Dr.",name:"Orrett",middleName:null,surname:"Ogle",fullName:"Orrett Ogle",slug:"orrett-ogle"},{id:"163742",title:"Dr.",name:"Levon",middleName:null,surname:"Nikoyan",fullName:"Levon Nikoyan",slug:"levon-nikoyan"}]},{id:"42180",title:"Bisphosphonate-Related Osteonecrosis of the Jaws – Diagnosis and Management",slug:"bisphosphonate-related-osteonecrosis-of-the-jaws-diagnosis-and-management",signatures:"Petia F. Pechalova, Elena G. Poriazova, Nikolai V. Pavlov and Angel\nG. Bakardjiev",authors:[{id:"163314",title:"Associate Prof.",name:"Petia",middleName:null,surname:"Pechalova",fullName:"Petia Pechalova",slug:"petia-pechalova"},{id:"163316",title:"Dr.",name:"Elena",middleName:null,surname:"Poriazova",fullName:"Elena Poriazova",slug:"elena-poriazova"},{id:"163317",title:"Dr.",name:"Nikolai",middleName:null,surname:"Pavlov",fullName:"Nikolai Pavlov",slug:"nikolai-pavlov"},{id:"163318",title:"Prof.",name:"Angel",middleName:"Georgiev",surname:"Bakardjiev",fullName:"Angel Bakardjiev",slug:"angel-bakardjiev"}]},{id:"45010",title:"Vascular Anomalies of the Maxillofacial Region: Diagnosis and Management",slug:"vascular-anomalies-of-the-maxillofacial-region-diagnosis-and-management",signatures:"Faris Fočo and Amila Brkić",authors:[{id:"111192",title:"Ph.D.",name:"Amila",middleName:null,surname:"Brkic",fullName:"Amila Brkic",slug:"amila-brkic"},{id:"162762",title:"Prof.",name:"Faris",middleName:null,surname:"Fočo",fullName:"Faris Fočo",slug:"faris-foco"}]},{id:"44494",title:"Applications of Low Level Laser Therapy",slug:"applications-of-low-level-laser-therapy",signatures:"Vanja Vučićević Boras, Danica Vidović Juras, Ana Andabak Rogulj,\nDragana Gabrić Pandurić, Željko Verzak and Vlaho Brailo",authors:[{id:"159295",title:"Prof.",name:"Vanja",middleName:null,surname:"Vucicevic Boras",fullName:"Vanja Vucicevic Boras",slug:"vanja-vucicevic-boras"}]},{id:"40152",title:"Application of Diode Laser in Oral and Maxillofacial Surgery",slug:"application-of-diode-laser-in-oral-and-maxillofacial-surgery",signatures:"Dragana Gabrić Pandurić, Ivona Bago, Irina Filipović Zore, Mato\nSušić, Davor Katanec, Aleksandar Milenović and Vanja Vučićević\nBoras",authors:[{id:"159295",title:"Prof.",name:"Vanja",middleName:null,surname:"Vucicevic Boras",fullName:"Vanja Vucicevic Boras",slug:"vanja-vucicevic-boras"},{id:"26946",title:"Prof.",name:"Dragana",middleName:null,surname:"Gabrić",fullName:"Dragana Gabrić",slug:"dragana-gabric"},{id:"33434",title:"Prof.",name:"Davor",middleName:null,surname:"Katanec",fullName:"Davor Katanec",slug:"davor-katanec"},{id:"33435",title:"Dr.",name:"Mato",middleName:null,surname:"Sušić",fullName:"Mato Sušić",slug:"mato-susic"},{id:"161983",title:"Prof.",name:"Irina",middleName:null,surname:"Filipović Zore",fullName:"Irina Filipović Zore",slug:"irina-filipovic-zore"},{id:"162745",title:"Dr.",name:"Ivona",middleName:null,surname:"Bago",fullName:"Ivona Bago",slug:"ivona-bago"},{id:"165609",title:"Dr.",name:"Aleksandar",middleName:null,surname:"Milenović",fullName:"Aleksandar Milenović",slug:"aleksandar-milenovic"}]},{id:"44969",title:"Management of Mandibular Fractures",slug:"management-of-mandibular-fractures",signatures:"Amrish Bhagol, Virendra Singh and Ruchi Singhal",authors:[{id:"153817",title:"Dr.",name:"Amrish",middleName:null,surname:"Bhagol",fullName:"Amrish Bhagol",slug:"amrish-bhagol"},{id:"165016",title:"Dr.",name:"Virendra",middleName:null,surname:"Singh",fullName:"Virendra Singh",slug:"virendra-singh"},{id:"165017",title:"Dr.",name:"Ruchi",middleName:null,surname:"Singhal",fullName:"Ruchi Singhal",slug:"ruchi-singhal"}]},{id:"44970",title:"Management of Midfacial Fractures",slug:"management-of-midfacial-fractures",signatures:"Sertac Aktop, Onur Gonul, Tulin Satilmis, Hasan Garip and Kamil\nGoker",authors:[{id:"86656",title:"Dr.",name:"Hasan",middleName:null,surname:"Garip",fullName:"Hasan Garip",slug:"hasan-garip"},{id:"87174",title:"Dr.",name:"Tülin",middleName:null,surname:"Satılmış",fullName:"Tülin Satılmış",slug:"tulin-satilmis"},{id:"87224",title:"Prof.",name:"Kamil",middleName:null,surname:"Göker",fullName:"Kamil Göker",slug:"kamil-goker"},{id:"166953",title:"Dr.",name:"Sertac",middleName:null,surname:"Aktop",fullName:"Sertac Aktop",slug:"sertac-aktop"},{id:"166970",title:"Dr.",name:"Onur",middleName:null,surname:"Gonul",fullName:"Onur Gonul",slug:"onur-gonul"}]},{id:"44952",title:"Distraction Osteogenesis",slug:"distraction-osteogenesis",signatures:"Hossein Behnia, Azita Tehranchi and Golnaz Morad",authors:[{id:"166844",title:"Prof.",name:"Hossein",middleName:null,surname:"Behnia",fullName:"Hossein Behnia",slug:"hossein-behnia"},{id:"167304",title:"Dr.",name:"Azita",middleName:null,surname:"Tehranchi",fullName:"Azita Tehranchi",slug:"azita-tehranchi"},{id:"167305",title:"Dr.",name:"Golnaz",middleName:null,surname:"Morad",fullName:"Golnaz Morad",slug:"golnaz-morad"}]},{id:"44953",title:"Reconstruction of Mandibular Defects",slug:"reconstruction-of-mandibular-defects",signatures:"Maiolino Thomaz Fonseca Oliveira, Flaviana Soares Rocha, Jonas\nDantas Batista, Sylvio Luiz Costa de Moraes and Darceny Zanetta-\nBarbosa",authors:[{id:"160638",title:"Prof.",name:"Maiolino Thomaz Fonseca",middleName:null,surname:"Oliveira",fullName:"Maiolino Thomaz Fonseca Oliveira",slug:"maiolino-thomaz-fonseca-oliveira"},{id:"166562",title:"Prof.",name:"Flaviana Soares",middleName:null,surname:"Rocha",fullName:"Flaviana Soares Rocha",slug:"flaviana-soares-rocha"},{id:"166563",title:"Dr.",name:"Jonas Dantas",middleName:null,surname:"Batista",fullName:"Jonas Dantas Batista",slug:"jonas-dantas-batista"},{id:"166564",title:"Dr.",name:"Sylvio Luiz",middleName:"Costa",surname:"De Moraes",fullName:"Sylvio Luiz De Moraes",slug:"sylvio-luiz-de-moraes"},{id:"166565",title:"Dr.",name:"Darceny",middleName:null,surname:"Zanetta-Barbosa",fullName:"Darceny Zanetta-Barbosa",slug:"darceny-zanetta-barbosa"}]},{id:"44954",title:"Microsurgical Reconstruction of Maxillary Defects",slug:"microsurgical-reconstruction-of-maxillary-defects",signatures:"Shahram Nazerani",authors:[{id:"164036",title:"Prof.",name:"Shahram",middleName:null,surname:"Nazerani",fullName:"Shahram Nazerani",slug:"shahram-nazerani"}]},{id:"44728",title:"Maxillofacial Reconstruction of Ballistic Injuries",slug:"maxillofacial-reconstruction-of-ballistic-injuries",signatures:"Mohammad Hosein Kalantar Motamedi, Seyed Hossein Mortazavi,\nHossein Behnia, Masoud Yaghmaei, Abbas Khodayari, Fahimeh\nAkhlaghi, Mohammad Ghasem Shams and Rashid Zargar Marandi",authors:[{id:"90148",title:"Dr.",name:"Mohammad Hosein",middleName:"Kalantar",surname:"Motamedi",fullName:"Mohammad Hosein Motamedi",slug:"mohammad-hosein-motamedi"}]},{id:"44971",title:"Cleft Lip and Palate Surgery",slug:"cleft-lip-and-palate-surgery",signatures:"Koroush Taheri Talesh and Mohammad Hosein Kalantar Motamedi",authors:[{id:"165544",title:"Prof.",name:"Koroush",middleName:null,surname:"Taheri Talesh",fullName:"Koroush Taheri Talesh",slug:"koroush-taheri-talesh"}]},{id:"40003",title:"The Cosmetic Considerations in Facial Defect Reconstruction",slug:"the-cosmetic-considerations-in-facial-defect-reconstruction",signatures:"Mazen Almasri",authors:[{id:"150413",title:"Dr.",name:"Mazen Ahmad",middleName:null,surname:"Almasri",fullName:"Mazen Ahmad Almasri",slug:"mazen-ahmad-almasri"}]},{id:"44521",title:"Current Advances in Mandibular Condyle Reconstruction",slug:"current-advances-in-mandibular-condyle-reconstruction",signatures:"Tarek El-Bialy and Adel Alhadlaq",authors:[{id:"6203",title:"Dr.",name:"Tarek",middleName:null,surname:"El-Bialy",fullName:"Tarek El-Bialy",slug:"tarek-el-bialy"},{id:"167542",title:"Dr.",name:"Adel",middleName:null,surname:"Alhadlaq",fullName:"Adel Alhadlaq",slug:"adel-alhadlaq"}]},{id:"44972",title:"Concepts in Bone Reconstruction for Implant Rehabilitation",slug:"concepts-in-bone-reconstruction-for-implant-rehabilitation",signatures:"Hany A. Emam and Mark R. Stevens",authors:[{id:"162960",title:"Dr.",name:"Hany",middleName:null,surname:"Emam",fullName:"Hany Emam",slug:"hany-emam"},{id:"162961",title:"Dr.",name:"Mark",middleName:null,surname:"Stevens",fullName:"Mark Stevens",slug:"mark-stevens"}]},{id:"44989",title:"Outfracture Osteotomy Sinus Graft: A Modified Technique Convenient for Maxillary Sinus Lifting",slug:"outfracture-osteotomy-sinus-graft-a-modified-technique-convenient-for-maxillary-sinus-lifting",signatures:"Jeong Keun Lee and Yong Seok Cho",authors:[{id:"25370",title:"Prof.",name:"Jeong Keun",middleName:null,surname:"Lee",fullName:"Jeong Keun Lee",slug:"jeong-keun-lee"},{id:"166214",title:"Dr.",name:"Yong Seok",middleName:null,surname:"Cho",fullName:"Yong Seok Cho",slug:"yong-seok-cho"}]},{id:"44588",title:"Inferior Alveolar Nerve Transpositioning for Implant Placement",slug:"inferior-alveolar-nerve-transpositioning-for-implant-placement",signatures:"Ali Hassani, Mohammad Hosein Kalantar Motamedi and Sarang\nSaadat",authors:[{id:"90148",title:"Dr.",name:"Mohammad Hosein",middleName:"Kalantar",surname:"Motamedi",fullName:"Mohammad Hosein Motamedi",slug:"mohammad-hosein-motamedi"},{id:"163066",title:"Associate Prof.",name:"Ali",middleName:null,surname:"Hassani",fullName:"Ali Hassani",slug:"ali-hassani"},{id:"165825",title:"Dr.",name:"Sarang",middleName:null,surname:"Saadat",fullName:"Sarang Saadat",slug:"sarang-saadat"}]},{id:"44750",title:"Basic and Advanced Operative Techniques in Orthognathic Surgery",slug:"basic-and-advanced-operative-techniques-in-orthognathic-surgery",signatures:"F. Arcuri, M. Giarda, L. Stellin, A. Gatti, M. Nicolotti, M. Brucoli, A.\nBenech and P. Boffano",authors:[{id:"155785",title:"Dr.",name:"Francesco",middleName:null,surname:"Arcuri",fullName:"Francesco Arcuri",slug:"francesco-arcuri"},{id:"165255",title:"Dr.",name:"Livia",middleName:null,surname:"Stellin",fullName:"Livia Stellin",slug:"livia-stellin"},{id:"165256",title:"Dr.",name:"Alessandro",middleName:null,surname:"Gatti",fullName:"Alessandro Gatti",slug:"alessandro-gatti"},{id:"165258",title:"Dr.",name:"Matteo",middleName:null,surname:"Brucoli",fullName:"Matteo Brucoli",slug:"matteo-brucoli"},{id:"165259",title:"Dr.",name:"Mariangela",middleName:null,surname:"Giarda",fullName:"Mariangela Giarda",slug:"mariangela-giarda"},{id:"165260",title:"Prof.",name:"Arnaldo",middleName:null,surname:"Benech",fullName:"Arnaldo Benech",slug:"arnaldo-benech"},{id:"165261",title:"Dr.",name:"Matteo",middleName:null,surname:"Nicolotti",fullName:"Matteo Nicolotti",slug:"matteo-nicolotti"}]},{id:"45357",title:"Rigid Fixation of Intraoral Vertico-Sagittal Ramus Osteotomy for Mandibular Prognathism",slug:"rigid-fixation-of-intraoral-vertico-sagittal-ramus-osteotomy-for-mandibular-prognathism",signatures:"Kazuma Fujimura and Kazuhisa Bessho",authors:[{id:"162569",title:"Associate Prof.",name:"Kazuma",middleName:null,surname:"Fujimura",fullName:"Kazuma Fujimura",slug:"kazuma-fujimura"}]},{id:"38528",title:"Soft-Tissue Response in Orthognathic Surgery Patients Treated by Bimaxillary Osteotomy. Cephalometry Compared with 2-D Photogrammetry",slug:"soft-tissue-response-in-orthognathic-surgery-patients-treated-by-bimaxillary-osteotomy-cephalometry-",signatures:"Jan Rustemeyer",authors:[{id:"159569",title:"Prof.",name:"Jan",middleName:null,surname:"Rustemeyer",fullName:"Jan Rustemeyer",slug:"jan-rustemeyer"}]},{id:"44955",title:"Corticotomy and Miniplate Anchorage for Treating Severe Anterior Open-Bite: Current Clinical Applications",slug:"corticotomy-and-miniplate-anchorage-for-treating-severe-anterior-open-bite-current-clinical-applicat",signatures:"Mehmet Cemal Akay",authors:[{id:"48935",title:"Prof.",name:"Mehmet Cemal",middleName:null,surname:"Akay",fullName:"Mehmet Cemal Akay",slug:"mehmet-cemal-akay"}]},{id:"45007",title:"Office – Based Facial Cosmetic Procedures",slug:"office-based-facial-cosmetic-procedures",signatures:"Farzin Sarkarat, Behnam Bohluli and Roozbeh Kahali",authors:[{id:"73778",title:"Dr.",name:"Behanm",middleName:null,surname:"Bohluli",fullName:"Behanm Bohluli",slug:"behanm-bohluli"},{id:"163344",title:"Dr.",name:"Farzin",middleName:null,surname:"Sarkarat",fullName:"Farzin Sarkarat",slug:"farzin-sarkarat"},{id:"163346",title:"Dr.",name:"Roozbeh",middleName:null,surname:"Kahali",fullName:"Roozbeh Kahali",slug:"roozbeh-kahali"}]},{id:"44956",title:"Facial Sculpturing by Fat Grafting",slug:"facial-sculpturing-by-fat-grafting",signatures:"Behnam Bohluli, Mehran Aghagoli, Farzin Sarkarat, Mansour\nMalekzadeh and Nima Moharamnejad",authors:[{id:"73778",title:"Dr.",name:"Behanm",middleName:null,surname:"Bohluli",fullName:"Behanm Bohluli",slug:"behanm-bohluli"},{id:"163344",title:"Dr.",name:"Farzin",middleName:null,surname:"Sarkarat",fullName:"Farzin Sarkarat",slug:"farzin-sarkarat"}]},{id:"44958",title:"Diagnosis and Management of Temporomandibular Disorders",slug:"diagnosis-and-management-of-temporomandibular-disorders",signatures:"Fina Navi, Mohammad Hosein Kalantar Motamedi, Koroush Taheri\nTalesh, Esshagh Lasemi and Zahra Nematollahi",authors:[{id:"166999",title:"Dr.",name:"Fina",middleName:null,surname:"Navi",fullName:"Fina Navi",slug:"fina-navi"}]}]}],publishedBooks:[{type:"book",id:"5112",title:"A Textbook of Advanced Oral and Maxillofacial Surgery",subtitle:"Volume 3",isOpenForSubmission:!1,hash:"9155af3479cbb41b2af5fc7e333d238f",slug:"a-textbook-of-advanced-oral-and-maxillofacial-surgery-volume-3",bookSignature:"Mohammad Hosein Kalantar Motamedi",coverURL:"https://cdn.intechopen.com/books/images_new/5112.jpg",editedByType:"Edited by",editors:[{id:"90148",title:"Dr.",name:"Mohammad Hosein",surname:"Motamedi",slug:"mohammad-hosein-motamedi",fullName:"Mohammad Hosein Motamedi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5927",title:"Issues in Flap Surgery",subtitle:null,isOpenForSubmission:!1,hash:"001d81ef8d1213b428ef9da8e29fb5e7",slug:"issues-in-flap-surgery",bookSignature:"Sherif Amr",coverURL:"https://cdn.intechopen.com/books/images_new/5927.jpg",editedByType:"Edited by",editors:[{id:"179930",title:"Prof.",name:"Sherif",surname:"Amr",slug:"sherif-amr",fullName:"Sherif Amr"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7157",title:"Bone Grafting",subtitle:"Recent Advances with Special References to Cranio-Maxillofacial Surgery",isOpenForSubmission:!1,hash:"536ef0d393c2af079dcc8b90dae0e68c",slug:"bone-grafting-recent-advances-with-special-references-to-cranio-maxillofacial-surgery",bookSignature:"Raja Kummoona",coverURL:"https://cdn.intechopen.com/books/images_new/7157.jpg",editedByType:"Edited by",editors:[{id:"93854",title:"Prof.",name:"Raja",surname:"Kummoona",slug:"raja-kummoona",fullName:"Raja Kummoona"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7928",title:"Maxillofacial Surgery and Craniofacial Deformity",subtitle:"Practices and Updates",isOpenForSubmission:!1,hash:"734c4a37da9817d5c3aa68c8f15a0d93",slug:"maxillofacial-surgery-and-craniofacial-deformity-practices-and-updates",bookSignature:"Mazen Ahmad Almasri and Raja Kummoona",coverURL:"https://cdn.intechopen.com/books/images_new/7928.jpg",editedByType:"Edited by",editors:[{id:"150413",title:"Dr.",name:"Mazen Ahmad",surname:"Almasri",slug:"mazen-ahmad-almasri",fullName:"Mazen Ahmad Almasri"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9523",title:"Oral and Maxillofacial Surgery",subtitle:null,isOpenForSubmission:!1,hash:"5eb6ec2db961a6c8965d11180a58d5c1",slug:"oral-and-maxillofacial-surgery",bookSignature:"Gokul Sridharan",coverURL:"https://cdn.intechopen.com/books/images_new/9523.jpg",editedByType:"Edited by",editors:[{id:"82453",title:"Dr.",name:"Gokul",surname:"Sridharan",slug:"gokul-sridharan",fullName:"Gokul Sridharan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],publishedBooksByAuthor:[{type:"book",id:"5927",title:"Issues in Flap Surgery",subtitle:null,isOpenForSubmission:!1,hash:"001d81ef8d1213b428ef9da8e29fb5e7",slug:"issues-in-flap-surgery",bookSignature:"Sherif Amr",coverURL:"https://cdn.intechopen.com/books/images_new/5927.jpg",editedByType:"Edited by",editors:[{id:"179930",title:"Prof.",name:"Sherif",surname:"Amr",slug:"sherif-amr",fullName:"Sherif Amr"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},onlineFirst:{chapter:{type:"chapter",id:"82203",title:"Resting-State Brain Network Analysis Methods and Applications",doi:"10.5772/intechopen.104827",slug:"resting-state-brain-network-analysis-methods-and-applications",body:'
1. Introduction
Magnetic resonance imaging (MRI) is a multimodal technique that can noninvasively reflect the structure and function of the human brain. Structural MRI (sMRI), including longitudinal (spin-lattice) relaxation time T1-weighted and transverse (spin-spin) relaxation time T2-weighted imaging, has been applied to investigate the structural features of the brain. Based on the different relaxation times of different tissue, T1-weighted and T2-weighted images can be used to reflect the volume of grey matter, white matter, as well as lesions caused by infarction or hemorrhage. Diffusion MRI (dMRI), such as diffusion-weighted imaging (DWI) and diffusion tensor imaging (DTI), can be used to measure water diffusion along different directions and tract neural fiber counts and orientation. Functional MRI (fMRI) reflects neural activity during a period of time by measuring the relative amount of deoxygenated hemoglobin and oxygenated hemoglobin in the blood flow, which is also called the blood-oxygen-level-dependent (BOLD) signal. The fMRI is becoming popular in clinical situations to investigate the functional alterations following disease or treatment.
The fMRI experiment can be categorized into task fMRI and resting-state fMRI (rs-fMRI). For task fMRI, subjects need to perform a specific task, such as finger tapping or receive external stimulation like heat or sound during the scanning session. Resting-state fMRI, on the other hand, is collected when the subject lies still in the scanner, without doing any movement or thinking anything particular, and keeping awake at all time. Researchers focus on the spontaneous neural activity reflected by the BOLD signal under resting conditions. The correlation of signals related to spatially distinct regions is commonly defined as functional connectivity (FC) [1].
In the recent two decades, several methods have been developed to analyze functional connectivity in the resting state, including seed-based analysis, independent component analysis (ICA) [2], and resting-state network (RSN) method [3, 4]. The network method characterizes brain spontaneous activity as a graph, where nodes are defined as brain regions and edges are represented as connectivity between regions. There are different ways to calculate the connectivity, including static and dynamic functional connectivity and directed connectivity. Furthermore, features proposed in network science can be adopted to characterize the brain network topology, such as graph theory attributes [5].
Resting-state fMRI has been applied to clinical research and applications [6, 7]. In clinical situations, a common research paradigm is performing group comparison and searching for inter-group significant different features. Researchers are interested in whether a group of patients is significantly different from a group of healthy controls, or whether the same group of patients shows significant recovery after treatment. The identified significant different features may be the potential biomarker to aid in diagnosis as well as treatment. More importantly, the location of the significant different feature is of great interest, since each brain region has its unique function. As a result, this requires comparing groups of brain networks and other extracted network features. In clinical research, there are two key techniques of brain network analysis, the method of network construction and significant difference analysis of groups of brain networks.
In the following sections, we first describe how to construct brain networks from resting-state fMRI data, including different node definitions and a range of connectivity measurements. Then, we present common group analysis methods of brain networks. The clinical application of brain network analysis is also reported. We also propose several future directions in brain network research and end the chapter with a conclusion.
2. Constructing brain networks
Unlike structural and diffusion MRI, the fMRI scanning captures the BOLD signal in a period of time that typically lasts for several minutes. The collected data are a time series, and the “sampling period” is called repetition time (TR). That is, whole-brain data are collected every TR seconds. Before constructing brain networks, the data need to be preprocessed to clean out non-neural artifacts, including physiological signals like breath and heartbeat, head movements, and scanner noise. Then the nodes of the network are defined and connectivity between each pair of nodes is calculated. The whole data processing pipeline is shown in Figure 1.
Figure 1.
Resting-state fMRI data process pipeline.
2.1 fMRI preprocessing
The preprocessing of fMRI data is necessary since there are non-neural noises in the signal. There are openly available toolboxes to carry out preprocessing, such as Statistical Parametric Mapping (SPM), FMRIB Software Library (FSL), and Data Processing Assistant for Resting-State fMRI (DPARSF)[8]. Common preprocessing procedures begin by removing the first 10 time points to let the subject be familiar with the scanning environment. Since the scanning of fMRI data within a repetition period (2s) is done in a slice-by-slice manner, the exact collection time of the first slice and the last slice has a time difference. To correct this difference, a procedure called slice timing correction needs to be performed. Then the head motion is corrected so that each voxel corresponds to the same brain location in the scanning series.
For group analysis, the data of different subjects need to be co-registered or normalized to the Montreal Neurological Institute (MNI) standard space. The data then undergoes smoothing using a Gaussian filter with a specified full-width-half-maximum (FWHM) value. After that, the linear trend in the signal is removed and nuisance covariates, such as white matter, cerebral spinal fluid (CSF), and global signal, are regressed out. At last, the data are filtered to keep signals within 0.01-0.08 Hz, since signals within this frequency range are reported to reflect spontaneous neural activities.
Although numerous preprocessing steps have been developed, there is still no consensus on the standard fMRI data preprocessing pipeline. The controversy is centered on the nuisance covariates regression, especially global signal regression (GSR)[9] and white matter signal regression [10]. Other researchers tried to optimize the preprocessing across multiple outcome measures [11], for low-frequency fluctuation analysis [12] and specific patients, such as stroke patients [13]. We have also investigated how the choices of preprocessing parameters and steps influence statistical analysis results [14]. The preprocessing of fMRI data remains to be a complex but important research topic.
2.2 Node definition
The most basic node definition is the voxel in a 3D fMRI image. Each voxel within the brain can be treated as a node and the constructed voxel-based network covers the whole brain. However, since the spatial resolution of fMRI is relatively high (2mm–4mm), the number of voxels is rather large (around the magnitude of 100,000) and the constructed network requires huge computation power for further analysis. Researchers have proposed specialized methods, such as the Parallel Graph-theoretical Analysis (PAGANI) toolkit to accelerate the processing of voxel-based whole-brain networks [15].
On the other hand, the nodes of the brain network can be defined as regions in the brain. The preprocessed data of voxels within a region are averaged spatially as the signal related to this node. The region can be specified manually by drawing regions of interest (ROI). Independent component analysis (ICA) can also reveal the component region but requires specifying parameters, such as the number of components. Both methods require human intervention and depend heavily on expert knowledge.
We proposed a fuzzy node definition method in Ref. [16] for tumor-brain, named “Spatial-Neighborhood and Functional-Correlation (SNFC)” based on fuzzy connectedness. It is a self-adapting method where the network was divided into functional connection and spatial adjacency. In the SNFC method, fuzzy connectedness between two voxels acts as a measurement to decide if they belong to the same node. Each voxel in the brain could be mapped into two feature spaces—structure feature space S and correlation feature space C. Let si,k represent the spatial relationship between voxel vi and voxel vk, acting as a judgment of the neighboring relationship. ci,k is the correlation coefficient between the BOLD signal of vi and vk. The features of structural space S guarantee the principle of the spatial neighborhood and the features of correlation space C ensure the principle of consistency. Fuzzy connectedness between two voxels could be defined as the following:
FCi,k=si,k⋅ci,kE1
If FCi,k>T, then vi and vk belong to the same node, where T is the correlation threshold determining whether the correlation of two voxels is strong enough to be in the same node.
The nodes can also be defined using regions in the brain atlas to avoid the subjective error caused by human intervention and enable automatic processing for large cohorts of data. The most known brain atlas is the Brodmann atlas, created by the German anatomist Korbinian Brodmann based on cytoarchitecture [17]. Another popular brain parcellation is the Automated Anatomical Labeling (AAL) atlas [18]. The AAL atlas focuses on brain structure and the finer partition of certain cortices was proposed in AAL2 [19] and AAL3 [20]. Apart from structure, the brain atlas derived from diffusion and functional data is getting more attention. The Brainnetome Atlas was proposed based on DTI data with fine-grained parcellation [21]. Researchers also developed functional atlas, such as the Atlas of Intrinsic Connectivity of Homotopic Areas (AICHA) that considered the homolog of regions in both hemispheres [22]. The above-defined network is called a region-based whole-brain network. We can also construct networks within a region. In this scenario, the voxels are defined as nodes, and the network only consists of voxels within a region. The constructed network is called a voxel-based local network, representing the topology within certain regions. We proposed a multilevel brain network joint analysis method on voxel-based whole-brain networks, voxel-based local networks as well as region-based whole-brain networks (Figure 2) [23].
Figure 2.
Construction of multilevel functional brain networks.
Node definition has a fundamental influence on the topology of the brain network. Different atlas parcels the cerebrum and cerebellum based on different information, and it plays a key role in linking physiological regions to abstract brain network nodes. However, similar to the preprocessing of fMRI data, there is no gold standard for the node definition. Several researches have been carried out to investigate the effect of node definition on network analysis [24], resting-state networks [25], and the topology of both functional networks [26] and structural networks [27]. It is still an open question and needs more thorough research.
2.3 Static and dynamic functional connectivity
Edges in brain networks are represented by the connectivity between nodes. One of the most common connectivity measures is functional connectivity (FC). In 1995, Biswal et al firstly reported the correlation of intrinsic low-frequency BOLD signal fluctuation under resting-state and since then, multiple efforts have been devoted to FC analysis [1, 3]. Functional connectivity is commonly defined as the Pearson correlation between the BOLD signal of spatially distant regions. In recent years, researchers realized that FC ignores the dynamics of neural activity and developed dynamic functional connectivity (DFC) or Chronnectome [28, 29, 30]. The research on DFC is becoming popular and has attracted lots of attention.
Technically speaking, FC or static functional connectivity (SFC) is calculated using the whole time series, whereas DFC utilizes a sliding time window and the correlation of signals within the window is calculated. The window then moves from the beginning of the BOLD signal to the end, with a pre-defined step size. As a result, the connectivity shows dynamic fluctuations as the window slides, and each scanning session is associated with a series of brain networks, or a dynamic brain network. In contrast, there is only one static network related to the scanning session. The network is usually represented by a graph adjacency matrix, which is a square symmetric matrix and the ij value equals the connection of node i to node j. For a dynamic network, there is a time axis along with the adjacency matrix.
There are two major parameters regarding DFC calculation—the window length and the sliding step size. With a longer window length, the dynamics of neural activity might be averaged out while a shorter window length can capture transient signal changes. The step size controls the temporal resolution of DFC. Normally it is specified as several TRs. We investigated the optimal window width by using the small-world property as criteria [31]. Node degree distribution has exponential truncated power-law in the small-world network, and the normal human brain network shows a strong small-world property. The reasonable window width range was verified on both SNFC-based and voxel-based whole-brain networks. Results show that the smallest window width is 200 seconds and 260 seconds for normal subjects and brain tumor patients, respectively. Leonardi et al also studied the theory between window length and filter cut-off frequency during preprocessing [32]. Apart from the two window parameters, the shape of the sliding window is another concern. The rectangular window is the simplest solution, but other choices such as tapered window exist. Mokhtari et al also proposed a modulated rectangular (mRect) window to reduce spectral modulations [33].
We also proposed a dynamic network analysis method for enlarging the training samples required by an unsupervised learning classification algorithm [34], such as a classical backpropagation neural network classifier containing a hidden layer. It reached the optimal accuracy of 100% for classifying glioma patients and normal subjects.
Despite controversies, DFC has been used to investigate diseases, such as schizophrenia [35], post-traumatic stress disorder (PTSD) [36], Parkinson’s Disease [37], and autism [38]. It has also been applied to lifespan studies [39] and cognitive research [40]. From either a methodological or application view, the research on DFC is still insufficient.
2.4 Directed connectivity
As the definition implies, both SFC and DFC contain no directional information. Effective connectivity (EC) can measure the directional influence of one region toward another area by calculating the causal relationships between time series. Commonly adopted EC estimation methods are structural equation modeling (SEM) [41], dynamic causal modeling (DCM) [42], and Granger causality analysis (GCA) [43, 44]. The computation cost becomes unacceptable for SEM and DCM as the number of nodes increases [43]. Several amendments have been proposed to reduce the computation requirement of DCM recently [45, 46], but the model complexity is still challenging for clinical applications. We proposed a method based on convergent cross-mapping (CCM) that can reflect the interactions between regions in a dynamic, nonlinear, and deterministic way, which is not covered by GCA [47]. The method overview, together with the extended network-based statistic, is shown in Figure 3.
Figure 3.
CCM-based directed connectivity estimation and extended network-based statistic method.
CCM was originally developed to detect causality in complex ecosystems [48]. It acts as a complement to GCA as CCM assumes the system to be deterministic and dynamical, while GCA works for a stochastic system and requires separability. In GCA, if removing X decreases the predictability of Y, it can be deduced that X causes Y, and in a brain network scenario, there is a directed connection from X to Y. On the other hand, in deterministic dynamic systems where CCM was developed, we can measure how well Y can estimate X to determine the causal relationship from X to Y, which then determines the directed connectivity strength from X to Y. The procedure of estimating X using Y is called cross-mapping. CCM is also applicable under situations where separability is not guaranteed. GCA, on the other hand, may produce erroneous results [49]. As for the brain, it is a dynamic system whose functional organization is poorly understood [50]. Utilizing CCM to estimate directed connectivity between regions could facilitate the investigation of brain activity as well as enable novel clinical applications.
3. Analyzing group differences in brain networks
After brain network construction, for each scanning of each subject, the preprocessed fMRI data were converted to a brain network represented by a graph adjacency matrix. The next question is how to find the difference between groups of brain networks. Here we summarize two popular methods to further analyze brain networks.
3.1 Significance analysis
The most basic method is analyzing functional connectivity directly. Specifically, suppose we are comparing two groups of networks. Each connectivity value is extracted from every network, forming two sets of values. Statistical hypothesis testing can be adopted to decide whether this connection shows a significant difference as well as which group is higher. After performing a comparison on every connection in the network, the group difference network consisting of significant different connections is obtained. All edges with a significant difference were stored in a network for further discussion. We can also select several regions based on prior knowledge, such as the sensorimotor area or visual area, to further filter the set of significant different connections.
Another method is calculating graph theory attributes. Graph theory characterizes the topology of the network by nodal and global attributes. Common node level graph theory attributes are betweenness centrality, clustering coefficient, local efficiency, modularity, and weighted degree, while the network level graph theory attributes include global efficiency and characteristic path length. Small-worldness is also a common index used in brain network analysis. For multilevel brain networks, we define intra-region features as the attributes calculated at voxel-based local networks, and the attributes calculated at region-based whole-brain networks are called inter-region features. We can calculate the global feature of the voxel-based local network (intra-region features), and the nodal feature of the region-based whole-brain network (inter-region features). As a result, for each graph attribute, we obtain a feature vector whose length equals the number of nodes in the network, representing the whole-brain network feature.
After obtaining feature vectors of graph theory attributes, we can perform a statistical comparison on each region similar to FC analysis. The feature at each region is extracted, forming two sets of values; and statistical testing is used to find significant regions or significant different features. Moreover, the clinical relevance of the features can be evaluated by assessing the correlation of features and clinical scores, which produces features with significant correlation. The intersection of significant different and significant correlated features is selected for further discussion and following analysis.
We also investigated methods to analyze dynamic graph theory attributes [51]. For dynamic brain networks, at each sliding window location, the obtained brain network is static, and graph theory attributes can be calculated. As the window slides, graph theory attributes at each window location are estimated, forming the dynamic graph theory attributes of the dynamic network. To combine static and dynamic attributes together with clinical scores, we proposed an analysis framework [51]. The strength and stability of dynamic graph attributes were calculated. We found significant different and correlated features for both static and dynamic networks, as well as their intersection. The resulting features were further analyzed using receiver-operating curves (ROC) to test their ability in classification.
A controversy regarding the above analysis method is the multiple comparison problem. For each single statistical comparison with a 0.05 significance level, there is a 0.05 chance of obtaining a false positive. However, when performing multiple statistical comparisons at the same time, the chance of getting at least one false positive would become higher as the number of comparisons increases. To tackle this problem, correction methods, such as Bonferroni correction and false discovery rate (FDR) correction, were proposed. The basic idea behind these correction methods is to decrease the single comparison significance level according to the number of comparisons. However, since the amount of comparison is related to the number of nodes in the network, and certain features show high within group variance, directly applying correction might result in no significant result. We argue that statistical comparison can be seen as a feature selection procedure. The significant or selected features are then fed into the next module, such as a classifier. During feature selection, we should keep as much useful information as possible. The uncorrected significant features are preliminary scanning results and taking the intersection of significant different and correlated features further select clinically relevant information. Searching for intersected significant features might be an alternative method to multiple comparison correction.
3.2 Network-based statistics
For brain networks, to overcome the multiple comparison issue, network-based statistics (NBS) was proposed, enabling direct comparison of groups of brain networks [52]. NBS assumes that the effect or the group difference forms a certain structure instead of distributed single connections. The edge-wise comparison is performed first and the links are thresholded according to the test statistics or p-values obtained from the edge-wise comparison, producing a binarized difference network. It then searches for structures or connected components in the binarized difference network. The size of the component, defined as the number of edges or nodes, is used to determine if the component is significant by a permutation test, where group labels of samples are randomly shuffled and the same procedure is performed to search for the maximum component size. The permutation is repeated 5000 times and the empirical distribution of the component size is obtained. An empirical p-value can be assigned to the original connected component by calculating the ratio of the number of permutations, where the maximal size is larger than the original size, to the total permutation number.
Compared with edge-wise comparison and direct edge-wise correction, NBS provides higher statistical power at the cost of coarser spatial resolution in detecting differences [52]. In other words, NBS can only declare the connected component as a whole to be significant. It draws no conclusion on the significance of each single connection within the component. However, the original NBS only works for symmetric adjacency matrices, which corresponds to functional connectivity.
Based on directed connectivity, we proposed the extended-NBS (e-NBS) to search for altered connected components in groups of directed networks [47]. The method overview is shown in Figure 3. We search for strongly connected components (SCC) and weakly connected components (WCC) with and without direction information. A classical depth-first search algorithm was adopted when searching for SCCs and WCCs. The edge-wise p-value was utilized to filter for candidate connections and construct a difference network. Since there is no consensus on how to choose the pre-defined p-value threshold, we changed it within a certain range to test method performance. Specifically, an edge is kept if the p-value is less than the pre-define p-value threshold. For edge-wise comparison, we also tried to use two-sample t-test and the non-parametric Mann-Whitney test. The e-NBS method, together with the CCM-based directed connection estimation method, was verified using a dataset of spinal cord injury patients and healthy controls.
Moreover, we note that given the framework of e-NBS, one can define connected components that suit research needs. For example, in a study of motor function alteration following spinal cord injury, researchers are interested in connections related to sensorimotor areas and visual regions. The connected component can be defined as significant different connections related to these regions of interest. Furthermore, we can define two-step connected components that comprise connections directly related to the ROIs in the binarized difference network, and connections related to regions (first level nodes) that connect with ROIs (Figure 4). Either way, the permutation test in e-NBS makes it possible to draw conclusion on the significance of the defined component.
Figure 4.
Two-step connected component. The first level node is directly connected to the ROI in the binarized difference network, while the second level node is connected with the first-level node.
4. Clinical applications
The resting-state fMRI has been applied to clinical research and applications, mainly investigating pathophysiological mechanisms and searching for sensitive biomarkers for early diagnosis [6, 7]. The prognosis predictability of rs-fMRI is intriguing as well [53, 54, 55]. In glioma research, resting-state fMRI has also shown potential in diagnosis and treatment planning. Here we introduce three examples of applications and related works.
4.1 Neurorehabilitation
It has been shown that changes in both brain function and structure occur following central nervous lesions, such as spinal cord injury [56] and cerebral stroke [57]. According to the theory of neuroplasticity, the brain function continues to change during rehabilitation, and it is the theoretical and physiological basis for individualized neurorehabilitation as well as assistive rehabilitation technologies, such as transcranial direct current stimulation (tDCS) [58, 59, 60] and brain-computer interfaces (BCI) [61, 62]. We performed a study on spinal cord injury patients and investigated the alteration of grey matter volume extracted from structural MRI and functional connectivity related to the sensorimotor area, combining clinical assessments [63]. We found that that the alteration of anatomical structure features and the brain network connectivity in the sensorimotor area were non-concomitant following spinal cord injury, and the functional connectivity within the sensorimotor area had a significant correlation with clinical sensory scores, indicating the potential of FC as a prediction biomarker.
Another issue related to neurorehabilitation is the automated objective evaluation of rehabilitation progress. Traditionally, patient recovery is assessed by clinical measurements, which can only reflect behavioral improvements and might include subjective bias. We proposed a distance-based rehabilitation evaluation method that takes resting-state fMRI data of patients and healthy controls as input (Figure 5) [64]. We hypothesize that the sample point distribution of patients and healthy controls in the feature space is dichotomous. A support vector machine (SVM) classifier was first trained using significantly different functional connectivity of healthy controls and the first scanning session of patients. The distance of the patient sample points to the separating hyperplane was calculated and used to evaluate patient recovery. If the patient recovered, the sample point of the patient would move toward healthy controls and the distance would decrease. The method was verified using both group level and individual longitudinal data, and the distance evaluation was consistent with clinical measurements.
Figure 5.
Method overview of the distance-based rehabilitation evaluation framework.
On the other hand, a stroke could lead to certain movement disabilities. Motor-related brain function alteration after stroke and during recovery is of great interest. Brain-Computer Interface (BCI) systems are helpful in motor recovery, possibly by stimulating neuroplasticity following brain activity [65]. The brain network reorganization of stroke patients after BCI training is of great significance. We conducted an experiment to investigate the functional changes after BCI training and their relations to clinical scores [66]. Functional connectivity was calculated using data collected before and after training and we searched for significant increased FC in groups with and without BCI training. The correlation between FC and clinical scores was also calculated. We found increased FC between certain cerebral and subcortical regions and the inter-hemisphere FC was positively correlated with motor scores.
4.2 Multiple system atrophy
Multiple system atrophy (MSA) is a neurodegenerative disease typically characterized by parkinsonism, cerebellar ataxia syndrome, and autonomic nervous dysfunction [67]. It is further divided into two subtypes, MSA with predominant parkinsonism (MSA-P) and MSA with predominant cerebellar ataxia (MSA-C) [67]. Previous studies mainly investigated the structural abnormalities related to MSA patients and compared subtypes of MSA with Parkinson’s Disease (PD) as well as healthy controls [68, 69, 70, 71]. The functional alteration induced by MSA is also studied by calculating regional homogeneity (ReHo) [72], the amplitude of low-frequency fluctuations (ALFF) [73], as well as functional and effective connectivity [74, 75].
The dynamic functional features of MSA-C patients not thoroughly investigated before. We conducted an experiment on MSA-C patients and proposed a method to combine static and dynamic functional connectivity features, as well as clinical scores (Figure 6) [51]. The static and dynamic brain networks were constructed using methods described in section 2.3 and static and dynamic graph theory attributes were calculated. Statistical comparisons and correlation analysis were carried out and significant different and correlated features were found. The significant regions mainly covered the cerebellum and certain cerebral areas, which is consistent with prior knowledge. The dynamic features showed the highest area under the curve (AUC) value during receiver-operating characteristic (ROC) analysis, indicating the potential of dynamic features in disease diagnosis.
Figure 6.
The coalition analysis of rs-fMRI data combining static, dynamic functional connectivity as well as clinical information.
Apart from structural and functional analysis, multimodal research on MSA is getting more attention. We also tried to combine structural, diffusion, tractography, and functional features extracted from T1, DTI, and fMRI to search for sensitive biomarkers for MSA-C patient diagnosis (Figure 7) [76]. The T1 data were processed to produce grey matter and white matter probability maps. We performed tractography on DTI data and counted the number of tracts crossing each brain region. The fraction anisotropy (FA) and mean diffusivity (MD) maps were also obtained. For rs-fMRI, we calculated functional connectivity and constructed brain networks. The extended network-based statistics for the undirected network were adopted to search for significant different connected components between the two groups. By using the AAL atlas, feature maps extracted from different modalities were converted to feature vectors and networks. After that, significant analysis was performed with false discovery rate correction and we identified significant different features, mainly distributed in cerebellar and certain cerebral regions. The correlation of these features with clinical scores was also tested. We also searched for sensitive biomarkers in disease diagnosis by applying a nested leave-one-out cross-validation framework and evaluated classification performance using the significant features of each region with a support vector machine (SVM) classifier, as shown in Figure 7. The identified biomarkers were mainly cerebellar regions. Different modalities contain complementary information. Merging multimodal data and clinical variables together can further reveal the neurological alteration related to the disease as well as increase the accuracy, robustness, and generalization of the disease diagnosis algorithm.
Figure 7.
The multimodal MRI feature fusion framework and the nested leave-one-out cross-validation procedure. GMV: grey matter volume; WMV: white matter volume; FA: fractional anisotropy; MD: mean diffusivity; NBS: network-based statistics; LOOCV: leave-one-out cross-validation.
4.3 Glioma
Glioma stems from the canceration of neurogliocyte and is the most common tumor in the human brain [77]. It has an intensive impact on the structure of the brain and further on the corresponding physiological functions. Different locations of the glioma will result in different functional alterations and prognosis outcomes. For a high-level glioma, it is highly likely to relapse even after being excised in a surgery [78]. As a result, it is necessary to analyze the brain function changes according to the location and volume of glioma for both diagnosis and treatment. We proposed a framework of multilevel functional network analysis to find the functional network characteristics of glioma patients [79]. The multilevel network consists of a hemisphere functional network, glioma voxel local network, and glioma region local network, as illustrated in Figure 8. The hemisphere functional network was constructed based on regions from a single hemisphere in the AAL atlas excluding cerebellar parcellation (Figure 9). The glioma voxel local network is constructed at the voxel level in the region of glioma that is extracted by a tumor segmentation method. And glioma region local network is also constructed at the voxel level, but within each atlas region containing the glioma. A ratio, defined as the number of voxels in an AAL area that belongs to the segmented glioma region over the total voxel number of the area, is used as the threshold for selecting areas containing the glioma in the AAL atlas.
Figure 8.
A framework of multilevel functional network analysis for finding the functional network characteristics of glioma patients.
Figure 9.
The process of the construction of the hemisphere functional networks is based on the AAL atlas of a glioma patient. The green dots stand for the nodes of the functional network. The yellow line segments represent the weighted edges whose thickness reflects the weight. The colored area shows the tumor region and different colors reflect the possibility of whether a voxel belongs to the tumor.
Network features, including connectivity strength, characteristic path length, average nodal betweenness centrality, and average nodal clustering coefficient, were calculated for all networks. The network connectivity strength was defined as the average z-scores of all edges. Network characteristic path length equals the average of shortest paths between each pair of nodes in the network. Nodal attributes, including betweenness centrality and clustering coefficients, are calculated at each node within the network and averaged as network features. For hemisphere functional networks, both static and dynamic functional connectivity were investigated. Since the period of the BOLD signal induced by the hemodynamic response of neuronal activity is about 20s [80], during the reconstruction of dynamic networks, a sliding window with a length of 50s and a step size of 10s was selected. Each glioma patient received functional scanning lasting for 460s. As a result, the sliding time window extracted 46 sub-signals with a length of 50s and constructed dynamic brain networks with 46-time slices.
In this study, 38 patients with tumors in one side of the brain were enrolled. We constructed 38 positive and 38 negative hemisphere functional networks. Among these patients, 15 subjects had glioma area segmentation. Moreover, 15 healthy subjects were collected as the control group. The local network analysis was performed on 15 patients with segmentation and 15 healthy controls. We used the two-sample t-test to evaluate the significant difference of each feature between hemisphere functional networks constructed on the healthy side and the glioma side. The glioma voxel local networks and glioma region local networks were constructed at the same location of glioma segmentation in data collected from healthy controls as well. Statistical comparison was performed to compare network features of glioma voxel local networks and glioma region local networks from patients and healthy controls. There were 41 glioma region local networks constructed from 15 patients, and for comparison, 41 local networks were estimated from healthy controls.
We also investigated the classification performance using hemisphere functional networks. Given that the sample size is small (38 networks with glioma and 38 networks with healthy tissue), linear support vector machine (SVM) was chosen as the classifier. Static and dynamic network features were extracted and aligned into a feature vector of dimensions 4 and 184 (46×4) as the input to the classifier, and the leave-one-out cross-validation method is employed to evaluate the performance. The results showed that both dynamic and static features can distinguish the normal and abnormal networks. In addition, dynamic features obtained 100% accuracy in our dataset, while static features showed 71.5% accuracy.
Results revealed by the multilevel functional network analysis method showed that the existence of glioma changed certain features of the normal functional networks. Our work finds that glioma weakened the connection strength of the global and local functional networks. Moreover, it decreased the clustering degree of the nodes in both local functional networks, indicating that glioma may destruct the non-randomness and the small-world property of brain networks.
Previous studies have already investigated how glioma alters functional connectivity [80, 81, 82, 83]. We find that glioma attenuates the connectivity of functional networks, which is in accordance with previous studies. Moreover, we also involved network features other than connectivity. Our study emphasized the characteristic features, such as betweenness centrality, clustering coefficient, and characteristic path length, which were not covered by previous research.
5. Future directions
Despite progress in recent years, there are lots of work to be done in developing new methods for constructing and analyzing brain networks, as well as performing group and individualized analysis. In this section, we propose some possible directions in the field of brain network research.
Network science has been used to analyze brain networks and advanced methods need to be developed to characterize the topological features of brain networks. The algebraic topological data analysis (TDA) method provides a new way to analyze the interactions between a set of nodes instead of bilateral connections. TDA could act as a complement to graph theoretical analysis in describing the topology characteristic of brain networks. More advanced network theory concepts, such as algebraic topology, have also been introduced to the analysis of brain networks [5]. Moreover, artificial neural networks and deep learning methods have been shown to be powerful in analyzing graph data. On the one hand, before network construction, models, such as Recurrent Neural Network (RNN) and Transformer, that were originally proposed to process sequential data, such as natural language and voice, can be applied to analyze the BOLD time series, both with and without preprocessing. Since the network perspective mainly models the inter-relationships between signals of spatially distinct regions, applying deep learning models directly to the time series could possibly extract information complementary to statistical dependency, as described by functional connectivity. On the other hand, after constructing brain networks using functional connectivity, directed connectivity, or DTI fiber tracking, Graph Neural Network (GNN) or Graph Convolutional Network (GCN) could be utilized to merge these multimodal networks and combine both edge-wise features (connections) and nodal features, such as graph theory attributes. GNN was proposed to directly analyze graphs that can model relationships between nodes and perform inference on node, edge, or graph level. Applying GNN to brain networks, especially multilevel static and dynamic brain networks, could possibly extract useful features and enable multimodal information fusion.
On the application side, multiple group comparison methods have been developed. However, for clinical application, individualized diagnosis and treatment are crucial. How to transform conclusions derived from group research into individual situations is a challenging question. We define “healthy templates” as a set of methods to delineate characteristics of a healthy population. The healthy templates describe the distribution of features of healthy people and need to be built for each feature extracted from different modalities. In its most basic form, the healthy template can be a value range given a specific feature. Subjects whose feature value falls within this value range would be considered to be normal, similar to the interpretation of a blood test result. Open-source datasets are valuable resources in the construction of healthy templates. However, the site effect of MRI data is a crucial issue and multi-site data harmonization techniques need to be adopted when combining data from different scanning locations. Several methods have been proposed for harmonization but their utility remains to be tested [84, 85]. With low variance healthy templates, individualized precise treatment planning and prognosis prediction would become possible.
6. Conclusion
The human brain is modeled as a functionally inter-connected network. Resting-state functional magnetic resonance imaging enables observing brain spontaneous activity in vivo. In this chapter, we reviewed the process of rs-fMRI data as well as group analysis methods. Different node definitions and edge estimation were discussed during the network construction stage. Nodes can be defined at the voxel level or with the help of a brain atlas. Lesions, such as glioma segmentation result, can also guide node definition. Edges are estimated in static, dynamic as well as directed scenarios. We presented two major methods to compare groups of brain networks data, significance analysis, and network-based statistics. Combined with the brain atlas, whole-brain networks are characterized by graph theory attributes developed in network science. Network-based statistics enables the direct comparison of groups of brain networks. We also discussed the clinical application of rs-fMRI data analysis in neurorehabilitation, multiple system atrophy, and glioma patients. At last, future research directions are discussed, with an emphasis on network science, novel deep learning models, and individualized clinical applications.
Acknowledgments
This work was supported by a grant from the Tsinghua University Initiative Scientific Research Program (No. 20131089382) and the National Natural Science Foundation of China (No. 61171002, 60372023). We would like to thank Zexuan Hao and Ziliang Zhang from the Department of Electronic Engineering, Beijing National Research Center for Information Science and Technology (BNRist), Tsinghua University for useful advice during the experiment and manuscript development.
Conflict of interest
The authors declare no conflict of interest.
\n',keywords:"resting-state fMRI, brain networks, graph theory attributes, dynamic functional connectivity, network-based statistics, neurorehabilitation, multiple system atrophy, glioma",chapterPDFUrl:"https://cdn.intechopen.com/pdfs/82203.pdf",chapterXML:"https://mts.intechopen.com/source/xml/82203.xml",downloadPdfUrl:"/chapter/pdf-download/82203",previewPdfUrl:"/chapter/pdf-preview/82203",totalDownloads:31,totalViews:0,totalCrossrefCites:0,dateSubmitted:"February 28th 2022",dateReviewed:"April 6th 2022",datePrePublished:"June 11th 2022",datePublished:null,dateFinished:"June 11th 2022",readingETA:"0",abstract:"Resting-state fMRI has been widely applied in clinical research. Brain networks constructed by functional connectivity can reveal alterations related to disease and treatment. One of the major concerns of brain network application under clinical situations is how to analyze groups of data to find the potential biomarkers that can aid in diagnosis. In this paper, we briefly review common methods to construct brain networks from resting-state fMRI data, including different ways of the node definition and edge calculation. We focus on using a brain atlas to define nodes and estimate edges by static and dynamic functional connectivity. The directed connectivity method is also mentioned. We then discuss the challenges and pitfalls when analyzing groups of brain networks, including functional connectivity alterations, graph theory attributes analysis, and network-based statistics. Finally, we review the clinical application of resting-state fMRI in neurorehabilitation of spinal cord injury patients and stroke patients, the research on the mechanism and early diagnosis of neurodegenerative diseases, such as multiple system atrophy, as well as the research on brain functional network alteration of glioma patients.",reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/82203",risUrl:"/chapter/ris/82203",signatures:"Yunxiang Ge and Weibei Dou",book:{id:"11742",type:"book",title:"Neurophysiology",subtitle:null,fullTitle:"Neurophysiology",slug:null,publishedDate:null,bookSignature:"Dr. Thomas Heinbockel",coverURL:"https://cdn.intechopen.com/books/images_new/11742.jpg",licenceType:"CC BY 3.0",editedByType:null,isbn:"978-1-80356-069-4",printIsbn:"978-1-80356-068-7",pdfIsbn:"978-1-80356-070-0",isAvailableForWebshopOrdering:!0,editors:[{id:"70569",title:"Dr.",name:"Thomas",middleName:null,surname:"Heinbockel",slug:"thomas-heinbockel",fullName:"Thomas Heinbockel"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:null,sections:[{id:"sec_1",title:"1. Introduction",level:"1"},{id:"sec_2",title:"2. Constructing brain networks",level:"1"},{id:"sec_2_2",title:"2.1 fMRI preprocessing",level:"2"},{id:"sec_3_2",title:"2.2 Node definition",level:"2"},{id:"sec_4_2",title:"2.3 Static and dynamic functional connectivity",level:"2"},{id:"sec_5_2",title:"2.4 Directed connectivity",level:"2"},{id:"sec_7",title:"3. Analyzing group differences in brain networks",level:"1"},{id:"sec_7_2",title:"3.1 Significance analysis",level:"2"},{id:"sec_8_2",title:"3.2 Network-based statistics",level:"2"},{id:"sec_10",title:"4. Clinical applications",level:"1"},{id:"sec_10_2",title:"4.1 Neurorehabilitation",level:"2"},{id:"sec_11_2",title:"4.2 Multiple system atrophy",level:"2"},{id:"sec_12_2",title:"4.3 Glioma",level:"2"},{id:"sec_14",title:"5. Future directions",level:"1"},{id:"sec_15",title:"6. Conclusion",level:"1"},{id:"sec_16",title:"Acknowledgments",level:"1"},{id:"sec_19",title:"Conflict of interest",level:"1"}],chapterReferences:[{id:"B1",body:'Biswal B, Zerrin Yetkin F, Haughton VM, Hyde JS. Functional connectivity in the motor cortex of resting human brain using echo-planar mri. Magnetic Resonance in Medicine. 1995;34(4):537-541'},{id:"B2",body:'Calhoun VD, Liu J, Adalı T. A review of group ICA for fMRI data and ICA for joint inference of imaging, genetic, and ERP data. NeuroImage. 2009;45(1):S163-S172'},{id:"B3",body:'van den Heuvel MP, Hulshoff Pol HE. Exploring the brain network: A review on resting-state fMRI functional connectivity. European Neuropsychopharmacology. 2010;20(8):519-534'},{id:"B4",body:'Rosazza C, Minati L. Resting-state brain networks: Literature review and clinical applications. Neurological Sciences. 2011;32(5):773-785'},{id:"B5",body:'Bassett DS, Sporns O. Network neuroscience. Nature Neuroscience. 2017;20(3):353-364'},{id:"B6",body:'Fox M, Greicius M. Clinical applications of resting state functional connectivity. Frontiers in Systems Neuroscience. 2010;4(19)'},{id:"B7",body:'Lee MH, Smyser CD, Shimony JS. Resting-State fMRI: A Review of Methods and Clinical Applications. American Journal of Neuroradiology. 2013;34(10):1866-1872'},{id:"B8",body:'Yan C, Zang Y. DPARSF: A MATLAB toolbox for" pipeline" data analysis of resting-state fMRI. Frontiers in Systems Neuroscience. 2010;4(13)'},{id:"B9",body:'Murphy K, Fox MD. Towards a consensus regarding global signal regression for resting state functional connectivity MRI. NeuroImage. 2017;154:169-173'},{id:"B10",body:'Grajauskas LA, Frizzell T, Song X, Darcy R. White matter fMRI activation cannot be treated as a nuisance regressor: Overcoming a historical blind spot. Frontiers in Neuroscience. 2019;13(1024)'},{id:"B11",body:'Shirer WR, Jiang H, Price CM, Ng B, Greicius MD. Optimization of rs-fMRI Pre-processing for Enhanced Signal-Noise Separation, Test-Retest Reliability, and Group Discrimination. NeuroImage. 2015;117:67-79'},{id:"B12",body:'Woletz M, Hoffmann A, Tik M, Sladky R, Lanzenberger R, Robinson S, et al. Beware detrending: Optimal preprocessing pipeline for low-frequency fluctuation analysis. Human Brain Mapping. 2019;40(5):1571-1582'},{id:"B13",body:'Yourganov G, Fridriksson J, Stark B, Rorden C. Removal of artifacts from resting-state fMRI data in stroke. NeuroImage: Clinical. 2018;17:297-305'},{id:"B14",body:'Ge Y, Pan Y, Dou W. Analysis of BOLD fMRI signal preprocessing pipeline on different datasets while reducing false positive rates. BIBE 2018; International Conference on Biological Information and Biomedical Engineering; 2018'},{id:"B15",body:'Du H, Xia M, Zhao K, Liao X, Yang H, Wang Y, et al. PAGANI Toolkit: Parallel graph-theoretical analysis package for brain network big data. Human Brain Mapping. 2018;39(5):1869-1885'},{id:"B16",body:'Wang X. Brain Function Analysis Method for Glioma Patient by Using Information Combination of MRI and fMRI Signal. Beijing, China: Tsinghua University; 2014'},{id:"B17",body:'Brodmann K. Vergleichende Lokalisationslehre der Grosshirnrinde in ihren Prinzipien dargestellt auf Grund des Zellenbaues. Barth; 1909'},{id:"B18",body:'Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage. 2002;15(1):273-289'},{id:"B19",body:'Rolls ET, Joliot M, Tzourio-Mazoyer N. Implementation of a new parcellation of the orbitofrontal cortex in the automated anatomical labeling atlas. NeuroImage. 2015;122:1-5'},{id:"B20",body:'Rolls ET, Huang C-C, Lin C-P, Feng J, Joliot M. Automated anatomical labelling atlas 3. NeuroImage. 2020;206:116189'},{id:"B21",body:'Fan L, Li H, Zhuo J, Zhang Y, Wang J, Chen L, et al. The human brainnetome atlas: A new brain atlas based on connectional architecture. Cerebral Cortex. 2016;26(8):3508-3526'},{id:"B22",body:'Joliot M, Jobard G, Naveau M, Delcroix N, Petit L, Zago L, et al. AICHA: An atlas of intrinsic connectivity of homotopic areas. Journal of Neuroscience Methods. 2015;254:46-59'},{id:"B23",body:'Luo H, Dou W, Pan Y, Wang Y, Mu Y, Li Y, et al. Joint analysis of multi-level functional brain networks. 2016 9th International Congress on Image and Signal Processing. BioMedical Engineering and Informatics (CISP-BMEI). Oct. 2016;2016:15-17'},{id:"B24",body:'Gong Y, Wu H, Li J, Wang N, Liu H, Tang X. Multi-granularity whole-brain segmentation based functional network analysis using resting-state fMRI. Frontiers in Neuroscience. 2018;12(942)'},{id:"B25",body:'Doucet GE, Lee WH, Frangou S. Evaluation of the spatial variability in the major resting-state networks across human brain functional atlases. Human Brain Mapping. 2019;40(15):4577-4587'},{id:"B26",body:'Wang J, Wang L, Zang Y, Yang H, Tang H, Gong Q , et al. Parcellation-dependent small-world brain functional networks: A resting-state fMRI study. Human Brain Mapping. 2009;30(5):1511-1523'},{id:"B27",body:'Wu Z, Xu D, Potter T, Zhang Y, TAsDNI. Effects of brain parcellation on the characterization of topological deterioration in Alzheimer’s disease. Frontiers in Aging Neuroscience. 2019;11(113)'},{id:"B28",body:'Allen EA, Damaraju E, Plis SM, Erhardt EB, Eichele T, Calhoun VD. Tracking whole-brain connectivity dynamics in the resting state. Cerebral Cortex. 2014;24(3):663-676'},{id:"B29",body:'Sakoğlu Ü, Pearlson GD, Kiehl KA, Wang YM, Michael AM, Calhoun VD. A method for evaluating dynamic functional network connectivity and task-modulation: Application to schizophrenia. Magnetic Resonance Materials in Physics, Biology and Medicine. 2010;23(5):351-366'},{id:"B30",body:'Calhoun Vince D, Miller R, Pearlson G, Adalı T. The cronnectome: Time-varying connectivity networks as the next frontier in fMRI data discovery. Neuron. 2014;84(2):262-274'},{id:"B31",body:'Wang Z, Zhang X, Dou W, Zhang M, Chen H, Lu M, et al. Best window width determination and glioma analysis application of dynamic brain network measure on resting-state functional magnetic resonance imaging. Journal of Medical Imaging and Health Informatics. 2016;6(7):1735-1740'},{id:"B32",body:'Leonardi N, Van De Ville D. On spurious and real fluctuations of dynamic functional connectivity during rest. NeuroImage. 2015;104:430-436'},{id:"B33",body:'Mokhtari F, Akhlaghi MI, Simpson SL, Wu G, Laurienti PJ. Sliding window correlation analysis: Modulating window shape for dynamic brain connectivity in resting state. NeuroImage. 2019;189:655-666'},{id:"B34",body:'Zhang W, Wang Z, Dou W, Wang X, Lu M, Zhang M, et al. Dynamic features extraction method of resting-state BOLD-fMRI signal and its application to brain data classification between normal and glioma. 2014 12th International Conference on Signal Processing (ICSP); 2014'},{id:"B35",body:'Rashid B, Damaraju E, Pearlson GD, Calhoun VD. Dynamic connectivity states estimated from resting fMRI Identify differences among Schizophrenia, bipolar disorder, and healthy control subjects. Frontiers in Human Neuroscience. 2014;8(897)'},{id:"B36",body:'Yuan H, Phillips R, Wong CK, Zotev V, Misaki M, Wurfel B, et al. Tracking resting state connectivity dynamics in veterans with PTSD. NeuroImage: Clinical. 2018;19:260-270'},{id:"B37",body:'Zhu H, Huang J, Deng L, He N, Cheng L, Shu P, et al. Abnormal dynamic functional connectivity associated with subcortical networks in Parkinson’s disease: A temporal variability perspective. Frontiers in Neuroscience. 2019;13(80)'},{id:"B38",body:'Aggarwal P, Gupta A. Multivariate graph learning for detecting aberrant connectivity of dynamic brain networks in autism. Medical Image Analysis. 2019;56:11-25'},{id:"B39",body:'Xia Y, Chen Q , Shi L, Li M, Gong W, Chen H, et al. Tracking the dynamic functional connectivity structure of the human brain across the adult lifespan. Human Brain Mapping. 2019;40(3):717-728'},{id:"B40",body:'Liu J, Liao X, Xia M, He Y. Chronnectome fingerprinting: Identifying individuals and predicting higher cognitive functions using dynamic brain connectivity patterns. Human Brain Mapping. 2018;39(2):902-915'},{id:"B41",body:'Mclntosh A, Gonzalez-Lima F. Structural equation modeling and its application to network analysis in functional brain imaging. Human Brain Mapping. 1994;2(1-2):2-22'},{id:"B42",body:'Friston KJ, Harrison L, Penny W. Dynamic causal modelling. NeuroImage. 2003;19(4):1273-1302'},{id:"B43",body:'Deshpande G, LaConte S, James GA, Peltier S, Hu X. Multivariate Granger causality analysis of fMRI data. Human Brain Mapping. 2009;30(4):1361-1373'},{id:"B44",body:'Granger CWJ. Investigating causal relations by econometric models and cross-spectral methods. Econometrica. 1969;37(3):424-438'},{id:"B45",body:'Razi A, Seghier ML, Zhou Y, McColgan P, Zeidman P, Park H-J, et al. Large-scale DCMs for resting-state fMRI. Network Neuroscience. 2017;1(3):222-241'},{id:"B46",body:'Friston KJ, Kahan J, Biswal B, Razi A. A DCM for resting state fMRI. NeuroImage. 2014;94:396-407'},{id:"B47",body:'Ge Y, Yang Z, Feng Y, Pan Y, Dou W. Extended network-based statistics for measuring altered directed connectivity components in the human brain. 2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM); 2021'},{id:"B48",body:'Sugihara G, May R, Ye H, Hsieh C-H, Deyle E, Fogarty M, et al. Detecting causality in complex ecosystems. Science. 2012;338(6106):496-500'},{id:"B49",body:'Duggento A, Guerrisi M, Toschi N. Echo state network models for nonlinear Granger causality. Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences. 2021;379(2212):20200256'},{id:"B50",body:'Korhonen O, Zanin M, Papo D. Principles and open questions in functional brain network reconstruction. Human Brain Mapping. 2021;42(11):3680-3711'},{id:"B51",body:'Zheng W, Ge Y, Ren S, Ran W, Zhang X, Tian W, et al. Abnormal static and dynamic functional connectivity of resting-state fMRI in multiple system atrophy. Aging (Albany NY). 2020;12(16):16341-16356'},{id:"B52",body:'Zalesky A, Fornito A, Bullmore ET. Network-based statistic: Identifying differences in brain networks. NeuroImage. 2010;53(4):1197-1207'},{id:"B53",body:'Arbabshirani MR, Plis S, Sui J, Calhoun VD. Single subject prediction of brain disorders in neuroimaging: Promises and pitfalls. NeuroImage. 2017;145:137-165'},{id:"B54",body:'Kim B, Winstein C. Can neurological biomarkers of brain impairment be used to predict poststroke motor recovery? A systematic review. Neurorehabilitation and Neural Repair. 2017;31(1):3-24'},{id:"B55",body:'Stinear CM, Ward NS. How useful is imaging in predicting outcomes in stroke rehabilitation? International Journal of Stroke. 2013;8(1):33-37'},{id:"B56",body:'Solstrand Dahlberg L, Becerra L, Borsook D, Linnman C. Brain changes after spinal cord injury, a quantitative meta-analysis and review. Neuroscience & Biobehavioral Reviews. 2018;90:272-293'},{id:"B57",body:'Thiel A, Vahdat S. Structural and resting-state brain connectivity of motor networks after stroke. Stroke. 2015;46(1):296-301'},{id:"B58",body:'Chen JL, Schlaug G. Increased resting state connectivity between ipsilesional motor cortex and contralesional premotor cortex after transcranial direct current stimulation with physical therapy. Scientific Reports. 2016;6(1):23271'},{id:"B59",body:'Allman C, Amadi U, Winkler AM, Wilkins L, Filippini N, Kischka U, et al. Ipsilesional anodal tDCS enhances the functional benefits of rehabilitation in patients after stroke. Science Translational Medicine. 2016;8(330):330re1-re1'},{id:"B60",body:'Caeyenberghs K, Clemente A, Imms P, Egan G, Hocking DR, Leemans A, et al. Evidence for training-dependent structural neuroplasticity in brain-injured patients: A critical review. Neurorehabilitation and Neural Repair. 2018;32(2):99-114'},{id:"B61",body:'Athanasiou A, Klados MA, Pandria N, Foroglou N, Kavazidi KR, Polyzoidis K, et al. A systematic review of investigations into functional brain connectivity following spinal cord injury. Frontiers in Human Neuroscience. 2017;11(517)'},{id:"B62",body:'Hu M, Ji F, Lu Z, Huang W, Khosrowabadi R, Zhao L, et al. Differential amplitude of low-frequency fluctuations in brain networks after BCI training with and without tDCS in stroke. 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC); 2018'},{id:"B63",body:'Pan Y, Dou W-B, Wang Y-H, Luo H-W, Ge Y-X, Yan S-Y, et al. Non-concomitant cortical structural and functional alterations in sensorimotor areas following incomplete spinal cord injury. Neural Regeneration Research. 2017;12(12):2059-2066'},{id:"B64",body:'Ge Y, Pan Y, Wu Q , Dou W. A distance-based neurorehabilitation evaluation method using linear SVM and resting-state fMRI. Frontiers in Neurology. 2019;10(1105)'},{id:"B65",body:'Song J, Nair VA, Young BM, Walton LM, Nigogosyan Z, Remsik A, et al. DTI measures track and predict motor function outcomes in stroke rehabilitation utilizing BCI technology. Frontiers in Human Neuroscience. 2015;9(195)'},{id:"B66",body:'Wu Q , Yue Z, Ge Y, Ma D, Yin H, Zhao H, et al. Brain functional networks study of subacute stroke patients with upper limb dysfunction after comprehensive rehabilitation including BCI training. Frontiers in Neurology. 2020;10(1419)'},{id:"B67",body:'Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ , et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71(9):670-676'},{id:"B68",body:'Huppertz H-J, Möller L, Südmeyer M, Hilker R, Hattingen E, Egger K, et al. Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification. Movement Disorders. 2016;31(10):1506-1517'},{id:"B69",body:'Planetta PJ, Kurani AS, Shukla P, Prodoehl J, Corcos DM, Comella CL, et al. Distinct functional and macrostructural brain changes in Parkinson\'s disease and multiple system atrophy. Human Brain Mapping. 2015;36(3):1165-1179'},{id:"B70",body:'Pellecchia MT, Barone P, Mollica C, Salvatore E, Ianniciello M, Longo K, et al. Diffusion-weighted imaging in multiple system atrophy: A comparison between clinical subtypes. Movement Disorders. 2009;24(5):689-696'},{id:"B71",body:'Chen B, Fan G, Sun W, Shang X, Shi S, Wang S, et al. Usefulness of diffusion-tensor MRI in the diagnosis of Parkinson variant of multiple system atrophy and Parkinson\'s disease: A valuable tool to differentiate between them? Clinical Radiology. 2017;72(7):610-615'},{id:"B72",body:'You H, Wang J, Wang H, Zang Y-F, Zheng F-L, Meng C-L, et al. Altered regional homogeneity in motor cortices in patients with multiple system atrophy. Neuroscience Letters. 2011;502(1):18-23'},{id:"B73",body:'Wang N, Edmiston EK, Luo X, Yang H, Chang M, Wang F, et al. Comparing abnormalities of amplitude of low-frequency fluctuations in multiple system atrophy and idiopathic Parkinson\'s disease measured with resting-state fMRI. Psychiatry Research: Neuroimaging. 2017;269:73-81'},{id:"B74",body:'Yao Q , Zhu D, Li F, Xiao C, Lin X, Huang Q , et al. Altered functional and causal connectivity of cerebello-cortical circuits between multiple system atrophy (Parkinsonian Type) and Parkinson’s disease. Frontiers in Aging Neuroscience. 2017;9(266)'},{id:"B75",body:'Ren S, Zhang H, Zheng W, Liu M, Gao F, Wang Z, et al. Altered functional connectivity of cerebello-cortical circuit in multiple system atrophy (Cerebellar-Type). Frontiers in Neuroscience. 2019;12(996)'},{id:"B76",body:'Ge Y, Zheng W, Li Y, Dou W, Ren S, Chen Z, et al. Altered Brain Volume, Microstructure Metrics and Functional Connectivity Features in Multiple System Atrophy. Frontiers in Aging Neuroscience. 2022;14:799251. doi: 10.3389/fnagi.2022.799251'},{id:"B77",body:'Mamelak AN, Jacoby DB. Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601). Expert Opinion on Drug Delivery. 2007;4(2):175-186'},{id:"B78",body:'Wong ET, Brem S. Taming glioblastoma: Targeting angiogenesis. Journal of Clinical Oncology. 2007;25(30):4705-4706'},{id:"B79",body:'Li Y. Multi-level Functional Network Characteristic Analysis for Glioma Patients Based on fMRI Information. Beijing, China: Tsinghua University; 2015'},{id:"B80",body:'Constable RT. Challenges in fMRI and its limitations. In: Faro SH, Mohamed FB, editors. Functional MRI: Basic Principles and Clinical Applications. New York, NY: Springer New York; 2006. pp. 75-98'},{id:"B81",body:'Manglore S, Bharath R, Panda R, George L, Thamodharan A, Gupta A. Utility of resting fMRI and connectivity in patients with brain tumor. Neurology India. 2013;61(2):144-151'},{id:"B82",body:'Esposito R, Mattei PA, Briganti C, Romani GL, Tartaro A, Caulo M. Modifications of default-mode network connectivity in patients with cerebral glioma. PLOS ONE. 2012;7(7):e40231'},{id:"B83",body:'Harris RJ, Bookheimer SY, Cloughesy TF, Kim HJ, Pope WB, Lai A, et al. Altered functional connectivity of the default mode network in diffuse gliomas measured with pseudo-resting state fMRI. Journal of Neuro-Oncology. 2014;116(2):373-379'},{id:"B84",body:'Fortin J-P, Parker D, Tunç B, Watanabe T, Elliott MA, Ruparel K, et al. Harmonization of multi-site diffusion tensor imaging data. NeuroImage. 2017;161:149-170'},{id:"B85",body:'Fortin J-P, Cullen N, Sheline YI, Taylor WD, Aselcioglu I, Cook PA, et al. Harmonization of cortical thickness measurements across scanners and sites. NeuroImage. 2018;167:104-120'}],footnotes:[],contributors:[{corresp:null,contributorFullName:"Yunxiang Ge",address:null,affiliation:'
Department of Electronic Engineering, Beijing National Research Center for Information Science and Technology (BNRist), Tsinghua University, Beijing, China
Department of Electronic Engineering, Beijing National Research Center for Information Science and Technology (BNRist), Tsinghua University, Beijing, China
The Open Access model is applied to all of our publications and is designed to eliminate subscriptions and pay-per-view fees. This approach ensures free, immediate access to full text versions of your research.
As a gold Open Access publisher, an Open Access Publishing Fee is payable on acceptance following peer review of the manuscript. In return, we provide high quality publishing services and exclusive benefits for all contributors. IntechOpen is the trusted publishing partner of over 140,000 international scientists and researchers.
\\n\\n
The Open Access Publishing Fee (OAPF) is payable only after your book chapter, monograph or journal article is accepted for publication.
\\n\\n
OAPF Publishing Options
\\n\\n
\\n\\t
1,400 GBP Chapter - Edited Volume
\\n\\t
850 GBP Chapter - Book Series Topic (Annual Volume)
\\n\\t
10,000 GBP Monograph - Long Form
\\n\\t
4,000 GBP Compacts Monograph - Short Form
\\n\\t
850 GBP Journal Article (Across Portfolio)
\\n
\\n\\n
During the launching phase journals do not charge an APC, rather they will be funded by IntechOpen.
\\n\\n
*These prices do not include Value-Added Tax (VAT). Residents of European Union countries need to add VAT based on the specific rate in their country of residence. Institutions and companies registered as VAT taxable entities in their own EU member state will not pay VAT as long as provision of the VAT registration number is made during the application process. This is made possible by the EU reverse charge method.
\\n\\n
Services included are:
\\n\\n
\\n\\t
An online manuscript tracking system to facilitate your work
\\n\\t
Personal contact and support throughout the publishing process from your dedicated Author Service Manager
\\n\\t
Assurance that your manuscript meets the highest publishing standards
\\n\\t
English language copyediting and proofreading, including the correction of grammatical, spelling, and other common errors
\\n\\t
XML Typesetting and pagination - web (PDF, HTML) and print files preparation
\\n\\t
Discoverability - electronic citation and linking via DOI
\\n\\t
Permanent and unrestricted online access to your work
\\n
\\n\\n
What isn't covered by the Open Access Publishing Fee?
\\n\\n
If your manuscript:
\\n\\n
\\n\\t
Exceeds the number of pages defined by the publishing guidelines, an additional fee per page may be required
\\n\\t
If a manuscript requires Heavy Editing or Language Polishing, this will incur additional fees.
\\n
\\n\\n
Your Author Service Manager will inform you of any items not covered by the OAPF and provide exact information regarding those additional costs before proceeding.
\\n\\n
Open Access Funding
\\n\\n
To explore funding opportunities and learn more about how you can finance your IntechOpen publication, go to our Open Access Funding page. IntechOpen offers expert assistance to all of its Authors. We can support you in approaching funding bodies and institutions in relation to publishing fees by providing information about compliance with the Open Access policies of your funder or institution. We can also assist with communicating the benefits of Open Access in order to support and strengthen your funding request and provide personal guidance through your application process. You can contact us at funders@intechopen.com for further details or assistance.
\\n\\n
For Authors who are still unable to obtain funding from their institutions or research funding bodies for individual projects, IntechOpen does offer the possibility of applying for a Waiver to offset some or all processing feed. Details regarding our Waiver Policy can be found here.
\\n\\n
Added Value of Publishing with IntechOpen
\\n\\n
Choosing to publish with IntechOpen ensures the following benefits:
\\n\\n
\\n\\t
Indexing and listing across major repositories, see details ...
\\n\\t
Long-term archiving
\\n\\t
Visibility on the world's strongest OA platform
\\n\\t
Live Performance Metrics to track readership and the impact of your chapter
\\n\\t
Dissemination and Promotion
\\n
\\n\\n
Benefits of Publishing with IntechOpen
\\n\\n
\\n\\t
Proven world leader in Open Access book publishing with over 10 years experience
\\n\\t
+5,700 OA books published
\\n\\t
Most competitive prices in the market
\\n\\t
Fully compliant with OA funding requirements
\\n\\t
Optimized processes that assure your research is made available to the scientific community without delay
\\n\\t
Personal support during every step of the publication process
\\n\\t
+184,650 citations in Web of Science databases
\\n\\t
Currently strongest OA platform with over 175 million downloads
As a gold Open Access publisher, an Open Access Publishing Fee is payable on acceptance following peer review of the manuscript. In return, we provide high quality publishing services and exclusive benefits for all contributors. IntechOpen is the trusted publishing partner of over 140,000 international scientists and researchers.
\n\n
The Open Access Publishing Fee (OAPF) is payable only after your book chapter, monograph or journal article is accepted for publication.
\n\n
OAPF Publishing Options
\n\n
\n\t
1,400 GBP Chapter - Edited Volume
\n\t
850 GBP Chapter - Book Series Topic (Annual Volume)
\n\t
10,000 GBP Monograph - Long Form
\n\t
4,000 GBP Compacts Monograph - Short Form
\n\t
850 GBP Journal Article (Across Portfolio)
\n
\n\n
During the launching phase journals do not charge an APC, rather they will be funded by IntechOpen.
\n\n
*These prices do not include Value-Added Tax (VAT). Residents of European Union countries need to add VAT based on the specific rate in their country of residence. Institutions and companies registered as VAT taxable entities in their own EU member state will not pay VAT as long as provision of the VAT registration number is made during the application process. This is made possible by the EU reverse charge method.
\n\n
Services included are:
\n\n
\n\t
An online manuscript tracking system to facilitate your work
\n\t
Personal contact and support throughout the publishing process from your dedicated Author Service Manager
\n\t
Assurance that your manuscript meets the highest publishing standards
\n\t
English language copyediting and proofreading, including the correction of grammatical, spelling, and other common errors
\n\t
XML Typesetting and pagination - web (PDF, HTML) and print files preparation
\n\t
Discoverability - electronic citation and linking via DOI
\n\t
Permanent and unrestricted online access to your work
\n
\n\n
What isn't covered by the Open Access Publishing Fee?
\n\n
If your manuscript:
\n\n
\n\t
Exceeds the number of pages defined by the publishing guidelines, an additional fee per page may be required
\n\t
If a manuscript requires Heavy Editing or Language Polishing, this will incur additional fees.
\n
\n\n
Your Author Service Manager will inform you of any items not covered by the OAPF and provide exact information regarding those additional costs before proceeding.
\n\n
Open Access Funding
\n\n
To explore funding opportunities and learn more about how you can finance your IntechOpen publication, go to our Open Access Funding page. IntechOpen offers expert assistance to all of its Authors. We can support you in approaching funding bodies and institutions in relation to publishing fees by providing information about compliance with the Open Access policies of your funder or institution. We can also assist with communicating the benefits of Open Access in order to support and strengthen your funding request and provide personal guidance through your application process. You can contact us at funders@intechopen.com for further details or assistance.
\n\n
For Authors who are still unable to obtain funding from their institutions or research funding bodies for individual projects, IntechOpen does offer the possibility of applying for a Waiver to offset some or all processing feed. Details regarding our Waiver Policy can be found here.
\n\n
Added Value of Publishing with IntechOpen
\n\n
Choosing to publish with IntechOpen ensures the following benefits:
\n\n
\n\t
Indexing and listing across major repositories, see details ...
\n\t
Long-term archiving
\n\t
Visibility on the world's strongest OA platform
\n\t
Live Performance Metrics to track readership and the impact of your chapter
\n\t
Dissemination and Promotion
\n
\n\n
Benefits of Publishing with IntechOpen
\n\n
\n\t
Proven world leader in Open Access book publishing with over 10 years experience
\n\t
+5,700 OA books published
\n\t
Most competitive prices in the market
\n\t
Fully compliant with OA funding requirements
\n\t
Optimized processes that assure your research is made available to the scientific community without delay
\n\t
Personal support during every step of the publication process
\n\t
+184,650 citations in Web of Science databases
\n\t
Currently strongest OA platform with over 175 million downloads
\n
\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{},profiles:[{id:"396",title:"Dr.",name:"Vedran",middleName:null,surname:"Kordic",slug:"vedran-kordic",fullName:"Vedran Kordic",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/396/images/7281_n.png",biography:"After obtaining his Master's degree in Mechanical Engineering he continued his education at the Vienna University of Technology where he obtained his PhD degree in 2004. He worked as a researcher at the Automation and Control Institute, Faculty of Electrical Engineering, Vienna University of Technology until 2008. His studies in robotics lead him not only to a PhD degree but also inspired him to co-found and build the International Journal of Advanced Robotic Systems - world's first Open Access journal in the field of robotics.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"441",title:"Ph.D.",name:"Jaekyu",middleName:null,surname:"Park",slug:"jaekyu-park",fullName:"Jaekyu Park",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/441/images/1881_n.jpg",biography:null,institutionString:null,institution:{name:"LG Corporation (South Korea)",country:{name:"Korea, South"}}},{id:"465",title:"Dr.",name:"Christian",middleName:null,surname:"Martens",slug:"christian-martens",fullName:"Christian Martens",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Rheinmetall (Germany)",country:{name:"Germany"}}},{id:"479",title:"Dr.",name:"Valentina",middleName:null,surname:"Colla",slug:"valentina-colla",fullName:"Valentina Colla",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/479/images/358_n.jpg",biography:null,institutionString:null,institution:{name:"Sant'Anna School of Advanced Studies",country:{name:"Italy"}}},{id:"494",title:"PhD",name:"Loris",middleName:null,surname:"Nanni",slug:"loris-nanni",fullName:"Loris Nanni",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/494/images/system/494.jpg",biography:"Loris Nanni received his Master Degree cum laude on June-2002 from the University of Bologna, and the April 26th 2006 he received his Ph.D. in Computer Engineering at DEIS, University of Bologna. On September, 29th 2006 he has won a post PhD fellowship from the university of Bologna (from October 2006 to October 2008), at the competitive examination he was ranked first in the industrial engineering area. He extensively served as referee for several international journals. He is author/coauthor of more than 100 research papers. He has been involved in some projects supported by MURST and European Community. His research interests include pattern recognition, bioinformatics, and biometric systems (fingerprint classification and recognition, signature verification, face recognition).",institutionString:null,institution:null},{id:"496",title:"Dr.",name:"Carlos",middleName:null,surname:"Leon",slug:"carlos-leon",fullName:"Carlos Leon",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Seville",country:{name:"Spain"}}},{id:"512",title:"Dr.",name:"Dayang",middleName:null,surname:"Jawawi",slug:"dayang-jawawi",fullName:"Dayang Jawawi",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Technology Malaysia",country:{name:"Malaysia"}}},{id:"528",title:"Dr.",name:"Kresimir",middleName:null,surname:"Delac",slug:"kresimir-delac",fullName:"Kresimir Delac",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/528/images/system/528.jpg",biography:"K. Delac received his B.Sc.E.E. degree in 2003 and is currentlypursuing a Ph.D. degree at the University of Zagreb, Faculty of Electrical Engineering andComputing. His current research interests are digital image analysis, pattern recognition andbiometrics.",institutionString:null,institution:{name:"University of Zagreb",country:{name:"Croatia"}}},{id:"557",title:"Dr.",name:"Andon",middleName:"Venelinov",surname:"Topalov",slug:"andon-topalov",fullName:"Andon Topalov",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/557/images/1927_n.jpg",biography:"Dr. Andon V. Topalov received the MSc degree in Control Engineering from the Faculty of Information Systems, Technologies, and Automation at Moscow State University of Civil Engineering (MGGU) in 1979. He then received his PhD degree in Control Engineering from the Department of Automation and Remote Control at Moscow State Mining University (MGSU), Moscow, in 1984. From 1985 to 1986, he was a Research Fellow in the Research Institute for Electronic Equipment, ZZU AD, Plovdiv, Bulgaria. In 1986, he joined the Department of Control Systems, Technical University of Sofia at the Plovdiv campus, where he is presently a Full Professor. He has held long-term visiting Professor/Scholar positions at various institutions in South Korea, Turkey, Mexico, Greece, Belgium, UK, and Germany. And he has coauthored one book and authored or coauthored more than 80 research papers in conference proceedings and journals. His current research interests are in the fields of intelligent control and robotics.",institutionString:null,institution:{name:"Technical University of Sofia",country:{name:"Bulgaria"}}},{id:"585",title:"Prof.",name:"Munir",middleName:null,surname:"Merdan",slug:"munir-merdan",fullName:"Munir Merdan",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/585/images/system/585.jpg",biography:"Munir Merdan received the M.Sc. degree in mechanical engineering from the Technical University of Sarajevo, Bosnia and Herzegovina, in 2001, and the Ph.D. degree in electrical engineering from the Vienna University of Technology, Vienna, Austria, in 2009.Since 2005, he has been at the Automation and Control Institute, Vienna University of Technology, where he is currently a Senior Researcher. His research interests include the application of agent technology for achieving agile control in the manufacturing environment.",institutionString:null,institution:null},{id:"605",title:"Prof",name:"Dil",middleName:null,surname:"Hussain",slug:"dil-hussain",fullName:"Dil Hussain",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/605/images/system/605.jpg",biography:"Dr. Dil Muhammad Akbar Hussain is a professor of Electronics Engineering & Computer Science at the Department of Energy Technology, Aalborg University Denmark. Professor Akbar has a Master degree in Digital Electronics from Govt. College University, Lahore Pakistan and a P-hD degree in Control Engineering from the School of Engineering and Applied Sciences, University of Sussex United Kingdom. Aalborg University has Two Satellite Campuses, one in Copenhagen (Aalborg University Copenhagen) and the other in Esbjerg (Aalborg University Esbjerg).\n· He is a member of prestigious IEEE (Institute of Electrical and Electronics Engineers), and IAENG (International Association of Engineers) organizations. \n· He is the chief Editor of the Journal of Software Engineering.\n· He is the member of the Editorial Board of International Journal of Computer Science and Software Technology (IJCSST) and International Journal of Computer Engineering and Information Technology. \n· He is also the Editor of Communication in Computer and Information Science CCIS-20 by Springer.\n· Reviewer For Many Conferences\nHe is the lead person in making collaboration agreements between Aalborg University and many universities of Pakistan, for which the MOU’s (Memorandum of Understanding) have been signed.\nProfessor Akbar is working in Academia since 1990, he started his career as a Lab demonstrator/TA at the University of Sussex. After finishing his P. hD degree in 1992, he served in the Industry as a Scientific Officer and continued his academic career as a visiting scholar for a number of educational institutions. In 1996 he joined National University of Science & Technology Pakistan (NUST) as an Associate Professor; NUST is one of the top few universities in Pakistan. In 1999 he joined an International Company Lineo Inc, Canada as Manager Compiler Group, where he headed the group for developing Compiler Tool Chain and Porting of Operating Systems for the BLACKfin processor. The processor development was a joint venture by Intel and Analog Devices. In 2002 Lineo Inc., was taken over by another company, so he joined Aalborg University Denmark as an Assistant Professor.\nProfessor Akbar has truly a multi-disciplined career and he continued his legacy and making progress in many areas of his interests both in teaching and research. He has contributed in stochastic estimation of control area especially, in the Multiple Target Tracking and Interactive Multiple Model (IMM) research, Ball & Beam Control Problem, Robotics, Levitation Control. He has contributed in developing Algorithms for Fingerprint Matching, Computer Vision and Face Recognition. He has been supervising Pattern Recognition, Formal Languages and Distributed Processing projects for several years. He has reviewed many books on Management, Computer Science. Currently, he is an active and permanent reviewer for many international conferences and symposia and the program committee member for many international conferences.\nIn teaching he has taught the core computer science subjects like, Digital Design, Real Time Embedded System Programming, Operating Systems, Software Engineering, Data Structures, Databases, Compiler Construction. In the Engineering side, Digital Signal Processing, Computer Architecture, Electronics Devices, Digital Filtering and Engineering Management.\nApart from his Academic Interest and activities he loves sport especially, Cricket, Football, Snooker and Squash. He plays cricket for Esbjerg city in the second division team as an opener wicket keeper batsman. He is a very good player of squash but has not played squash since his arrival in Denmark.",institutionString:null,institution:null},{id:"611",title:"Prof.",name:"T",middleName:null,surname:"Nagarajan",slug:"t-nagarajan",fullName:"T Nagarajan",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universiti Teknologi Petronas",country:{name:"Malaysia"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:13389},{group:"region",caption:"Middle and South America",value:2,count:11662},{group:"region",caption:"Africa",value:3,count:4168},{group:"region",caption:"Asia",value:4,count:22333},{group:"region",caption:"Australia and Oceania",value:5,count:2019},{group:"region",caption:"Europe",value:6,count:33644}],offset:12,limit:12,total:135278},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{sort:"-dateEndThirdStepPublish"},books:[{type:"book",id:"9985",title:"Geostatistics",subtitle:null,isOpenForSubmission:!0,hash:"423cb3896195a618c4acb493ce4fd23d",slug:null,bookSignature:"Prof. Jeffrey M. Yarus, Dr. Marko Maucec, Dr. Timothy C. Coburn and Associate Prof. Michael Pyrcz",coverURL:"https://cdn.intechopen.com/books/images_new/9985.jpg",editedByType:null,editors:[{id:"78011",title:"Prof.",name:"Jeffrey M.",surname:"Yarus",slug:"jeffrey-m.-yarus",fullName:"Jeffrey M. Yarus"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12456",title:"Arthroscopis Surgery",subtitle:null,isOpenForSubmission:!0,hash:"7c8c783b20d7e2e1ee6cf53df3bf0750",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/12456.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12215",title:"Cell Death and Disease",subtitle:null,isOpenForSubmission:!0,hash:"dfd456a29478fccf4ebd3294137eb1e3",slug:null,bookSignature:"Dr. Ke Xu",coverURL:"https://cdn.intechopen.com/books/images_new/12215.jpg",editedByType:null,editors:[{id:"59529",title:"Dr.",name:"Ke",surname:"Xu",slug:"ke-xu",fullName:"Ke Xu"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12112",title:"The Colorectal Surgery",subtitle:null,isOpenForSubmission:!0,hash:"21c65e742d31d5b69fb681ef78cfa0be",slug:null,bookSignature:"Dr. Muhammad Shamim",coverURL:"https://cdn.intechopen.com/books/images_new/12112.jpg",editedByType:null,editors:[{id:"235128",title:"Dr.",name:"Muhammad",surname:"Shamim",slug:"muhammad-shamim",fullName:"Muhammad Shamim"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11998",title:"Biocomposites - Recent Advances",subtitle:null,isOpenForSubmission:!0,hash:"8bc7ffd7544fff1901301c787e64fada",slug:null,bookSignature:"Prof. Magdy Elnashar",coverURL:"https://cdn.intechopen.com/books/images_new/11998.jpg",editedByType:null,editors:[{id:"12075",title:"Prof.",name:"Magdy",surname:"Elnashar",slug:"magdy-elnashar",fullName:"Magdy Elnashar"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11999",title:"Earthquakes - Recent Advances, New Perspectives and Applications",subtitle:null,isOpenForSubmission:!0,hash:"b2af07109b13b76e5af9583532ab5bee",slug:null,bookSignature:"Dr. Walter Salazar",coverURL:"https://cdn.intechopen.com/books/images_new/11999.jpg",editedByType:null,editors:[{id:"236461",title:"Dr.",name:"Walter",surname:"Salazar",slug:"walter-salazar",fullName:"Walter Salazar"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12058",title:"Future Housing",subtitle:null,isOpenForSubmission:!0,hash:"e7f4a1e57fab392b61156956c1247b9e",slug:null,bookSignature:"Dr. Ivan Oropeza-Perez and Dr. Astrid Helena Petzold-Rodríguez",coverURL:"https://cdn.intechopen.com/books/images_new/12058.jpg",editedByType:null,editors:[{id:"282172",title:"Dr.",name:"Ivan",surname:"Oropeza-Perez",slug:"ivan-oropeza-perez",fullName:"Ivan Oropeza-Perez"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12079",title:"Strategies Towards the Synthesis of Heterocycles and Their Applications",subtitle:null,isOpenForSubmission:!0,hash:"bc4022af925c0883636e0819008971ee",slug:null,bookSignature:"Dr. Premlata Kumari and Dr. Amit B Patel",coverURL:"https://cdn.intechopen.com/books/images_new/12079.jpg",editedByType:null,editors:[{id:"177041",title:"Dr.",name:"Premlata",surname:"Kumari",slug:"premlata-kumari",fullName:"Premlata Kumari"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12172",title:"Health Risks of Food Additives - Recent Developments and Trends in Food Sector",subtitle:null,isOpenForSubmission:!0,hash:"f6aa23b1045d266d0928fcef04fa3417",slug:null,bookSignature:"Dr. Muhammad Sajid Arshad and Mr. Waseem Khalid",coverURL:"https://cdn.intechopen.com/books/images_new/12172.jpg",editedByType:null,editors:[{id:"192998",title:"Dr.",name:"Muhammad Sajid",surname:"Arshad",slug:"muhammad-sajid-arshad",fullName:"Muhammad Sajid Arshad"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12196",title:"Sepsis - New Perspectives",subtitle:null,isOpenForSubmission:!0,hash:"3590e6f6047122bd96d1d57da29c4054",slug:null,bookSignature:"Dr. Lixing Huang, Dr. Youyu Zhang and Dr. Lingbin Sun",coverURL:"https://cdn.intechopen.com/books/images_new/12196.jpg",editedByType:null,editors:[{id:"333148",title:"Dr.",name:"Lixing",surname:"Huang",slug:"lixing-huang",fullName:"Lixing Huang"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11500",title:"Multi-Objective Optimization - Recent Advances, New Perspectives and Applications",subtitle:null,isOpenForSubmission:!0,hash:"842f84f308439c0a55c4e8e6a8fd9c01",slug:null,bookSignature:"Dr. Adel El-Shahat",coverURL:"https://cdn.intechopen.com/books/images_new/11500.jpg",editedByType:null,editors:[{id:"193331",title:"Dr.",name:"Adel",surname:"El-Shahat",slug:"adel-el-shahat",fullName:"Adel El-Shahat"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12113",title:"Tendons - Trauma, Inflammation, Degeneration, and Treatment",subtitle:null,isOpenForSubmission:!0,hash:"2387a4e0d2a76883b16dcccd452281ab",slug:null,bookSignature:"Dr. Nahum Rosenberg",coverURL:"https://cdn.intechopen.com/books/images_new/12113.jpg",editedByType:null,editors:[{id:"68911",title:"Dr.",name:"Nahum",surname:"Rosenberg",slug:"nahum-rosenberg",fullName:"Nahum Rosenberg"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:22},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:6},{group:"topic",caption:"Business, Management and Economics",value:7,count:4},{group:"topic",caption:"Chemistry",value:8,count:15},{group:"topic",caption:"Computer and Information Science",value:9,count:18},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:8},{group:"topic",caption:"Engineering",value:11,count:37},{group:"topic",caption:"Environmental Sciences",value:12,count:5},{group:"topic",caption:"Immunology and Microbiology",value:13,count:8},{group:"topic",caption:"Materials Science",value:14,count:15},{group:"topic",caption:"Mathematics",value:15,count:8},{group:"topic",caption:"Medicine",value:16,count:61},{group:"topic",caption:"Nanotechnology and Nanomaterials",value:17,count:2},{group:"topic",caption:"Neuroscience",value:18,count:2},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:7},{group:"topic",caption:"Physics",value:20,count:5},{group:"topic",caption:"Psychology",value:21,count:5},{group:"topic",caption:"Robotics",value:22,count:2},{group:"topic",caption:"Social Sciences",value:23,count:8},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:2}],offset:12,limit:12,total:467},popularBooks:{featuredBooks:[{type:"book",id:"7827",title:"Interpersonal Relationships",subtitle:null,isOpenForSubmission:!1,hash:"ebf41f4d17c75010eb3294cc8cac3d47",slug:"interpersonal-relationships",bookSignature:"Martha Peaslee Levine",coverURL:"https://cdn.intechopen.com/books/images_new/7827.jpg",editors:[{id:"186919",title:"Dr.",name:"Martha",middleName:null,surname:"Peaslee Levine",slug:"martha-peaslee-levine",fullName:"Martha Peaslee Levine"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10808",title:"Current Concepts in Dental Implantology",subtitle:"From Science to Clinical Research",isOpenForSubmission:!1,hash:"4af8830e463f89c57515c2da2b9777b0",slug:"current-concepts-in-dental-implantology-from-science-to-clinical-research",bookSignature:"Dragana Gabrić and Marko Vuletić",coverURL:"https://cdn.intechopen.com/books/images_new/10808.jpg",editors:[{id:"26946",title:"Prof.",name:"Dragana",middleName:null,surname:"Gabrić",slug:"dragana-gabric",fullName:"Dragana Gabrić"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10796",title:"Extracellular Vesicles",subtitle:"Role in Diseases, Pathogenesis and Therapy",isOpenForSubmission:!1,hash:"eb5407fcf93baff7bca3fae5640153a2",slug:"extracellular-vesicles-role-in-diseases-pathogenesis-and-therapy",bookSignature:"Manash K. Paul",coverURL:"https://cdn.intechopen.com/books/images_new/10796.jpg",editors:[{id:"319365",title:"Assistant Prof.",name:"Manash K.",middleName:null,surname:"Paul",slug:"manash-k.-paul",fullName:"Manash K. Paul"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10908",title:"Advances in Decision Making",subtitle:null,isOpenForSubmission:!1,hash:"126486f7f91e18e2e3539a32c38be7b1",slug:"advances-in-decision-making",bookSignature:"Fausto Pedro García Márquez",coverURL:"https://cdn.intechopen.com/books/images_new/10908.jpg",editors:[{id:"22844",title:"Prof.",name:"Fausto Pedro",middleName:null,surname:"García Márquez",slug:"fausto-pedro-garcia-marquez",fullName:"Fausto Pedro García Márquez"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"95",title:"Applications and Experiences of Quality Control",subtitle:null,isOpenForSubmission:!1,hash:"4bcb22b1eee68210a977a97d5a0f363a",slug:"applications-and-experiences-of-quality-control",bookSignature:"Ognyan Ivanov",coverURL:"https://cdn.intechopen.com/books/images_new/95.jpg",editors:[{id:"22230",title:"Prof.",name:"Ognyan",middleName:null,surname:"Ivanov",slug:"ognyan-ivanov",fullName:"Ognyan Ivanov"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"2160",title:"MATLAB",subtitle:"A Fundamental Tool for Scientific Computing and Engineering Applications - Volume 1",isOpenForSubmission:!1,hash:"dd9c658341fbd264ed4f8d9e6aa8ca29",slug:"matlab-a-fundamental-tool-for-scientific-computing-and-engineering-applications-volume-1",bookSignature:"Vasilios N. Katsikis",coverURL:"https://cdn.intechopen.com/books/images_new/2160.jpg",editors:[{id:"12289",title:"Prof.",name:"Vasilios",middleName:"N.",surname:"Katsikis",slug:"vasilios-katsikis",fullName:"Vasilios Katsikis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"3560",title:"Advances in Landscape Architecture",subtitle:null,isOpenForSubmission:!1,hash:"a20614517ec5f7e91188fe8e42832138",slug:"advances-in-landscape-architecture",bookSignature:"Murat Özyavuz",coverURL:"https://cdn.intechopen.com/books/images_new/3560.jpg",editors:[{id:"93073",title:"Dr.",name:"Murat",middleName:null,surname:"Ozyavuz",slug:"murat-ozyavuz",fullName:"Murat Ozyavuz"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10739",title:"Global Decline of Insects",subtitle:null,isOpenForSubmission:!1,hash:"543783652b9092962a8fa4bed38eeb17",slug:"global-decline-of-insects",bookSignature:"Hamadttu Abdel Farag El-Shafie",coverURL:"https://cdn.intechopen.com/books/images_new/10739.jpg",editors:[{id:"192142",title:"Dr.",name:"Hamadttu",middleName:null,surname:"Abdel Farag El-Shafie",slug:"hamadttu-abdel-farag-el-shafie",fullName:"Hamadttu Abdel Farag El-Shafie"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10911",title:"Higher Education",subtitle:"New Approaches to Accreditation, Digitalization, and Globalization in the Age of Covid",isOpenForSubmission:!1,hash:"223a02337498e535e967174c1f648fbc",slug:"higher-education-new-approaches-to-accreditation-digitalization-and-globalization-in-the-age-of-covid",bookSignature:"Lee Waller and Sharon Waller",coverURL:"https://cdn.intechopen.com/books/images_new/10911.jpg",editors:[{id:"263301",title:"Dr.",name:"Lee",middleName:null,surname:"Waller",slug:"lee-waller",fullName:"Lee Waller"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"3568",title:"Recent Advances in Plant in vitro Culture",subtitle:null,isOpenForSubmission:!1,hash:"830bbb601742c85a3fb0eeafe1454c43",slug:"recent-advances-in-plant-in-vitro-culture",bookSignature:"Annarita Leva and Laura M. R. Rinaldi",coverURL:"https://cdn.intechopen.com/books/images_new/3568.jpg",editors:[{id:"142145",title:"Dr.",name:"Annarita",middleName:null,surname:"Leva",slug:"annarita-leva",fullName:"Annarita Leva"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"3737",title:"MATLAB",subtitle:"Modelling, Programming and Simulations",isOpenForSubmission:!1,hash:null,slug:"matlab-modelling-programming-and-simulations",bookSignature:"Emilson Pereira Leite",coverURL:"https://cdn.intechopen.com/books/images_new/3737.jpg",editors:[{id:"12051",title:"Prof.",name:"Emilson",middleName:null,surname:"Pereira Leite",slug:"emilson-pereira-leite",fullName:"Emilson Pereira Leite"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"1770",title:"Gel Electrophoresis",subtitle:"Principles and Basics",isOpenForSubmission:!1,hash:"279701f6c802cf02deef45103e0611ff",slug:"gel-electrophoresis-principles-and-basics",bookSignature:"Sameh Magdeldin",coverURL:"https://cdn.intechopen.com/books/images_new/1770.jpg",editors:[{id:"123648",title:"Dr.",name:"Sameh",middleName:null,surname:"Magdeldin",slug:"sameh-magdeldin",fullName:"Sameh Magdeldin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:4797},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"7827",title:"Interpersonal Relationships",subtitle:null,isOpenForSubmission:!1,hash:"ebf41f4d17c75010eb3294cc8cac3d47",slug:"interpersonal-relationships",bookSignature:"Martha Peaslee Levine",coverURL:"https://cdn.intechopen.com/books/images_new/7827.jpg",publishedDate:"July 27th 2022",numberOfDownloads:7175,editors:[{id:"186919",title:"Dr.",name:"Martha",middleName:null,surname:"Peaslee Levine",slug:"martha-peaslee-levine",fullName:"Martha Peaslee Levine"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10808",title:"Current Concepts in Dental Implantology",subtitle:"From Science to Clinical Research",isOpenForSubmission:!1,hash:"4af8830e463f89c57515c2da2b9777b0",slug:"current-concepts-in-dental-implantology-from-science-to-clinical-research",bookSignature:"Dragana Gabrić and Marko Vuletić",coverURL:"https://cdn.intechopen.com/books/images_new/10808.jpg",publishedDate:"July 27th 2022",numberOfDownloads:1981,editors:[{id:"26946",title:"Prof.",name:"Dragana",middleName:null,surname:"Gabrić",slug:"dragana-gabric",fullName:"Dragana Gabrić"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10796",title:"Extracellular Vesicles",subtitle:"Role in Diseases, Pathogenesis and Therapy",isOpenForSubmission:!1,hash:"eb5407fcf93baff7bca3fae5640153a2",slug:"extracellular-vesicles-role-in-diseases-pathogenesis-and-therapy",bookSignature:"Manash K. Paul",coverURL:"https://cdn.intechopen.com/books/images_new/10796.jpg",publishedDate:"July 20th 2022",numberOfDownloads:2308,editors:[{id:"319365",title:"Assistant Prof.",name:"Manash K.",middleName:null,surname:"Paul",slug:"manash-k.-paul",fullName:"Manash K. Paul"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10908",title:"Advances in Decision Making",subtitle:null,isOpenForSubmission:!1,hash:"126486f7f91e18e2e3539a32c38be7b1",slug:"advances-in-decision-making",bookSignature:"Fausto Pedro García Márquez",coverURL:"https://cdn.intechopen.com/books/images_new/10908.jpg",publishedDate:"July 27th 2022",numberOfDownloads:1473,editors:[{id:"22844",title:"Prof.",name:"Fausto Pedro",middleName:null,surname:"García Márquez",slug:"fausto-pedro-garcia-marquez",fullName:"Fausto Pedro García Márquez"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"95",title:"Applications and Experiences of Quality Control",subtitle:null,isOpenForSubmission:!1,hash:"4bcb22b1eee68210a977a97d5a0f363a",slug:"applications-and-experiences-of-quality-control",bookSignature:"Ognyan Ivanov",coverURL:"https://cdn.intechopen.com/books/images_new/95.jpg",publishedDate:"April 26th 2011",numberOfDownloads:318571,editors:[{id:"22230",title:"Prof.",name:"Ognyan",middleName:null,surname:"Ivanov",slug:"ognyan-ivanov",fullName:"Ognyan Ivanov"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"2160",title:"MATLAB",subtitle:"A Fundamental Tool for Scientific Computing and Engineering Applications - Volume 1",isOpenForSubmission:!1,hash:"dd9c658341fbd264ed4f8d9e6aa8ca29",slug:"matlab-a-fundamental-tool-for-scientific-computing-and-engineering-applications-volume-1",bookSignature:"Vasilios N. Katsikis",coverURL:"https://cdn.intechopen.com/books/images_new/2160.jpg",publishedDate:"September 26th 2012",numberOfDownloads:271836,editors:[{id:"12289",title:"Prof.",name:"Vasilios",middleName:"N.",surname:"Katsikis",slug:"vasilios-katsikis",fullName:"Vasilios Katsikis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"3560",title:"Advances in Landscape Architecture",subtitle:null,isOpenForSubmission:!1,hash:"a20614517ec5f7e91188fe8e42832138",slug:"advances-in-landscape-architecture",bookSignature:"Murat Özyavuz",coverURL:"https://cdn.intechopen.com/books/images_new/3560.jpg",publishedDate:"July 1st 2013",numberOfDownloads:243450,editors:[{id:"93073",title:"Dr.",name:"Murat",middleName:null,surname:"Ozyavuz",slug:"murat-ozyavuz",fullName:"Murat Ozyavuz"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10739",title:"Global Decline of Insects",subtitle:null,isOpenForSubmission:!1,hash:"543783652b9092962a8fa4bed38eeb17",slug:"global-decline-of-insects",bookSignature:"Hamadttu Abdel Farag El-Shafie",coverURL:"https://cdn.intechopen.com/books/images_new/10739.jpg",publishedDate:"July 20th 2022",numberOfDownloads:1582,editors:[{id:"192142",title:"Dr.",name:"Hamadttu",middleName:null,surname:"Abdel Farag El-Shafie",slug:"hamadttu-abdel-farag-el-shafie",fullName:"Hamadttu Abdel Farag El-Shafie"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10911",title:"Higher Education",subtitle:"New Approaches to Accreditation, Digitalization, and Globalization in the Age of Covid",isOpenForSubmission:!1,hash:"223a02337498e535e967174c1f648fbc",slug:"higher-education-new-approaches-to-accreditation-digitalization-and-globalization-in-the-age-of-covid",bookSignature:"Lee Waller and Sharon Waller",coverURL:"https://cdn.intechopen.com/books/images_new/10911.jpg",publishedDate:"July 13th 2022",numberOfDownloads:2082,editors:[{id:"263301",title:"Dr.",name:"Lee",middleName:null,surname:"Waller",slug:"lee-waller",fullName:"Lee Waller"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"3568",title:"Recent Advances in Plant in vitro Culture",subtitle:null,isOpenForSubmission:!1,hash:"830bbb601742c85a3fb0eeafe1454c43",slug:"recent-advances-in-plant-in-vitro-culture",bookSignature:"Annarita Leva and Laura M. R. Rinaldi",coverURL:"https://cdn.intechopen.com/books/images_new/3568.jpg",publishedDate:"October 17th 2012",numberOfDownloads:256294,editors:[{id:"142145",title:"Dr.",name:"Annarita",middleName:null,surname:"Leva",slug:"annarita-leva",fullName:"Annarita Leva"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"8452",title:"Organizational Conflict",subtitle:"New Insights",isOpenForSubmission:!1,hash:"96bdaaba38a7850a7e7379aa5a505748",slug:"organizational-conflict-new-insights",bookSignature:"Josiane Fahed-Sreih",coverURL:"https://cdn.intechopen.com/books/images_new/8452.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"103784",title:"Dr.",name:"Josiane",middleName:null,surname:"Fahed-Sreih",slug:"josiane-fahed-sreih",fullName:"Josiane Fahed-Sreih"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10778",title:"Model-Based Control Engineering",subtitle:"Recent Design and Implementations for Varied Applications",isOpenForSubmission:!1,hash:"e39a567d9b6d2a45d0a1d927362c9005",slug:"model-based-control-engineering-recent-design-and-implementations-for-varied-applications",bookSignature:"Umar Zakir Abdul Hamid and Ahmad `Athif Mohd Faudzi",coverURL:"https://cdn.intechopen.com/books/images_new/10778.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"268173",title:"Dr.",name:"Umar Zakir Abdul",middleName:null,surname:"Hamid",slug:"umar-zakir-abdul-hamid",fullName:"Umar Zakir Abdul Hamid"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10780",title:"Current Trends in Orthodontics",subtitle:null,isOpenForSubmission:!1,hash:"badce0e23eb5176fd653b049d5295c0a",slug:"current-trends-in-orthodontics",bookSignature:"Farid Bourzgui",coverURL:"https://cdn.intechopen.com/books/images_new/10780.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"52177",title:"Prof.",name:"Farid",middleName:null,surname:"Bourzgui",slug:"farid-bourzgui",fullName:"Farid Bourzgui"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10793",title:"Molecular Mechanisms in Cancer",subtitle:null,isOpenForSubmission:!1,hash:"3ed2817275edb3de6f5683602314706e",slug:"molecular-mechanisms-in-cancer",bookSignature:"Metin Budak and Rajamanickam Rajkumar",coverURL:"https://cdn.intechopen.com/books/images_new/10793.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"226275",title:"Ph.D.",name:"Metin",middleName:null,surname:"Budak",slug:"metin-budak",fullName:"Metin Budak"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11308",title:"Selected Topics on Infant Feeding",subtitle:null,isOpenForSubmission:!1,hash:"213c3e403327a2919eca1dc5e82a0ec3",slug:"selected-topics-on-infant-feeding",bookSignature:"Isam Jaber AL-Zwaini and Haider Hadi AL-Musawi",coverURL:"https://cdn.intechopen.com/books/images_new/11308.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"30993",title:"Prof.",name:"Isam Jaber",middleName:null,surname:"Al-Zwaini",slug:"isam-jaber-al-zwaini",fullName:"Isam Jaber Al-Zwaini"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10808",title:"Current Concepts in Dental Implantology",subtitle:"From Science to Clinical Research",isOpenForSubmission:!1,hash:"4af8830e463f89c57515c2da2b9777b0",slug:"current-concepts-in-dental-implantology-from-science-to-clinical-research",bookSignature:"Dragana Gabrić and Marko Vuletić",coverURL:"https://cdn.intechopen.com/books/images_new/10808.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"26946",title:"Prof.",name:"Dragana",middleName:null,surname:"Gabrić",slug:"dragana-gabric",fullName:"Dragana Gabrić"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11331",title:"Secondary Metabolites",subtitle:"Trends and Reviews",isOpenForSubmission:!1,hash:"7d6274f42d5441e537c5fa744bc84523",slug:"secondary-metabolites-trends-and-reviews",bookSignature:"Ramasamy Vijayakumar and Suresh Selvapuram Sudalaimuthu Raja",coverURL:"https://cdn.intechopen.com/books/images_new/11331.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"176044",title:"Dr.",name:"Ramasamy",middleName:null,surname:"Vijayakumar",slug:"ramasamy-vijayakumar",fullName:"Ramasamy Vijayakumar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10820",title:"Data Clustering",subtitle:null,isOpenForSubmission:!1,hash:"086d299ffd05aacd2311c3ca4ebf0d3a",slug:"data-clustering",bookSignature:"Niansheng Tang",coverURL:"https://cdn.intechopen.com/books/images_new/10820.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"221831",title:"Prof.",name:"Niansheng",middleName:null,surname:"Tang",slug:"niansheng-tang",fullName:"Niansheng Tang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10827",title:"Oral Health Care",subtitle:"An Important Issue of the Modern Society",isOpenForSubmission:!1,hash:"9a0ceb9ced4598aea3f3723f6dc4ea04",slug:"oral-health-care-an-important-issue-of-the-modern-society",bookSignature:"Lavinia Cosmina Ardelean and Laura Cristina Rusu",coverURL:"https://cdn.intechopen.com/books/images_new/10827.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"180569",title:"Dr.",name:"Lavinia",middleName:null,surname:"Ardelean",slug:"lavinia-ardelean",fullName:"Lavinia Ardelean"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11139",title:"Geochemistry and Mineral Resources",subtitle:null,isOpenForSubmission:!1,hash:"928cebbdce21d9b3f081267b24f12dfb",slug:"geochemistry-and-mineral-resources",bookSignature:"Hosam M. Saleh and Amal I. Hassan",coverURL:"https://cdn.intechopen.com/books/images_new/11139.jpg",editedByType:"Edited by",publishedDate:"August 17th 2022",editors:[{id:"144691",title:"Prof.",name:"Hosam M.",middleName:null,surname:"Saleh",slug:"hosam-m.-saleh",fullName:"Hosam M. Saleh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"14",title:"Materials Science",slug:"materials-science",parent:{id:"1",title:"Physical Sciences, Engineering and Technology",slug:"physical-sciences-engineering-and-technology"},numberOfBooks:320,numberOfSeries:0,numberOfAuthorsAndEditors:8300,numberOfWosCitations:17589,numberOfCrossrefCitations:9120,numberOfDimensionsCitations:21479,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicId:"14",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"10945",title:"Collagen Biomaterials",subtitle:null,isOpenForSubmission:!1,hash:"721724968654675a93937e3b5645a266",slug:"collagen-biomaterials",bookSignature:"Nirmal Mazumder and Sanjiban Chakrabarty",coverURL:"https://cdn.intechopen.com/books/images_new/10945.jpg",editedByType:"Edited by",editors:[{id:"256296",title:"Dr.",name:"Nirmal",middleName:null,surname:"Mazumder",slug:"nirmal-mazumder",fullName:"Nirmal Mazumder"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10669",title:"Corrosion",subtitle:"Fundamentals and Protection Mechanisms",isOpenForSubmission:!1,hash:"4a76d54f8a40fc2e7002a8d13fd617c1",slug:"corrosion-fundamentals-and-protection-mechanisms",bookSignature:"Fahmina Zafar, Anujit Ghosal and Eram Sharmin",coverURL:"https://cdn.intechopen.com/books/images_new/10669.jpg",editedByType:"Edited by",editors:[{id:"89672",title:"Dr.",name:"Fahmina",middleName:null,surname:"Zafar",slug:"fahmina-zafar",fullName:"Fahmina Zafar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10847",title:"Aluminium Alloys",subtitle:"Design and Development of Innovative Alloys, Manufacturing Processes and Applications",isOpenForSubmission:!1,hash:"f4ecc3e8fea00488cb2213b7d34b42aa",slug:"aluminium-alloys-design-and-development-of-innovative-alloys-manufacturing-processes-and-applications",bookSignature:"Giulio Timelli",coverURL:"https://cdn.intechopen.com/books/images_new/10847.jpg",editedByType:"Edited by",editors:[{id:"44147",title:"Prof.",name:"Giulio",middleName:null,surname:"Timelli",slug:"giulio-timelli",fullName:"Giulio Timelli"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11210",title:"Chalcogenides",subtitle:"Preparation and Applications",isOpenForSubmission:!1,hash:"f5bf032bc55f99e48f4b0e5375ca7442",slug:"chalcogenides-preparation-and-applications",bookSignature:"Dhanasekaran Vikraman",coverURL:"https://cdn.intechopen.com/books/images_new/11210.jpg",editedByType:"Edited by",editors:[{id:"199404",title:"Prof.",name:"Dhanasekaran",middleName:null,surname:"Vikraman",slug:"dhanasekaran-vikraman",fullName:"Dhanasekaran Vikraman"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11208",title:"Current Trends in Magnesium (Mg) Research",subtitle:null,isOpenForSubmission:!1,hash:"21372a0c65f42d075d4519c2f891e203",slug:"current-trends-in-magnesium-mg-research",bookSignature:"Sailaja S. Sunkari",coverURL:"https://cdn.intechopen.com/books/images_new/11208.jpg",editedByType:"Edited by",editors:[{id:"325832",title:"Dr.",name:"Sailaja S.",middleName:"S.",surname:"Sunkari",slug:"sailaja-s.-sunkari",fullName:"Sailaja S. Sunkari"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10798",title:"Starch",subtitle:"Evolution and Recent Advances",isOpenForSubmission:!1,hash:"f197f6062c1574a9a90e50a369271bcf",slug:"starch-evolution-and-recent-advances",bookSignature:"Martins Ochubiojo Emeje",coverURL:"https://cdn.intechopen.com/books/images_new/10798.jpg",editedByType:"Edited by",editors:[{id:"94311",title:"Prof.",name:"Martins",middleName:"Ochubiojo",surname:"Ochubiojo Emeje",slug:"martins-ochubiojo-emeje",fullName:"Martins Ochubiojo Emeje"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11123",title:"Epoxy-Based Composites",subtitle:null,isOpenForSubmission:!1,hash:"c1c5447cf3b9d6c7688276ac30e80de6",slug:"epoxy-based-composites",bookSignature:"Samson Jerold Samuel Chelladurai, Ramesh Arthanari and M.R.Meera",coverURL:"https://cdn.intechopen.com/books/images_new/11123.jpg",editedByType:"Edited by",editors:[{id:"247421",title:"Dr.",name:"Samson Jerold Samuel",middleName:null,surname:"Chelladurai",slug:"samson-jerold-samuel-chelladurai",fullName:"Samson Jerold Samuel Chelladurai"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10942",title:"Fiber-Reinforced Plastics",subtitle:null,isOpenForSubmission:!1,hash:"50dc791b1036b236a6676986cb295c6f",slug:"fiber-reinforced-plastics",bookSignature:"Martin Alberto Masuelli",coverURL:"https://cdn.intechopen.com/books/images_new/10942.jpg",editedByType:"Edited by",editors:[{id:"99994",title:"Dr.",name:"Martin",middleName:"Alberto",surname:"Alberto Masuelli",slug:"martin-alberto-masuelli",fullName:"Martin Alberto Masuelli"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10489",title:"Biocomposites",subtitle:null,isOpenForSubmission:!1,hash:"c794533fcae9dcea38672f814ae182db",slug:"biocomposites",bookSignature:"Brajesh Kumar",coverURL:"https://cdn.intechopen.com/books/images_new/10489.jpg",editedByType:"Edited by",editors:[{id:"176093",title:"Dr.",name:"Brajesh",middleName:null,surname:"Kumar",slug:"brajesh-kumar",fullName:"Brajesh Kumar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9926",title:"Magnesium Alloys Structure and Properties",subtitle:null,isOpenForSubmission:!1,hash:"a6d1a99f4befe885857743f77e81524c",slug:"magnesium-alloys-structure-and-properties",bookSignature:"Tomasz Tański and Paweł Jarka",coverURL:"https://cdn.intechopen.com/books/images_new/9926.jpg",editedByType:"Edited by",editors:[{id:"15700",title:"Prof.",name:"Tomasz Arkadiusz",middleName:null,surname:"Tański",slug:"tomasz-arkadiusz-tanski",fullName:"Tomasz Arkadiusz Tański"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10700",title:"Titanium Dioxide",subtitle:"Advances and Applications",isOpenForSubmission:!1,hash:"d9448d83caa34d90fd58464268c869a0",slug:"titanium-dioxide-advances-and-applications",bookSignature:"Hafiz Muhammad Ali",coverURL:"https://cdn.intechopen.com/books/images_new/10700.jpg",editedByType:"Edited by",editors:[{id:"187624",title:"Dr.",name:"Hafiz Muhammad",middleName:null,surname:"Ali",slug:"hafiz-muhammad-ali",fullName:"Hafiz Muhammad Ali"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6832",title:"Ruthenium",subtitle:"An Element Loved by Researchers",isOpenForSubmission:!1,hash:"9a3be4dd6035f78add07d239b8eae379",slug:"ruthenium-an-element-loved-by-researchers",bookSignature:"Hitoshi Ishida",coverURL:"https://cdn.intechopen.com/books/images_new/6832.jpg",editedByType:"Edited by",editors:[{id:"210140",title:"Dr.",name:"Hitoshi",middleName:null,surname:"Ishida",slug:"hitoshi-ishida",fullName:"Hitoshi Ishida"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:320,seriesByTopicCollection:[],seriesByTopicTotal:0,mostCitedChapters:[{id:"60680",doi:"10.5772/intechopen.76082",title:"Environmental Contamination by Heavy Metals",slug:"environmental-contamination-by-heavy-metals",totalDownloads:16254,totalCrossrefCites:188,totalDimensionsCites:408,abstract:"The environment and its compartments have been severely polluted by heavy metals. This has compromised the ability of the environment to foster life and render its intrinsic values. Heavy metals are known to be naturally occurring compounds, but anthropogenic activities introduce them in large quantities in different environmental compartments. This leads to the environment’s ability to foster life being reduced as human, animal, and plant health become threatened. This occurs due to bioaccumulation in the food chains as a result of the nondegradable state of the heavy metals. Remediation of heavy metals requires special attention to protect soil quality, air quality, water quality, human health, animal health, and all spheres as a collection. Developed physical and chemical heavy metal remediation technologies are demanding costs which are not feasible, time-consuming, and release additional waste to the environment. This chapter summarises the problems related to heavy metal pollution and various remediation technologies. A case study in South Africa mines were also used.",book:{id:"6534",slug:"heavy-metals",title:"Heavy Metals",fullTitle:"Heavy Metals"},signatures:"Vhahangwele Masindi and Khathutshelo L. Muedi",authors:[{id:"225304",title:"Dr.",name:"Vhahangwele",middleName:null,surname:"Masindi",slug:"vhahangwele-masindi",fullName:"Vhahangwele Masindi"},{id:"241403",title:"M.Sc.",name:"Khathutshelo",middleName:"Lilith",surname:"Muedi",slug:"khathutshelo-muedi",fullName:"Khathutshelo Muedi"}]},{id:"37067",doi:"10.5772/35482",title:"Fourier Transform Infrared Spectroscopy for Natural Fibres",slug:"fourier-transform-infrared-spectroscopy-for-natural-fibres",totalDownloads:9291,totalCrossrefCites:167,totalDimensionsCites:400,abstract:null,book:{id:"2270",slug:"fourier-transform-materials-analysis",title:"Fourier Transform",fullTitle:"Fourier Transform - Materials Analysis"},signatures:"Mizi Fan, Dasong Dai and Biao Huang",authors:[{id:"104647",title:"Prof.",name:"Mizi",middleName:null,surname:"Fan",slug:"mizi-fan",fullName:"Mizi Fan"}]},{id:"42566",doi:"10.5772/53706",title:"Challenges and Opportunities for Spark Plasma Sintering: A Key Technology for a New Generation of Materials",slug:"challenges-and-opportunities-for-spark-plasma-sintering-a-key-technology-for-a-new-generation-of-mat",totalDownloads:9168,totalCrossrefCites:99,totalDimensionsCites:213,abstract:null,book:{id:"3478",slug:"sintering-applications",title:"Sintering Applications",fullTitle:"Sintering Applications"},signatures:"M. Suárez, A. Fernández, J.L. Menéndez, R. Torrecillas, H. U. Kessel, J. Hennicke, R. Kirchner and T. Kessel",authors:[{id:"102383",title:"Dr.",name:"Marta",middleName:null,surname:"Suárez",slug:"marta-suarez",fullName:"Marta Suárez"},{id:"103822",title:"Dr.",name:"J.L",middleName:null,surname:"Menendez",slug:"j.l-menendez",fullName:"J.L Menendez"},{id:"103833",title:"Prof.",name:"Ramón",middleName:null,surname:"Torrecillas",slug:"ramon-torrecillas",fullName:"Ramón Torrecillas"},{id:"162633",title:"Dr.",name:"Adolfo",middleName:null,surname:"Fernández",slug:"adolfo-fernandez",fullName:"Adolfo Fernández"}]},{id:"23617",doi:"10.5772/24118",title:"Collagen- vs. Gelatine-Based Biomaterials and Their Biocompatibility: Review and Perspectives",slug:"collagen-vs-gelatine-based-biomaterials-and-their-biocompatibility-review-and-perspectives",totalDownloads:9461,totalCrossrefCites:63,totalDimensionsCites:203,abstract:null,book:{id:"1487",slug:"biomaterials-applications-for-nanomedicine",title:"Biomaterials",fullTitle:"Biomaterials Applications for Nanomedicine"},signatures:"Selestina Gorgieva and Vanja Kokol",authors:[{id:"55577",title:"Prof.",name:"Vanja",middleName:null,surname:"Kokol",slug:"vanja-kokol",fullName:"Vanja Kokol"},{id:"61285",title:"BSc",name:"Selestina",middleName:null,surname:"Gorgieva",slug:"selestina-gorgieva",fullName:"Selestina Gorgieva"}]},{id:"46243",doi:"10.5772/57255",title:"Corrosion Inhibitors – Principles, Mechanisms and Applications",slug:"corrosion-inhibitors-principles-mechanisms-and-applications",totalDownloads:13737,totalCrossrefCites:40,totalDimensionsCites:163,abstract:null,book:{id:"3817",slug:"developments-in-corrosion-protection",title:"Developments in Corrosion Protection",fullTitle:"Developments in Corrosion Protection"},signatures:"Camila G. Dariva and Alexandre F. Galio",authors:[{id:"169261",title:"Dr.",name:"Camila",middleName:"G.",surname:"Dariva",slug:"camila-dariva",fullName:"Camila Dariva"},{id:"170138",title:"Dr.",name:"Alexandre",middleName:"Ferreira",surname:"Galio",slug:"alexandre-galio",fullName:"Alexandre Galio"}]}],mostDownloadedChaptersLast30Days:[{id:"76780",title:"Basics of Clay Minerals and Their Characteristic Properties",slug:"basics-of-clay-minerals-and-their-characteristic-properties",totalDownloads:1930,totalCrossrefCites:16,totalDimensionsCites:25,abstract:"Clay minerals such as kaolinite, smectite, chlorite, micas are main components of raw materials of clay and formed in presence of water. A large number of clays used to form the different structure which completely depends on their mining source. They are known as hydrous phyllosilicate having silica, alumina and water with variable amount of inorganic ions like Mg2+, Na+, Ca2+ which are found either in interlayer space or on the planetary surface. Clay minerals are described by presence of two-dimensional sheets, tetrahedral (SiO4) and octahedral (Al2O3). There are different clay minerals which are categorized based on presence of tetrahedral and octahedral layer in their structure like kaolinite (1:1 of tetrahedral and octahedral layers), smectite group of clay minerals (2:1 of tetrahedral and octahedral layers) and chlorite (2:1:1 of tetrahedral, octahedral and octahedral layers). The particle size of clay minerals is <2microns which can be present in form of plastic in presence of water and solidified when dried. The small size and their distinctive crystal structure make clay minerals very special with their unique properties including high cation exchange capacity, swelling behavior, specific surface area, adsorption capacity, etc. which are described in this chapter. Due to all these unique properties, clay minerals are gaining interest in different fields.",book:{id:"10949",slug:"clay-and-clay-minerals",title:"Clay and Clay Minerals",fullTitle:"Clay and Clay Minerals"},signatures:"Neeraj Kumari and Chandra Mohan",authors:[{id:"258132",title:"Dr.",name:"Chandra",middleName:null,surname:"Mohan",slug:"chandra-mohan",fullName:"Chandra Mohan"},{id:"352399",title:"Dr.",name:"Neeraj",middleName:null,surname:"Kumari",slug:"neeraj-kumari",fullName:"Neeraj Kumari"}]},{id:"51535",title:"An Introduction to Hydrogels and Some Recent Applications",slug:"an-introduction-to-hydrogels-and-some-recent-applications",totalDownloads:11734,totalCrossrefCites:70,totalDimensionsCites:140,abstract:"Hydrogels have existed for more than half a century, and today they have many applications in various processes ranging from industrial to biological. There are numerous original papers, reviews, and monographs focused on the synthesis, properties, and applications of hydrogels. This chapter covers the fundamental aspects and several applications of hydrogels based on the old and the most recent publications in this field.",book:{id:"5251",slug:"emerging-concepts-in-analysis-and-applications-of-hydrogels",title:"Emerging Concepts in Analysis and Applications of Hydrogels",fullTitle:"Emerging Concepts in Analysis and Applications of Hydrogels"},signatures:"Morteza Bahram, Naimeh Mohseni and Mehdi Moghtader",authors:[{id:"179718",title:"Prof.",name:"Morteza",middleName:null,surname:"Bahram",slug:"morteza-bahram",fullName:"Morteza Bahram"},{id:"185713",title:"Dr.",name:"Naimeh",middleName:null,surname:"Mohseni",slug:"naimeh-mohseni",fullName:"Naimeh Mohseni"},{id:"185714",title:"Dr.",name:"Mehdi",middleName:null,surname:"Moghtader",slug:"mehdi-moghtader",fullName:"Mehdi Moghtader"}]},{id:"70661",title:"Bioremediation Techniques for Polluted Environment: Concept, Advantages, Limitations, and Prospects",slug:"bioremediation-techniques-for-polluted-environment-concept-advantages-limitations-and-prospects",totalDownloads:2672,totalCrossrefCites:10,totalDimensionsCites:27,abstract:"Environmental pollution has been rising in the past few decades due to increased anthropogenic activities. Bioremediation is an attractive and successful cleaning technique to remove toxic waste from polluted environment. Bioremediation is highly involved in degradation, eradication, immobilization, or detoxification diverse chemical wastes and physical hazardous materials from the surrounding through the all-inclusive and action of microorganisms. The main principle is degrading and converting pollutants to less toxic forms. Bioremediation can be carried out ex-situ and in-situ, depending on several factors, which include but not limited to cost, site characteristics, type, and concentration of pollutants. Hence, appropriate bioremediation technique is selected. Additionally, the major methodologies to develop bioremediation are biostimulation, bioaugmentation, bioventing, biopiles, and bioattenuation provided the environmental factors that decide the completion of bioremediation. Bioremediation is the most effective, economical, eco-friendly management tool to manage the polluted environment. All bioremediation techniques have its own advantage and disadvantage because it has its own specific applications.",book:{id:"9343",slug:"trace-metals-in-the-environment-new-approaches-and-recent-advances",title:"Trace Metals in the Environment",fullTitle:"Trace Metals in the Environment - New Approaches and Recent Advances"},signatures:"Indu Sharma",authors:[{id:"301262",title:"Associate Prof.",name:"Indu",middleName:null,surname:"Sharma",slug:"indu-sharma",fullName:"Indu Sharma"}]},{id:"18275",title:"Modeling and Identification of Parameters the Piezoelectric Transducers in Ultrasonic Systems",slug:"modeling-and-identification-of-parameters-the-piezoelectric-transducers-in-ultrasonic-systems",totalDownloads:10197,totalCrossrefCites:3,totalDimensionsCites:5,abstract:null,book:{id:"201",slug:"advances-in-ceramics-electric-and-magnetic-ceramics-bioceramics-ceramics-and-environment",title:"Advances in Ceramics",fullTitle:"Advances in Ceramics - Electric and Magnetic Ceramics, Bioceramics, Ceramics and Environment"},signatures:"Pawel Fabijanski and Ryszard Lagoda",authors:[{id:"13086",title:"Dr.",name:"Pawel",middleName:null,surname:"Fabijański",slug:"pawel-fabijanski",fullName:"Pawel Fabijański"}]},{id:"60680",title:"Environmental Contamination by Heavy Metals",slug:"environmental-contamination-by-heavy-metals",totalDownloads:16251,totalCrossrefCites:187,totalDimensionsCites:407,abstract:"The environment and its compartments have been severely polluted by heavy metals. This has compromised the ability of the environment to foster life and render its intrinsic values. Heavy metals are known to be naturally occurring compounds, but anthropogenic activities introduce them in large quantities in different environmental compartments. This leads to the environment’s ability to foster life being reduced as human, animal, and plant health become threatened. This occurs due to bioaccumulation in the food chains as a result of the nondegradable state of the heavy metals. Remediation of heavy metals requires special attention to protect soil quality, air quality, water quality, human health, animal health, and all spheres as a collection. Developed physical and chemical heavy metal remediation technologies are demanding costs which are not feasible, time-consuming, and release additional waste to the environment. This chapter summarises the problems related to heavy metal pollution and various remediation technologies. A case study in South Africa mines were also used.",book:{id:"6534",slug:"heavy-metals",title:"Heavy Metals",fullTitle:"Heavy Metals"},signatures:"Vhahangwele Masindi and Khathutshelo L. Muedi",authors:[{id:"225304",title:"Dr.",name:"Vhahangwele",middleName:null,surname:"Masindi",slug:"vhahangwele-masindi",fullName:"Vhahangwele Masindi"},{id:"241403",title:"M.Sc.",name:"Khathutshelo",middleName:"Lilith",surname:"Muedi",slug:"khathutshelo-muedi",fullName:"Khathutshelo Muedi"}]}],onlineFirstChaptersFilter:{topicId:"14",limit:6,offset:0},onlineFirstChaptersCollection:[{id:"82948",title:"Study on Miniaturization of Antenna Using Metamaterials",slug:"study-on-miniaturization-of-antenna-using-metamaterials",totalDownloads:0,totalDimensionsCites:null,doi:"10.5772/intechopen.106222",abstract:"Metamaterials (MTMs) are artificially built materials intended to give its properties from the internal structure, rather than the chemical composition found in natural materials. Electric permittivity (ε) and magnetic permeability (μ) are the two basic parameters which describe the electromagnetic property of a material or medium. Permittivity describes how a material is affected when it is placed in electric field. And permeability describes how a material is affected in presence of magnetic field. Metamaterials may have either negative permittivity or permeability or both may be negative simultaneously. The concept of metamaterials has additionally been utilized to design different kinds of patches with upgraded performance, such as improved gain and enhanced efficiency. Also, it has been utilized for the scaling down of patches. Two parameters are utilized in the collected works for antennas using metamaterials. We can adjust the refractive index of the metamaterial to positive, near-zero or negative values. Utilization of epsilon negative, MNG (μ - Mu negative) or DNG (double negative) are called metamaterial- based antennas and the use of metamaterial unit cell for example complementary split ring resonator, split ring resonator and so on are alluded as metamaterial inspired antennas. The design of complementary split ring resonator and its equivalent circuit will be discussed in this work. CSRR (complementary split ring resonator) provides both isolation enhancement and miniaturization for MIMO antenna.",book:{id:"11824",title:"Metamaterials - History, Current State, Applications, and Perspectives",coverURL:"https://cdn.intechopen.com/books/images_new/11824.jpg"},signatures:"Andrews Christina Josephine Malathi"},{id:"83080",title:"Boron Doping in Next-Generation Materials for Semiconductor Device",slug:"boron-doping-in-next-generation-materials-for-semiconductor-device",totalDownloads:2,totalDimensionsCites:0,doi:"10.5772/intechopen.106450",abstract:"The article surveys the most recent achievements starting with the boron doping mechanism, mainly focused on doping in semiconductor materials such as Si, Ge, graphene, carbon nanotube, or other 2D materials. Frequently used doping methodologies are discussed, including ion implantation and solid-phase doping, mainly focused on recent developing techniques of monolayer doping. These doped materials’ structural, electronic, and chemical properties are addressed to understand the boron doping effect better. Theoretical and experimental information and data are used to support such atomic-level effects. Therefore, this review can provide valuable suggestions and guidelines for materials’ properties manipulation by boron doping for further research exploration.",book:{id:"11762",title:"Characteristics and Applications of Boron",coverURL:"https://cdn.intechopen.com/books/images_new/11762.jpg"},signatures:"Linh Chi T. Cao, Luqman Hakim and Shu-Han Hsu"},{id:"83055",title:"Boron Clusters in Biomedical Applications: A Theoretical Viewpoint",slug:"boron-clusters-in-biomedical-applications-a-theoretical-viewpoint",totalDownloads:6,totalDimensionsCites:0,doi:"10.5772/intechopen.106215",abstract:"In this chapter, we presented an analysis of the recent advances in the applications of boron clusters in biomedical fields such as the development of biosensors and drug delivery systems on the basis of quantum chemical calculations. Biosensors play an essential role in many sectors, e.g., law enforcement agencies for sensing illicit drugs, medical communities for detecting overdosed medications from human and animal bodies, etc. The drug delivery systems have theoretically been proposed for many years and subsequently implemented by experiments to deliver the drug to the targeted sites by reducing the harmful side effects significantly. Boron clusters form a rich and colorful family of atomic clusters due to their unconventional structures and bonding phenomena. Boron clusters and their complexes have various biological activities such as the drug delivery, imaging for diagnosis, treatment of cancer, and probe of protein-biomolecular interactions. For all of these reactivities, the interaction mechanisms and the corresponding energetics between biomaterials and boron clusters are of essential importance as a basic step in the understanding, and thereby design of relevant materials. During the past few years, attempts have been made to probe the nature of these interactions using quantum chemical calculations mainly with density functional theory (DFT) methods. This chapter provides a summary of the theoretical viewpoint on this issue.",book:{id:"11762",title:"Characteristics and Applications of Boron",coverURL:"https://cdn.intechopen.com/books/images_new/11762.jpg"},signatures:"Ehsan Shakerzadeh, Elham Tahmasebi, Long Van Duong and Minh Tho Nguyen"},{id:"83048",title:"Structural, Magnetic, and Magnetodielectric Properties of Bi-Based Modified Ceramic Composites",slug:"structural-magnetic-and-magnetodielectric-properties-of-bi-based-modified-ceramic-composites",totalDownloads:2,totalDimensionsCites:0,doi:"10.5772/intechopen.106569",abstract:"In this chapter, we introduce a promising composite material, which can be used as a potential candidate in the field of charge storage, sensors, and spintronic devices. The structural, magnetic, and magnetodielectric properties of the pure cum composite samples are investigated. The Rietveld refinement of the X-ray data confirmed the presence of a single (A21am) and mixed phases (A21am + R-3c + Pbam) in the pure and composite sample, correspondingly. The SEM microstructure suggests the contrasting nature of the homogeneous and heterogeneous distribution of grains in the corresponding pure and composite sample. The magnetic properties of the composite sample increase due to the enhanced exchange interaction between the different magnetic ions. The frequency-dependent dielectric subjected to a constant magnetic field indicates the signature of magnetodielectric (MD) coupling for both the samples. The field variation of the MD loop shows the symmetric hysteresis loop in the composite due to the addition of magnetostrictive La0.67Sr0.33MnO3 and the non-collinear antiferromagnetic Bi2Fe4O9 phase. The maximum value of MD% (~0.12%) is enhanced by ~13 times in the composite than in the pure sample. Therefore, the improved MD coupling and symmetric switching of the MD loop of the composite make it a suitable candidate for low power consumption storage devices.",book:{id:"11117",title:"Smart and Advanced Ceramics and Applications",coverURL:"https://cdn.intechopen.com/books/images_new/11117.jpg"},signatures:"Rasmita Jena, Kouru Chandrakanta and Anil Kumar Singh"},{id:"83035",title:"Breaking the Property Trade-Offs by Using Entropic Conceptions",slug:"breaking-the-property-trade-offs-by-using-entropic-conceptions",totalDownloads:11,totalDimensionsCites:0,doi:"10.5772/intechopen.106532",abstract:"Entropic conception has been used as an effective strategy for developing materials to break the property recordings of current materials, for example, breaking the trade-off between the high-strength and low-ductility structural alloys. The performance of materials usually under a complex circumstance, a balance of multiple properties, for example, combined the high-strength, high ductility, high conductivity, high corrosion resistance, high irradiation resistance, etc., the strategy of high-entropy-alloy (HEA) will provide a materials design and development technology to realize the goal. Magnetic materials usually exhibit excellent magnetic properties but weak mechanical properties and corrosion resistance. The reported unique behaviors of HEAs, for example, self-healing effects may be the mechanism for the high irradiation resistance of the HEAs, and self-sharpening behaviors of the tungsten-based HEAs main closely be related to the serration behaviors.",book:{id:"11468",title:"High Entropy Materials - Microstructures and Properties",coverURL:"https://cdn.intechopen.com/books/images_new/11468.jpg"},signatures:"Yong Zhang and Xuehui Yan"},{id:"82929",title:"Prediction of Solubility and Miscibility Parameters of Bismuth-Arsenic Complex and Amorphous Mineral Compounds Using Molecular Dynamics Simulation",slug:"prediction-of-solubility-and-miscibility-parameters-of-bismuth-arsenic-complex-and-amorphous-mineral",totalDownloads:4,totalDimensionsCites:0,doi:"10.5772/intechopen.106316",abstract:"Bismuth is one of the most difficult impurities to remove in mining concentrates and low concentrations generate problems in silver and copper refineries. Therefore, financial penalties are established when concentrations exceed 0.05%. Some researchers had used arsenic to remove bismuth with results of up to 52% of extraction. Unfortunately, this mechanism is not yet fully understood. The objective of this research was to obtain the solubility parameters of amorphous mineral compounds, including bismuth-based compounds, through computational simulation using molecular dynamics. The composition of the mineral sample was determined by X-ray diffraction and the crystalline species were obtained and modeled using Materials Studio software. The nanostructures were optimized by an energy minimization methodology using the Broyden-Fletcher-Goldfarb-Shanno algorithm and were validated using the figure of merit equation and density. Simulations were performed using the Universal Force Field at constant pressure and temperature. The results of the minerals identified in the sample were compared with arsenic trioxide, indicating miscibility between As2O3 and Bi2O3, possible miscibility with 10 other minerals, and immiscibility with the rest. The results indicate that As2O3 can be successfully used for the removal of Bi2O3 without a negative effect on the recovery of other minerals of higher commercial value.",book:{id:"11467",title:"Bismuth-Based Nanostructured Materials",coverURL:"https://cdn.intechopen.com/books/images_new/11467.jpg"},signatures:"Francisco Adrián De la Torre-Martínez, Efren Delgado, María Dolores Josefina Rodríguez Rosales, Hiram Medrano-Roldán, Javier López-Miranda and Damián Reyes-Jáquez"}],onlineFirstChaptersTotal:82},preDownload:{success:null,errors:{}},subscriptionForm:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[],offset:8,limit:8,total:0},allSeries:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:11,numberOfPublishedChapters:91,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:108,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:33,numberOfPublishedChapters:332,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:14,numberOfPublishedChapters:145,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:11,numberOfPublishedChapters:142,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!0},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:124,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:11,numberOfPublishedChapters:112,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:22,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2753-894X",doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:12,numberOfOpenTopics:1,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!0},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:5,numberOfUpcomingTopics:0,issn:"2753-6580",doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],testimonialsList:[{id:"6",text:"It is great to work with the IntechOpen to produce a worthwhile collection of research that also becomes a great educational resource and guide for future research endeavors.",author:{id:"259298",name:"Edward",surname:"Narayan",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/259298/images/system/259298.jpeg",slug:"edward-narayan",institution:{id:"3",name:"University of Queensland",country:{id:null,name:"Australia"}}}},{id:"13",text:"The collaboration with and support of the technical staff of IntechOpen is fantastic. The whole process of submitting an article and editing of the submitted article goes extremely smooth and fast, the number of reads and downloads of chapters is high, and the contributions are also frequently cited.",author:{id:"55578",name:"Antonio",surname:"Jurado-Navas",institutionString:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRisIQAS/Profile_Picture_1626166543950",slug:"antonio-jurado-navas",institution:{id:"720",name:"University of Malaga",country:{id:null,name:"Spain"}}}}]},series:{item:{id:"11",title:"Biochemistry",doi:"10.5772/intechopen.72877",issn:"2632-0983",scope:"Biochemistry, the study of chemical transformations occurring within living organisms, impacts all areas of life sciences, from molecular crystallography and genetics to ecology, medicine, and population biology. Biochemistry examines macromolecules - proteins, nucleic acids, carbohydrates, and lipids – and their building blocks, structures, functions, and interactions. Much of biochemistry is devoted to enzymes, proteins that catalyze chemical reactions, enzyme structures, mechanisms of action and their roles within cells. Biochemistry also studies small signaling molecules, coenzymes, inhibitors, vitamins, and hormones, which play roles in life processes. Biochemical experimentation, besides coopting classical chemistry methods, e.g., chromatography, adopted new techniques, e.g., X-ray diffraction, electron microscopy, NMR, radioisotopes, and developed sophisticated microbial genetic tools, e.g., auxotroph mutants and their revertants, fermentation, etc. More recently, biochemistry embraced the ‘big data’ omics systems. Initial biochemical studies have been exclusively analytic: dissecting, purifying, and examining individual components of a biological system; in the apt words of Efraim Racker (1913 –1991), “Don’t waste clean thinking on dirty enzymes.” Today, however, biochemistry is becoming more agglomerative and comprehensive, setting out to integrate and describe entirely particular biological systems. The ‘big data’ metabolomics can define the complement of small molecules, e.g., in a soil or biofilm sample; proteomics can distinguish all the comprising proteins, e.g., serum; metagenomics can identify all the genes in a complex environment, e.g., the bovine rumen. This Biochemistry Series will address the current research on biomolecules and the emerging trends with great promise.",coverUrl:"https://cdn.intechopen.com/series/covers/11.jpg",latestPublicationDate:"August 17th, 2022",hasOnlineFirst:!0,numberOfPublishedBooks:33,editor:{id:"31610",title:"Dr.",name:"Miroslav",middleName:null,surname:"Blumenberg",slug:"miroslav-blumenberg",fullName:"Miroslav Blumenberg",profilePictureURL:"https://mts.intechopen.com/storage/users/31610/images/system/31610.jpg",biography:"Miroslav Blumenberg, Ph.D., was born in Subotica and received his BSc in Belgrade, Yugoslavia. He completed his Ph.D. at MIT in Organic Chemistry; he followed up his Ph.D. with two postdoctoral study periods at Stanford University. Since 1983, he has been a faculty member of the RO Perelman Department of Dermatology, NYU School of Medicine, where he is codirector of a training grant in cutaneous biology. Dr. Blumenberg’s research is focused on the epidermis, expression of keratin genes, transcription profiling, keratinocyte differentiation, inflammatory diseases and cancers, and most recently the effects of the microbiome on the skin. He has published more than 100 peer-reviewed research articles and graduated numerous Ph.D. and postdoctoral students.",institutionString:null,institution:{name:"New York University Langone Medical Center",institutionURL:null,country:{name:"United States of America"}}},editorTwo:null,editorThree:null},subseries:{paginationCount:2,paginationItems:[{id:"89",title:"Education",coverUrl:"https://cdn.intechopen.com/series_topics/covers/89.jpg",isOpenForSubmission:!1,editor:{id:"260066",title:"Associate Prof.",name:"Michail",middleName:null,surname:"Kalogiannakis",slug:"michail-kalogiannakis",fullName:"Michail Kalogiannakis",profilePictureURL:"https://mts.intechopen.com/storage/users/260066/images/system/260066.jpg",biography:"Michail Kalogiannakis is an Associate Professor of the Department of Preschool Education, University of Crete, and an Associate Tutor at School of Humanities at the Hellenic Open University. He graduated from the Physics Department of the University of Crete and continued his post-graduate studies at the University Paris 7-Denis Diderot (D.E.A. in Didactic of Physics), University Paris 5-René Descartes-Sorbonne (D.E.A. in Science Education) and received his Ph.D. degree at the University Paris 5-René Descartes-Sorbonne (PhD in Science Education). His research interests include science education in early childhood, science teaching and learning, e-learning, the use of ICT in science education, games simulations, and mobile learning. He has published over 120 articles in international conferences and journals and has served on the program committees of numerous international conferences.",institutionString:"University of Crete",institution:{name:"University of Crete",institutionURL:null,country:{name:"Greece"}}},editorTwo:{id:"422488",title:"Dr.",name:"Maria",middleName:null,surname:"Ampartzaki",slug:"maria-ampartzaki",fullName:"Maria Ampartzaki",profilePictureURL:"https://mts.intechopen.com/storage/users/422488/images/system/422488.jpg",biography:"Dr Maria Ampartzaki is an Assistant Professor in Early Childhood Education in the Department of Preschool Education at the University of Crete. Her research interests include ICT in education, science education in the early years, inquiry-based and art-based learning, teachers’ professional development, action research, and the Pedagogy of Multiliteracies, among others. She has run and participated in several funded and non-funded projects on the teaching of Science, Social Sciences, and ICT in education. She also has the experience of participating in five Erasmus+ projects.",institutionString:"University of Crete",institution:{name:"University of Crete",institutionURL:null,country:{name:"Greece"}}},editorThree:null},{id:"90",title:"Human Development",coverUrl:"https://cdn.intechopen.com/series_topics/covers/90.jpg",isOpenForSubmission:!0,editor:{id:"191040",title:"Dr.",name:"Tal",middleName:null,surname:"Dotan Ben-Soussan",slug:"tal-dotan-ben-soussan",fullName:"Tal Dotan Ben-Soussan",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSBf1QAG/Profile_Picture_2022-03-18T07:56:11.jpg",biography:"Tal Dotan Ben-Soussan, Ph.D., is the director of the Research Institute for Neuroscience, Education and Didactics (RINED) – Paoletti Foundation. Ben-Soussan leads international studies on training and neuroplasticity from neurophysiological and psychobiological perspectives. As a neuroscientist and bio-psychologist, she has published numerous articles on neuroplasticity, movement and meditation. She acts as an editor and reviewer in several renowned journals and coordinates international conferences integrating theoretical, methodological and practical approaches on various topics, such as silence, logics and neuro-education. She lives in Assisi, Italy.",institutionString:"Research Institute for Neuroscience, Education and Didactics, Patrizio Paoletti Foundation",institution:null},editorTwo:null,editorThree:null}]},overviewPageOFChapters:{paginationCount:12,paginationItems:[{id:"83113",title:"Agoraphobic Dispositions towards Action Research: Teacher Education Students’ Perceptions and Experiences",doi:"10.5772/intechopen.106188",signatures:"Davison Zireva",slug:"agoraphobic-dispositions-towards-action-research-teacher-education-students-perceptions-and-experien",totalDownloads:1,totalCrossrefCites:null,totalDimensionsCites:0,authors:[{name:"Davison",surname:"Zireva"}],book:{title:"Active Learning - Research and Practice for STEAM and social sciences education",coverURL:"https://cdn.intechopen.com/books/images_new/11481.jpg",subseries:{id:"89",title:"Education"}}},{id:"83053",title:"Apologies in L2 French in Canadian Context",doi:"10.5772/intechopen.106557",signatures:"Bernard Mulo Farenkia",slug:"apologies-in-l2-french-in-canadian-context",totalDownloads:0,totalCrossrefCites:0,totalDimensionsCites:0,authors:[{name:"Bernard",surname:"Mulo Farenkia"}],book:{title:"Second Language Acquisition - Learning Theories and Recent Approaches",coverURL:"https://cdn.intechopen.com/books/images_new/11480.jpg",subseries:{id:"89",title:"Education"}}},{id:"82903",title:"Walking Accessibility to Primary Healthcare Services: An Inequity Factor for Olders in the Lisbon Metropolitan Area (Portugal)",doi:"10.5772/intechopen.106265",signatures:"Eduarda Marques da Costa, Ana Louro, Nuno Marques da Costa, Mariana Dias and Marcela Barata",slug:"walking-accessibility-to-primary-healthcare-services-an-inequity-factor-for-olders-in-the-lisbon-met",totalDownloads:4,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Social Aspects of Ageing - Selected Challenges, Analyses, and Solutions",coverURL:"https://cdn.intechopen.com/books/images_new/11479.jpg",subseries:{id:"90",title:"Human Development"}}},{id:"82622",title:"Contemporary Geographical Gerontology: Reconciling Space and Place in Population Ageing",doi:"10.5772/intechopen.105863",signatures:"Hamish Robertson",slug:"contemporary-geographical-gerontology-reconciling-space-and-place-in-population-ageing",totalDownloads:13,totalCrossrefCites:0,totalDimensionsCites:0,authors:[{name:"Hamish",surname:"Robertson"}],book:{title:"Social Aspects of Ageing - Selected Challenges, Analyses, and Solutions",coverURL:"https://cdn.intechopen.com/books/images_new/11479.jpg",subseries:{id:"90",title:"Human Development"}}}]},overviewPagePublishedBooks:{paginationCount:0,paginationItems:[]},openForSubmissionBooks:{paginationCount:1,paginationItems:[{id:"11568",title:"Staphylococcal Infections - Recent Advances and Perspectives",coverURL:"https://cdn.intechopen.com/books/images_new/11568.jpg",hash:"92c881664d1921c7f2d0fee34b78cd08",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"July 8th 2022",isOpenForSubmission:!0,editors:[{id:"59719",title:"Dr.",name:"Jaime",surname:"Bustos-Martínez",slug:"jaime-bustos-martinez",fullName:"Jaime Bustos-Martínez"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},onlineFirstChapters:{paginationCount:21,paginationItems:[{id:"83000",title:"Purine and Pyrimidine Pathways as Antimalarial Targets",doi:"10.5772/intechopen.106468",signatures:"Yacoba V.T. Minnow and Vern L. Schramm",slug:"purine-and-pyrimidine-pathways-as-antimalarial-targets",totalDownloads:1,totalCrossrefCites:0,totalDimensionsCites:null,authors:null,book:{title:"Malaria - Recent Advances, and New Perspectives",coverURL:"https://cdn.intechopen.com/books/images_new/11576.jpg",subseries:{id:"5",title:"Parasitic Infectious Diseases"}}},{id:"83065",title:"Interventions and Practical Approaches to Reduce the Burden of Malaria on School-Aged Children",doi:"10.5772/intechopen.106469",signatures:"Andrew Macnab",slug:"interventions-and-practical-approaches-to-reduce-the-burden-of-malaria-on-school-aged-children",totalDownloads:4,totalCrossrefCites:0,totalDimensionsCites:0,authors:[{name:"Andrew",surname:"Macnab"}],book:{title:"Malaria - Recent Advances, and New Perspectives",coverURL:"https://cdn.intechopen.com/books/images_new/11576.jpg",subseries:{id:"5",title:"Parasitic Infectious Diseases"}}},{id:"82804",title:"Psychiatric Problems in HIV Care",doi:"10.5772/intechopen.106077",signatures:"Seggane Musisi and Noeline Nakasujja",slug:"psychiatric-problems-in-hiv-care",totalDownloads:2,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Future Opportunities and Tools for Emerging Challenges for HIV/AIDS Control",coverURL:"https://cdn.intechopen.com/books/images_new/11575.jpg",subseries:{id:"6",title:"Viral Infectious Diseases"}}},{id:"82827",title:"Epidemiology and Control of Schistosomiasis",doi:"10.5772/intechopen.105170",signatures:"Célestin Kyambikwa Bisangamo",slug:"epidemiology-and-control-of-schistosomiasis",totalDownloads:6,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"New Horizons for Schistosomiasis Research",coverURL:"https://cdn.intechopen.com/books/images_new/10829.jpg",subseries:{id:"5",title:"Parasitic Infectious Diseases"}}},{id:"82817",title:"Perspective Chapter: Microfluidic Technologies for On-Site Detection and Quantification of Infectious Diseases - The Experience with SARS-CoV-2/COVID-19",doi:"10.5772/intechopen.105950",signatures:"Andres Escobar and Chang-qing Xu",slug:"perspective-chapter-microfluidic-technologies-for-on-site-detection-and-quantification-of-infectious",totalDownloads:3,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"SARS-CoV-2 Variants - Two Years After",coverURL:"https://cdn.intechopen.com/books/images_new/11573.jpg",subseries:{id:"6",title:"Viral Infectious Diseases"}}},{id:"82667",title:"Perspective Chapter: Analysis of SARS-CoV-2 Indirect Spreading Routes and Possible Countermeasures",doi:"10.5772/intechopen.105914",signatures:"Cesare Saccani, Marco Pellegrini and Alessandro Guzzini",slug:"perspective-chapter-analysis-of-sars-cov-2-indirect-spreading-routes-and-possible-countermeasures",totalDownloads:10,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"SARS-CoV-2 Variants - Two Years After",coverURL:"https://cdn.intechopen.com/books/images_new/11573.jpg",subseries:{id:"6",title:"Viral Infectious Diseases"}}},{id:"82559",title:"Perspective Chapter: Bioinformatics Study of the Evolution of SARS-CoV-2 Spike Protein",doi:"10.5772/intechopen.105915",signatures:"Črtomir Podlipnik, Radostina Alexandrova, Sebastian Pleško, Urban Bren and Marko Jukič",slug:"perspective-chapter-bioinformatics-study-of-the-evolution-of-sars-cov-2-spike-protein",totalDownloads:16,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"SARS-CoV-2 Variants - Two Years After",coverURL:"https://cdn.intechopen.com/books/images_new/11573.jpg",subseries:{id:"6",title:"Viral Infectious Diseases"}}},{id:"82521",title:"Challenges in Platelet Functions in HIV/AIDS Management",doi:"10.5772/intechopen.105731",signatures:"Gordon Ogweno",slug:"challenges-in-platelet-functions-in-hiv-aids-management",totalDownloads:16,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Future Opportunities and Tools for Emerging Challenges for HIV/AIDS Control",coverURL:"https://cdn.intechopen.com/books/images_new/11575.jpg",subseries:{id:"6",title:"Viral Infectious Diseases"}}},{id:"82701",title:"Pathology of Streptococcal Infections",doi:"10.5772/intechopen.105814",signatures:"Yutaka Tsutsumi",slug:"pathology-of-streptococcal-infections",totalDownloads:8,totalCrossrefCites:0,totalDimensionsCites:0,authors:[{name:"Yutaka",surname:"Tsutsumi"}],book:{title:"Streptococcal Infections",coverURL:"https://cdn.intechopen.com/books/images_new/10828.jpg",subseries:{id:"3",title:"Bacterial Infectious Diseases"}}},{id:"82634",title:"Bacterial Sexually Transmitted Disease",doi:"10.5772/intechopen.105747",signatures:"Lebeza Alemu Tenaw",slug:"bacterial-sexually-transmitted-disease",totalDownloads:12,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Bacterial Sexually Transmitted Infections - New Findings, Diagnosis, Treatment, and Prevention",coverURL:"https://cdn.intechopen.com/books/images_new/11569.jpg",subseries:{id:"3",title:"Bacterial Infectious Diseases"}}}]},subseriesFiltersForOFChapters:[{caption:"Fungal Infectious Diseases",value:4,count:1,group:"subseries"},{caption:"Bacterial Infectious Diseases",value:3,count:5,group:"subseries"},{caption:"Parasitic Infectious Diseases",value:5,count:5,group:"subseries"},{caption:"Viral Infectious Diseases",value:6,count:10,group:"subseries"}],publishedBooks:{paginationCount:33,paginationItems:[{type:"book",id:"10840",title:"Benzimidazole",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10840.jpg",slug:"benzimidazole",publishedDate:"July 13th 2022",editedByType:"Edited by",bookSignature:"Pravin Kendrekar and Vinayak Adimule",hash:"e28c770013e7a8dd0fc37aea6aa9def8",volumeInSeries:34,fullTitle:"Benzimidazole",editors:[{id:"310674",title:"Dr.",name:"Pravin",middleName:null,surname:"Kendrekar",slug:"pravin-kendrekar",fullName:"Pravin Kendrekar",profilePictureURL:"https://mts.intechopen.com/storage/users/310674/images/system/310674.jpg",institutionString:"Visiting Scientist at Lipid Nanostructures Laboratory, Centre for Smart Materials, School of Natural Sciences, University of Central Lancashire",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10798",title:"Starch",subtitle:"Evolution and Recent Advances",coverURL:"https://cdn.intechopen.com/books/images_new/10798.jpg",slug:"starch-evolution-and-recent-advances",publishedDate:"June 28th 2022",editedByType:"Edited by",bookSignature:"Martins Ochubiojo Emeje",hash:"f197f6062c1574a9a90e50a369271bcf",volumeInSeries:33,fullTitle:"Starch - Evolution and Recent Advances",editors:[{id:"94311",title:"Prof.",name:"Martins",middleName:"Ochubiojo",surname:"Ochubiojo Emeje",slug:"martins-ochubiojo-emeje",fullName:"Martins Ochubiojo Emeje",profilePictureURL:"https://mts.intechopen.com/storage/users/94311/images/system/94311.jpeg",institutionString:"National Institute for Pharmaceutical Research and Development",institution:{name:"National Institute for Pharmaceutical Research and Development",institutionURL:null,country:{name:"Nigeria"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"11332",title:"Essential Oils",subtitle:"Advances in Extractions and Biological Applications",coverURL:"https://cdn.intechopen.com/books/images_new/11332.jpg",slug:"essential-oils-advances-in-extractions-and-biological-applications",publishedDate:"June 23rd 2022",editedByType:"Edited by",bookSignature:"Mozaniel Santana de Oliveira and Eloisa Helena de Aguiar Andrade",hash:"742e6cae3a35686f975edc8d7f9afa94",volumeInSeries:32,fullTitle:"Essential Oils - Advances in Extractions and Biological Applications",editors:[{id:"195290",title:"Ph.D.",name:"Mozaniel",middleName:null,surname:"Santana De Oliveira",slug:"mozaniel-santana-de-oliveira",fullName:"Mozaniel Santana De Oliveira",profilePictureURL:"https://mts.intechopen.com/storage/users/195290/images/system/195290.png",institutionString:"Museu Paraense Emílio Goeldi",institution:{name:"Museu Paraense Emílio Goeldi",institutionURL:null,country:{name:"Brazil"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10839",title:"Protein Detection",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10839.jpg",slug:"protein-detection",publishedDate:"June 23rd 2022",editedByType:"Edited by",bookSignature:"Yusuf Tutar and Lütfi Tutar",hash:"2f1c0e4e0207fc45c936e7d22a5369c4",volumeInSeries:31,fullTitle:"Protein Detection",editors:[{id:"158492",title:"Prof.",name:"Yusuf",middleName:null,surname:"Tutar",slug:"yusuf-tutar",fullName:"Yusuf Tutar",profilePictureURL:"https://mts.intechopen.com/storage/users/158492/images/system/158492.jpeg",institutionString:"University of Health Sciences",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10797",title:"Cell Culture",subtitle:"Advanced Technology and Applications in Medical and Life Sciences",coverURL:"https://cdn.intechopen.com/books/images_new/10797.jpg",slug:"cell-culture-advanced-technology-and-applications-in-medical-and-life-sciences",publishedDate:"June 15th 2022",editedByType:"Edited by",bookSignature:"Xianquan Zhan",hash:"2c628f4757f9639a4450728d839a7842",volumeInSeries:30,fullTitle:"Cell Culture - Advanced Technology and Applications in Medical and Life Sciences",editors:[{id:"223233",title:"Prof.",name:"Xianquan",middleName:null,surname:"Zhan",slug:"xianquan-zhan",fullName:"Xianquan Zhan",profilePictureURL:"https://mts.intechopen.com/storage/users/223233/images/system/223233.png",institutionString:"Shandong First Medical University",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10841",title:"Hydrolases",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10841.jpg",slug:"hydrolases",publishedDate:"June 15th 2022",editedByType:"Edited by",bookSignature:"Sajjad Haider, Adnan Haider and Angel Catalá",hash:"4e868cde273d65a7ff54b1817d640629",volumeInSeries:29,fullTitle:"Hydrolases",editors:[{id:"110708",title:"Dr.",name:"Sajjad",middleName:null,surname:"Haider",slug:"sajjad-haider",fullName:"Sajjad Haider",profilePictureURL:"https://mts.intechopen.com/storage/users/110708/images/system/110708.png",institutionString:"King Saud University",institution:{name:"King Saud University",institutionURL:null,country:{name:"Saudi Arabia"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10803",title:"Reactive Oxygen Species",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10803.jpg",slug:"reactive-oxygen-species",publishedDate:"April 28th 2022",editedByType:"Edited by",bookSignature:"Rizwan Ahmad",hash:"176adcf090fdd1f93cb8ce3146e79ca1",volumeInSeries:28,fullTitle:"Reactive Oxygen Species",editors:[{id:"40482",title:null,name:"Rizwan",middleName:null,surname:"Ahmad",slug:"rizwan-ahmad",fullName:"Rizwan Ahmad",profilePictureURL:"https://mts.intechopen.com/storage/users/40482/images/system/40482.jpeg",institutionString:"Imam Abdulrahman Bin Faisal University",institution:{name:"Imam Abdulrahman Bin Faisal University",institutionURL:null,country:{name:"Saudi Arabia"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9008",title:"Vitamin K",subtitle:"Recent Topics on the Biology and Chemistry",coverURL:"https://cdn.intechopen.com/books/images_new/9008.jpg",slug:"vitamin-k-recent-topics-on-the-biology-and-chemistry",publishedDate:"March 23rd 2022",editedByType:"Edited by",bookSignature:"Hiroyuki Kagechika and Hitoshi Shirakawa",hash:"8b43add5389ba85743e0a9491e4b9943",volumeInSeries:27,fullTitle:"Vitamin K - Recent Topics on the Biology and Chemistry",editors:[{id:"180528",title:"Dr.",name:"Hiroyuki",middleName:null,surname:"Kagechika",slug:"hiroyuki-kagechika",fullName:"Hiroyuki Kagechika",profilePictureURL:"https://mts.intechopen.com/storage/users/180528/images/system/180528.jpg",institutionString:"Tokyo Medical and Dental University",institution:{name:"Tokyo Medical and Dental University",institutionURL:null,country:{name:"Japan"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10799",title:"Phenolic Compounds",subtitle:"Chemistry, Synthesis, Diversity, Non-Conventional Industrial, Pharmaceutical and Therapeutic Applications",coverURL:"https://cdn.intechopen.com/books/images_new/10799.jpg",slug:"phenolic-compounds-chemistry-synthesis-diversity-non-conventional-industrial-pharmaceutical-and-therapeutic-applications",publishedDate:"February 23rd 2022",editedByType:"Edited by",bookSignature:"Farid A. Badria",hash:"339199f254d2987ef3167eef74fb8a38",volumeInSeries:26,fullTitle:"Phenolic Compounds - Chemistry, Synthesis, Diversity, Non-Conventional Industrial, Pharmaceutical and Therapeutic Applications",editors:[{id:"41865",title:"Prof.",name:"Farid A.",middleName:null,surname:"Badria",slug:"farid-a.-badria",fullName:"Farid A. Badria",profilePictureURL:"https://mts.intechopen.com/storage/users/41865/images/system/41865.jpg",institutionString:"Mansoura University",institution:{name:"Mansoura University",institutionURL:null,country:{name:"Egypt"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9659",title:"Fibroblasts",subtitle:"Advances in Inflammation, Autoimmunity and Cancer",coverURL:"https://cdn.intechopen.com/books/images_new/9659.jpg",slug:"fibroblasts-advances-in-inflammation-autoimmunity-and-cancer",publishedDate:"December 22nd 2021",editedByType:"Edited by",bookSignature:"Mojca Frank Bertoncelj and Katja Lakota",hash:"926fa6446f6befbd363fc74971a56de2",volumeInSeries:25,fullTitle:"Fibroblasts - Advances in Inflammation, Autoimmunity and Cancer",editors:[{id:"328755",title:"Ph.D.",name:"Mojca",middleName:null,surname:"Frank Bertoncelj",slug:"mojca-frank-bertoncelj",fullName:"Mojca Frank Bertoncelj",profilePictureURL:"https://mts.intechopen.com/storage/users/328755/images/system/328755.jpg",institutionString:"BioMed X Institute",institution:{name:"University Hospital of Zurich",institutionURL:null,country:{name:"Switzerland"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8977",title:"Protein Kinases",subtitle:"Promising Targets for Anticancer Drug Research",coverURL:"https://cdn.intechopen.com/books/images_new/8977.jpg",slug:"protein-kinases-promising-targets-for-anticancer-drug-research",publishedDate:"December 8th 2021",editedByType:"Edited by",bookSignature:"Rajesh Kumar Singh",hash:"6d200cc031706a565b554fdb1c478901",volumeInSeries:24,fullTitle:"Protein Kinases - Promising Targets for Anticancer Drug Research",editors:[{id:"329385",title:"Dr.",name:"Rajesh K.",middleName:"Kumar",surname:"Singh",slug:"rajesh-k.-singh",fullName:"Rajesh K. Singh",profilePictureURL:"https://mts.intechopen.com/storage/users/329385/images/system/329385.png",institutionString:"Punjab Technical University",institution:{name:"Punjab Technical University",institutionURL:null,country:{name:"India"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8018",title:"Extracellular Matrix",subtitle:"Developments and Therapeutics",coverURL:"https://cdn.intechopen.com/books/images_new/8018.jpg",slug:"extracellular-matrix-developments-and-therapeutics",publishedDate:"October 27th 2021",editedByType:"Edited by",bookSignature:"Rama Sashank Madhurapantula, Joseph Orgel P.R.O. and Zvi Loewy",hash:"c85e82851e80b40282ff9be99ddf2046",volumeInSeries:23,fullTitle:"Extracellular Matrix - Developments and Therapeutics",editors:[{id:"212416",title:"Dr.",name:"Rama Sashank",middleName:null,surname:"Madhurapantula",slug:"rama-sashank-madhurapantula",fullName:"Rama Sashank Madhurapantula",profilePictureURL:"https://mts.intechopen.com/storage/users/212416/images/system/212416.jpg",institutionString:"Illinois Institute of Technology",institution:{name:"Illinois Institute of Technology",institutionURL:null,country:{name:"United States of America"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},subseriesFiltersForPublishedBooks:[{group:"subseries",caption:"Proteomics",value:18,count:4},{group:"subseries",caption:"Metabolism",value:17,count:6},{group:"subseries",caption:"Cell and Molecular Biology",value:14,count:9},{group:"subseries",caption:"Chemical Biology",value:15,count:14}],publicationYearFilters:[{group:"publicationYear",caption:"2022",value:2022,count:9},{group:"publicationYear",caption:"2021",value:2021,count:7},{group:"publicationYear",caption:"2020",value:2020,count:12},{group:"publicationYear",caption:"2019",value:2019,count:3},{group:"publicationYear",caption:"2018",value:2018,count:2}],authors:{paginationCount:755,paginationItems:[{id:"310674",title:"Dr.",name:"Pravin",middleName:null,surname:"Kendrekar",slug:"pravin-kendrekar",fullName:"Pravin Kendrekar",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/310674/images/system/310674.jpg",biography:"Dr. Pravin Kendrekar, MSc, MBA, Ph.D., is currently a visiting scientist at the Lipid Nanostructure Laboratory, University of Central Lancashire, England. He previously worked as a post-doctoral fellow at the Ben-Gurion University of Negev, Israel; University of the Free State, South Africa; and Central University of Technology Bloemfontein, South Africa. He obtained his Ph.D. in Organic Chemistry from Nagaoka University of Technology, Japan. He has published more than seventy-four journal articles and attended several national and international conferences as speaker and chair. Dr. Kendrekar has received many international awards. He has several funded projects, namely, anti-malaria drug development, MRSA, and SARS-CoV-2 activity of curcumin and its formulations. He has filed four patents in collaboration with the University of Central Lancashire and Mayo Clinic Infectious Diseases. His present research includes organic synthesis, drug discovery and development, biochemistry, nanoscience, and nanotechnology.",institutionString:"Visiting Scientist at Lipid Nanostructures Laboratory, Centre for Smart Materials, School of Natural Sciences, University of Central Lancashire",institution:null},{id:"428125",title:"Dr.",name:"Vinayak",middleName:null,surname:"Adimule",slug:"vinayak-adimule",fullName:"Vinayak Adimule",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/428125/images/system/428125.jpg",biography:"Dr. Vinayak Adimule, MSc, Ph.D., is a professor and dean of R&D, Angadi Institute of Technology and Management, India. He has 15 years of research experience as a senior research scientist and associate research scientist in R&D organizations. He has published more than fifty research articles as well as several book chapters. He has two Indian patents and two international patents to his credit. Dr. Adimule has attended, chaired, and presented papers at national and international conferences. He is a guest editor for Topics in Catalysis and other journals. He is also an editorial board member, life member, and associate member for many international societies and research institutions. His research interests include nanoelectronics, material chemistry, artificial intelligence, sensors and actuators, bio-nanomaterials, and medicinal chemistry.",institutionString:"Angadi Institute of Technology and Management",institution:null},{id:"284317",title:"Prof.",name:"Kantharaju",middleName:null,surname:"Kamanna",slug:"kantharaju-kamanna",fullName:"Kantharaju Kamanna",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/284317/images/21050_n.jpg",biography:"Prof. K. Kantharaju has received Bachelor of science (PCM), master of science (Organic Chemistry) and Doctor of Philosophy in Chemistry from Bangalore University. He worked as a Executive Research & Development @ Cadila Pharmaceuticals Ltd, Ahmedabad. He received DBT-postdoc fellow @ Molecular Biophysics Unit, Indian Institute of Science, Bangalore under the supervision of Prof. P. Balaram, later he moved to NIH-postdoc researcher at Drexel University College of Medicine, Philadelphia, USA, after his return from postdoc joined NITK-Surthakal as a Adhoc faculty at department of chemistry. Since from August 2013 working as a Associate Professor, and in 2016 promoted to Profeesor in the School of Basic Sciences: Department of Chemistry and having 20 years of teaching and research experiences.",institutionString:null,institution:{name:"Rani Channamma University, Belagavi",country:{name:"India"}}},{id:"158492",title:"Prof.",name:"Yusuf",middleName:null,surname:"Tutar",slug:"yusuf-tutar",fullName:"Yusuf Tutar",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/158492/images/system/158492.jpeg",biography:"Prof. Dr. Yusuf Tutar conducts his research at the Hamidiye Faculty of Pharmacy, Department of Basic Pharmaceutical Sciences, Division of Biochemistry, University of Health Sciences, Turkey. He is also a faculty member in the Molecular Oncology Program. He obtained his MSc and Ph.D. at Oregon State University and Texas Tech University, respectively. He pursued his postdoctoral studies at Rutgers University Medical School and the National Institutes of Health (NIH/NIDDK), USA. His research focuses on biochemistry, biophysics, genetics, molecular biology, and molecular medicine with specialization in the fields of drug design, protein structure-function, protein folding, prions, microRNA, pseudogenes, molecular cancer, epigenetics, metabolites, proteomics, genomics, protein expression, and characterization by spectroscopic and calorimetric methods.",institutionString:"University of Health Sciences",institution:null},{id:"180528",title:"Dr.",name:"Hiroyuki",middleName:null,surname:"Kagechika",slug:"hiroyuki-kagechika",fullName:"Hiroyuki Kagechika",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/180528/images/system/180528.jpg",biography:"Hiroyuki Kagechika received his bachelor’s degree and Ph.D. in Pharmaceutical Sciences from the University of Tokyo, Japan, where he served as an associate professor until 2004. He is currently a professor at the Institute of Biomaterials and Bioengineering (IBB), Tokyo Medical and Dental University (TMDU). From 2010 to 2012, he was the dean of the Graduate School of Biomedical Science. Since 2012, he has served as the vice dean of the Graduate School of Medical and Dental Sciences. He has been the director of the IBB since 2020. Dr. Kagechika’s major research interests are the medicinal chemistry of retinoids, vitamins D/K, and nuclear receptors. He has developed various compounds including a drug for acute promyelocytic leukemia.",institutionString:"Tokyo Medical and Dental University",institution:{name:"Tokyo Medical and Dental University",country:{name:"Japan"}}},{id:"94311",title:"Prof.",name:"Martins",middleName:"Ochubiojo",surname:"Ochubiojo Emeje",slug:"martins-ochubiojo-emeje",fullName:"Martins Ochubiojo Emeje",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/94311/images/system/94311.jpeg",biography:"Martins Emeje obtained a BPharm with distinction from Ahmadu Bello University, Nigeria, and an MPharm and Ph.D. from the University of Nigeria (UNN), where he received the best Ph.D. award and was enlisted as UNN’s “Face of Research.” He established the first nanomedicine center in Nigeria and was the pioneer head of the intellectual property and technology transfer as well as the technology innovation and support center. Prof. Emeje’s several international fellowships include the prestigious Raman fellowship. He has published more than 150 articles and patents. He is also the head of R&D at NIPRD and holds a visiting professor position at Nnamdi Azikiwe University, Nigeria. He has a postgraduate certificate in Project Management from Walden University, Minnesota, as well as a professional teaching certificate and a World Bank certification in Public Procurement. Prof. Emeje was a national chairman of academic pharmacists in Nigeria and the 2021 winner of the May & Baker Nigeria Plc–sponsored prize for professional service in research and innovation.",institutionString:"National Institute for Pharmaceutical Research and Development",institution:{name:"National Institute for Pharmaceutical Research and Development",country:{name:"Nigeria"}}},{id:"436430",title:"Associate Prof.",name:"Mesut",middleName:null,surname:"Işık",slug:"mesut-isik",fullName:"Mesut Işık",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/436430/images/19686_n.jpg",biography:null,institutionString:null,institution:{name:"Bilecik University",country:{name:"Turkey"}}},{id:"268659",title:"Ms.",name:"Xianquan",middleName:null,surname:"Zhan",slug:"xianquan-zhan",fullName:"Xianquan Zhan",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/268659/images/8143_n.jpg",biography:"Dr. Zhan received his undergraduate and graduate training in the fields of preventive medicine and epidemiology and statistics at the West China University of Medical Sciences in China during 1989 to 1999. He received his post-doctoral training in oncology and cancer proteomics for two years at the Cancer Research Institute of Human Medical University in China. In 2001, he went to the University of Tennessee Health Science Center (UTHSC) in USA, where he was a post-doctoral researcher and focused on mass spectrometry and cancer proteomics. Then, he was appointed as an Assistant Professor of Neurology, UTHSC in 2005. He moved to the Cleveland Clinic in USA as a Project Scientist/Staff in 2006 where he focused on the studies of eye disease proteomics and biomarkers. He returned to UTHSC as an Assistant Professor of Neurology in the end of 2007, engaging in proteomics and biomarker studies of lung diseases and brain tumors, and initiating the studies of predictive, preventive, and personalized medicine (PPPM) in cancer. In 2010, he was promoted to Associate Professor of Neurology, UTHSC. Currently, he is a Professor at Xiangya Hospital of Central South University in China, Fellow of Royal Society of Medicine (FRSM), the European EPMA National Representative in China, Regular Member of American Association for the Advancement of Science (AAAS), European Cooperation of Science and Technology (e-COST) grant evaluator, Associate Editors of BMC Genomics, BMC Medical Genomics, EPMA Journal, and Frontiers in Endocrinology, Executive Editor-in-Chief of Med One. He has\npublished 116 peer-reviewed research articles, 16 book chapters, 2 books, and 2 US patents. His current main research interest focuses on the studies of cancer proteomics and biomarkers, and the use of modern omics techniques and systems biology for PPPM in cancer, and on the development and use of 2DE-LC/MS for the large-scale study of human proteoforms.",institutionString:null,institution:{name:"Xiangya Hospital Central South University",country:{name:"China"}}},{id:"40482",title:null,name:"Rizwan",middleName:null,surname:"Ahmad",slug:"rizwan-ahmad",fullName:"Rizwan Ahmad",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/40482/images/system/40482.jpeg",biography:"Dr. Rizwan Ahmad is a University Professor and Coordinator, Quality and Development, College of Medicine, Imam Abdulrahman bin Faisal University, Saudi Arabia. Previously, he was Associate Professor of Human Function, Oman Medical College, Oman, and SBS University, Dehradun. Dr. Ahmad completed his education at Aligarh Muslim University, Aligarh. He has published several articles in peer-reviewed journals, chapters, and edited books. His area of specialization is free radical biochemistry and autoimmune diseases.",institutionString:"Imam Abdulrahman Bin Faisal University",institution:{name:"Imam Abdulrahman Bin Faisal University",country:{name:"Saudi Arabia"}}},{id:"41865",title:"Prof.",name:"Farid A.",middleName:null,surname:"Badria",slug:"farid-a.-badria",fullName:"Farid A. Badria",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/41865/images/system/41865.jpg",biography:"Farid A. Badria, Ph.D., is the recipient of several awards, including The World Academy of Sciences (TWAS) Prize for Public Understanding of Science; the World Intellectual Property Organization (WIPO) Gold Medal for best invention; Outstanding Arab Scholar, Kuwait; and the Khwarizmi International Award, Iran. He has 250 publications, 12 books, 20 patents, and several marketed pharmaceutical products to his credit. He continues to lead research projects on developing new therapies for liver, skin disorders, and cancer. Dr. Badria was listed among the world’s top 2% of scientists in medicinal and biomolecular chemistry in 2019 and 2020. He is a member of the Arab Development Fund, Kuwait; International Cell Research Organization–United Nations Educational, Scientific and Cultural Organization (ICRO–UNESCO), Chile; and UNESCO Biotechnology France",institutionString:"Mansoura University",institution:{name:"Mansoura University",country:{name:"Egypt"}}},{id:"329385",title:"Dr.",name:"Rajesh K.",middleName:"Kumar",surname:"Singh",slug:"rajesh-k.-singh",fullName:"Rajesh K. Singh",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/329385/images/system/329385.png",biography:"Dr. Singh received a BPharm (2003) and MPharm (2005) from Panjab University, Chandigarh, India, and a Ph.D. (2013) from Punjab Technical University (PTU), Jalandhar, India. He has more than sixteen years of teaching experience and has supervised numerous postgraduate and Ph.D. students. He has to his credit more than seventy papers in SCI- and SCOPUS-indexed journals, fifty-five conference proceedings, four books, six Best Paper Awards, and five projects from different government agencies. He is currently an editorial board member of eight international journals and a reviewer for more than fifty scientific journals. He received Top Reviewer and Excellent Peer Reviewer Awards from Publons in 2016 and 2017, respectively. He is also on the panel of The International Reviewer for reviewing research proposals for grants from the Royal Society. He also serves as a Publons Academy mentor and Bentham brand ambassador.",institutionString:"Punjab Technical University",institution:{name:"Punjab Technical University",country:{name:"India"}}},{id:"142388",title:"Dr.",name:"Thiago",middleName:"Gomes",surname:"Gomes Heck",slug:"thiago-gomes-heck",fullName:"Thiago Gomes Heck",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/142388/images/7259_n.jpg",biography:null,institutionString:null,institution:{name:"Universidade Regional do Noroeste do Estado do Rio Grande do Sul",country:{name:"Brazil"}}},{id:"336273",title:"Assistant Prof.",name:"Janja",middleName:null,surname:"Zupan",slug:"janja-zupan",fullName:"Janja Zupan",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/336273/images/14853_n.jpeg",biography:"Janja Zupan graduated in 2005 at the Department of Clinical Biochemistry (superviser prof. dr. Janja Marc) in the field of genetics of osteoporosis. Since November 2009 she is working as a Teaching Assistant at the Faculty of Pharmacy, Department of Clinical Biochemistry. In 2011 she completed part of her research and PhD work at Institute of Genetics and Molecular Medicine, University of Edinburgh. She finished her PhD entitled The influence of the proinflammatory cytokines on the RANK/RANKL/OPG in bone tissue of osteoporotic and osteoarthritic patients in 2012. From 2014-2016 she worked at the Institute of Biomedical Sciences, University of Aberdeen as a postdoctoral research fellow on UK Arthritis research project where she gained knowledge in mesenchymal stem cells and regenerative medicine. She returned back to University of Ljubljana, Faculty of Pharmacy in 2016. She is currently leading project entitled Mesenchymal stem cells-the keepers of tissue endogenous regenerative capacity facing up to aging of the musculoskeletal system funded by Slovenian Research Agency.",institutionString:null,institution:{name:"University of Ljubljana",country:{name:"Slovenia"}}},{id:"357453",title:"Dr.",name:"Radheshyam",middleName:null,surname:"Maurya",slug:"radheshyam-maurya",fullName:"Radheshyam Maurya",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/357453/images/16535_n.jpg",biography:null,institutionString:null,institution:{name:"University of Hyderabad",country:{name:"India"}}},{id:"418340",title:"Dr.",name:"Jyotirmoi",middleName:null,surname:"Aich",slug:"jyotirmoi-aich",fullName:"Jyotirmoi Aich",position:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000038Ugi5QAC/Profile_Picture_2022-04-15T07:48:28.png",biography:"Biotechnologist with 15 years of research including 6 years of teaching experience. Demonstrated record of scientific achievements through consistent publication record (H index = 13, with 874 citations) in high impact journals such as Nature Communications, Oncotarget, Annals of Oncology, PNAS, and AJRCCM, etc. Strong research professional with a post-doctorate from ACTREC where I gained experimental oncology experience in clinical settings and a doctorate from IGIB where I gained expertise in asthma pathophysiology. A well-trained biotechnologist with diverse experience on the bench across different research themes ranging from asthma to cancer and other infectious diseases. An individual with a strong commitment and innovative mindset. Have the ability to work on diverse projects such as regenerative and molecular medicine with an overall mindset of improving healthcare.",institutionString:"DY Patil Deemed to Be University",institution:null},{id:"349288",title:"Prof.",name:"Soumya",middleName:null,surname:"Basu",slug:"soumya-basu",fullName:"Soumya Basu",position:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000035QxIDQA0/Profile_Picture_2022-04-15T07:47:01.jpg",biography:"Soumya Basu, Ph.D., is currently working as an Associate Professor at Dr. D. Y. Patil Biotechnology and Bioinformatics Institute, Dr. D. Y. Patil Vidyapeeth, Pune, Maharashtra, India. With 16+ years of trans-disciplinary research experience in Drug Design, development, and pre-clinical validation; 20+ research article publications in journals of repute, 9+ years of teaching experience, trained with cross-disciplinary education, Dr. Basu is a life-long learner and always thrives for new challenges.\r\nHer research area is the design and synthesis of small molecule partial agonists of PPAR-γ in lung cancer. She is also using artificial intelligence and deep learning methods to understand the exosomal miRNA’s role in cancer metastasis. Dr. Basu is the recipient of many awards including the Early Career Research Award from the Department of Science and Technology, Govt. of India. She is a reviewer of many journals like Molecular Biology Reports, Frontiers in Oncology, RSC Advances, PLOS ONE, Journal of Biomolecular Structure & Dynamics, Journal of Molecular Graphics and Modelling, etc. She has edited and authored/co-authored 21 journal papers, 3 book chapters, and 15 abstracts. She is a Board of Studies member at her university. She is a life member of 'The Cytometry Society”-in India and 'All India Cell Biology Society”- in India.",institutionString:"Dr. D.Y. Patil Vidyapeeth, Pune",institution:{name:"Dr. D.Y. Patil Vidyapeeth, Pune",country:{name:"India"}}},{id:"354817",title:"Dr.",name:"Anubhab",middleName:null,surname:"Mukherjee",slug:"anubhab-mukherjee",fullName:"Anubhab Mukherjee",position:null,profilePictureURL:"https://intech-files.s3.amazonaws.com/0033Y0000365PbRQAU/ProfilePicture%202022-04-15%2005%3A11%3A18.480",biography:"A former member of Laboratory of Nanomedicine, Brigham and Women’s Hospital, Harvard University, Boston, USA, Dr. Anubhab Mukherjee is an ardent votary of science who strives to make an impact in the lives of those afflicted with cancer and other chronic/acute ailments. He completed his Ph.D. from CSIR-Indian Institute of Chemical Technology, Hyderabad, India, having been skilled with RNAi, liposomal drug delivery, preclinical cell and animal studies. He pursued post-doctoral research at College of Pharmacy, Health Science Center, Texas A & M University and was involved in another postdoctoral research at Department of Translational Neurosciences and Neurotherapeutics, John Wayne Cancer Institute, Santa Monica, California. In 2015, he worked in Harvard-MIT Health Sciences & Technology as a visiting scientist. He has substantial experience in nanotechnology-based formulation development and successfully served various Indian organizations to develop pharmaceuticals and nutraceutical products. He is an inventor in many US patents and an author in many peer-reviewed articles, book chapters and books published in various media of international repute. Dr. Mukherjee is currently serving as Principal Scientist, R&D at Esperer Onco Nutrition (EON) Pvt. Ltd. and heads the Hyderabad R&D center of the organization.",institutionString:"Esperer Onco Nutrition Pvt Ltd.",institution:null},{id:"319365",title:"Assistant Prof.",name:"Manash K.",middleName:null,surname:"Paul",slug:"manash-k.-paul",fullName:"Manash K. Paul",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/319365/images/system/319365.png",biography:"Manash K. Paul is a scientist and Principal Investigator at the University of California Los Angeles. He has contributed significantly to the fields of stem cell biology, regenerative medicine, and lung cancer. His research focuses on various signaling processes involved in maintaining stem cell homeostasis during the injury-repair process, deciphering the lung stem cell niche, pulmonary disease modeling, immuno-oncology, and drug discovery. He is currently investigating the role of extracellular vesicles in premalignant lung cell migration and detecting the metastatic phenotype of lung cancer via artificial intelligence-based analyses of exosomal Raman signatures. Dr. Paul also works on spatial multiplex immunofluorescence-based tissue mapping to understand the immune repertoire in lung cancer. Dr. Paul has published in more than sixty-five peer-reviewed international journals and is highly cited. He is the recipient of many awards, including the UCLA Vice Chancellor’s award and the 2022 AAISCR-R Vijayalaxmi Award for Innovative Cancer Research. He is a senior member of the Institute of Electrical and Electronics Engineers (IEEE) and an editorial board member for several international journals.",institutionString:"University of California Los Angeles",institution:{name:"University of California Los Angeles",country:{name:"United States of America"}}},{id:"311457",title:"Dr.",name:"Júlia",middleName:null,surname:"Scherer Santos",slug:"julia-scherer-santos",fullName:"Júlia Scherer Santos",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/311457/images/system/311457.jpg",biography:"Dr. Júlia Scherer Santos works in the areas of cosmetology, nanotechnology, pharmaceutical technology, beauty, and aesthetics. Dr. Santos also has experience as a professor of graduate courses. Graduated in Pharmacy, specialization in Cosmetology and Cosmeceuticals applied to aesthetics, specialization in Aesthetic and Cosmetic Health, and a doctorate in Pharmaceutical Nanotechnology. Teaching experience in Pharmacy and Aesthetics and Cosmetics courses. She works mainly on the following subjects: nanotechnology, cosmetology, pharmaceutical technology, aesthetics.",institutionString:"Universidade Federal de Juiz de Fora",institution:{name:"Universidade Federal de Juiz de Fora",country:{name:"Brazil"}}},{id:"219081",title:"Dr.",name:"Abdulsamed",middleName:null,surname:"Kükürt",slug:"abdulsamed-kukurt",fullName:"Abdulsamed Kükürt",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/219081/images/system/219081.png",biography:"Dr. Kükürt graduated from Uludağ University in Turkey. He started his academic career as a Research Assistant in the Department of Biochemistry at Kafkas University. In 2019, he completed his Ph.D. program in the Department of Biochemistry at the Institute of Health Sciences. He is currently working at the Department of Biochemistry, Kafkas University. He has 27 published research articles in academic journals, 11 book chapters, and 37 papers. He took part in 10 academic projects. He served as a reviewer for many articles. He still serves as a member of the review board in many academic journals. He is currently working on the protective activity of phenolic compounds in disorders associated with oxidative stress and inflammation.",institutionString:null,institution:{name:"Kafkas University",country:{name:"Turkey"}}},{id:"178366",title:"Dr.",name:"Volkan",middleName:null,surname:"Gelen",slug:"volkan-gelen",fullName:"Volkan Gelen",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/178366/images/system/178366.jpg",biography:"Volkan Gelen is a Physiology specialist who received his veterinary degree from Kafkas University in 2011. Between 2011-2015, he worked as an assistant at Atatürk University, Faculty of Veterinary Medicine, Department of Physiology. In 2016, he joined Kafkas University, Faculty of Veterinary Medicine, Department of Physiology as an assistant professor. Dr. Gelen has been engaged in various academic activities at Kafkas University since 2016. There he completed 5 projects and has 3 ongoing projects. He has 60 articles published in scientific journals and 20 poster presentations in scientific congresses. His research interests include physiology, endocrine system, cancer, diabetes, cardiovascular system diseases, and isolated organ bath system studies.",institutionString:"Kafkas University",institution:{name:"Kafkas University",country:{name:"Turkey"}}},{id:"418963",title:"Dr.",name:"Augustine Ododo",middleName:"Augustine",surname:"Osagie",slug:"augustine-ododo-osagie",fullName:"Augustine Ododo Osagie",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/418963/images/16900_n.jpg",biography:"Born into the family of Osagie, a prince of the Benin Kingdom. I am currently an academic in the Department of Medical Biochemistry, University of Benin. Part of the duties are to teach undergraduate students and conduct academic research.",institutionString:null,institution:{name:"University of Benin",country:{name:"Nigeria"}}},{id:"192992",title:"Prof.",name:"Shagufta",middleName:null,surname:"Perveen",slug:"shagufta-perveen",fullName:"Shagufta Perveen",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/192992/images/system/192992.png",biography:"Prof. Shagufta Perveen is a Distinguish Professor in the Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. Dr. Perveen has acted as the principal investigator of major research projects funded by the research unit of King Saud University. She has more than ninety original research papers in peer-reviewed journals of international repute to her credit. She is a fellow member of the Royal Society of Chemistry UK and the American Chemical Society of the United States.",institutionString:"King Saud University",institution:{name:"King Saud University",country:{name:"Saudi Arabia"}}},{id:"49848",title:"Dr.",name:"Wen-Long",middleName:null,surname:"Hu",slug:"wen-long-hu",fullName:"Wen-Long Hu",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/49848/images/system/49848.jpg",biography:"Wen-Long Hu is Chief of the Division of Acupuncture, Department of Chinese Medicine at Kaohsiung Chang Gung Memorial Hospital, as well as an adjunct associate professor at Fooyin University and Kaohsiung Medical University. Wen-Long is President of Taiwan Traditional Chinese Medicine Medical Association. He has 28 years of experience in clinical practice in laser acupuncture therapy and 34 years in acupuncture. He is an invited speaker for lectures and workshops in laser acupuncture at many symposiums held by medical associations. He owns the patent for herbal preparation and producing, and for the supercritical fluid-treated needle. Dr. Hu has published three books, 12 book chapters, and more than 30 papers in reputed journals, besides serving as an editorial board member of repute.",institutionString:"Kaohsiung Chang Gung Memorial Hospital",institution:{name:"Kaohsiung Chang Gung Memorial Hospital",country:{name:"Taiwan"}}},{id:"298472",title:"Prof.",name:"Andrey V.",middleName:null,surname:"Grechko",slug:"andrey-v.-grechko",fullName:"Andrey V. Grechko",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/298472/images/system/298472.png",biography:"Andrey Vyacheslavovich Grechko, Ph.D., Professor, is a Corresponding Member of the Russian Academy of Sciences. He graduated from the Semashko Moscow Medical Institute (Semashko National Research Institute of Public Health) with a degree in Medicine (1998), the Clinical Department of Dermatovenerology (2000), and received a second higher education in Psychology (2009). Professor A.V. Grechko held the position of Сhief Physician of the Central Clinical Hospital in Moscow. He worked as a professor at the faculty and was engaged in scientific research at the Medical University. Starting in 2013, he has been the initiator of the creation of the Federal Scientific and Clinical Center for Intensive Care and Rehabilitology, Moscow, Russian Federation, where he also serves as Director since 2015. He has many years of experience in research and teaching in various fields of medicine, is an author/co-author of more than 200 scientific publications, 13 patents, 15 medical books/chapters, including Chapter in Book «Metabolomics», IntechOpen, 2020 «Metabolomic Discovery of Microbiota Dysfunction as the Cause of Pathology».",institutionString:"Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology",institution:null},{id:"199461",title:"Prof.",name:"Natalia V.",middleName:null,surname:"Beloborodova",slug:"natalia-v.-beloborodova",fullName:"Natalia V. Beloborodova",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/199461/images/system/199461.jpg",biography:'Natalia Vladimirovna Beloborodova was educated at the Pirogov Russian National Research Medical University, with a degree in pediatrics in 1980, a Ph.D. in 1987, and a specialization in Clinical Microbiology from First Moscow State Medical University in 2004. She has been a Professor since 1996. Currently, she is the Head of the Laboratory of Metabolism, a division of the Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russian Federation. N.V. Beloborodova has many years of clinical experience in the field of intensive care and surgery. She studies infectious complications and sepsis. She initiated a series of interdisciplinary clinical and experimental studies based on the concept of integrating human metabolism and its microbiota. Her scientific achievements are widely known: she is the recipient of the Marie E. Coates Award \\"Best lecturer-scientist\\" Gustafsson Fund, Karolinska Institutes, Stockholm, Sweden, and the International Sepsis Forum Award, Pasteur Institute, Paris, France (2014), etc. Professor N.V. Beloborodova wrote 210 papers, five books, 10 chapters and has edited four books.',institutionString:"Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology",institution:null},{id:"354260",title:"Ph.D.",name:"Tércio Elyan",middleName:"Azevedo",surname:"Azevedo Martins",slug:"tercio-elyan-azevedo-martins",fullName:"Tércio Elyan Azevedo Martins",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/354260/images/16241_n.jpg",biography:"Graduated in Pharmacy from the Federal University of Ceará with the modality in Industrial Pharmacy, Specialist in Production and Control of Medicines from the University of São Paulo (USP), Master in Pharmaceuticals and Medicines from the University of São Paulo (USP) and Doctor of Science in the program of Pharmaceuticals and Medicines by the University of São Paulo. Professor at Universidade Paulista (UNIP) in the areas of chemistry, cosmetology and trichology. Assistant Coordinator of the Higher Course in Aesthetic and Cosmetic Technology at Universidade Paulista Campus Chácara Santo Antônio. Experience in the Pharmacy area, with emphasis on Pharmacotechnics, Pharmaceutical Technology, Research and Development of Cosmetics, acting mainly on topics such as cosmetology, antioxidant activity, aesthetics, photoprotection, cyclodextrin and thermal analysis.",institutionString:null,institution:{name:"University of Sao Paulo",country:{name:"Brazil"}}},{id:"334285",title:"Ph.D. Student",name:"Sameer",middleName:"Kumar",surname:"Jagirdar",slug:"sameer-jagirdar",fullName:"Sameer Jagirdar",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/334285/images/14691_n.jpg",biography:"I\\'m a graduate student at the center for biosystems science and engineering at the Indian Institute of Science, Bangalore, India. I am interested in studying host-pathogen interactions at the biomaterial interface.",institutionString:null,institution:{name:"Indian Institute of Science Bangalore",country:{name:"India"}}},{id:"329248",title:"Dr.",name:"Md. Faheem",middleName:null,surname:"Haider",slug:"md.-faheem-haider",fullName:"Md. Faheem Haider",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/329248/images/system/329248.jpg",biography:"Dr. Md. Faheem Haider completed his BPharm in 2012 at Integral University, Lucknow, India. In 2014, he completed his MPharm with specialization in Pharmaceutics at Babasaheb Bhimrao Ambedkar University, Lucknow, India. He received his Ph.D. degree from Jamia Hamdard University, New Delhi, India, in 2018. He was selected for the GPAT six times and his best All India Rank was 34. Currently, he is an assistant professor at Integral University. Previously he was an assistant professor at IIMT University, Meerut, India. He has experience teaching DPharm, Pharm.D, BPharm, and MPharm students. He has more than five publications in reputed journals to his credit. Dr. Faheem’s research area is the development and characterization of nanoformulation for the delivery of drugs to various organs.",institutionString:"Integral University",institution:{name:"Integral University",country:{name:"India"}}},{id:"329795",title:"Dr.",name:"Mohd Aftab",middleName:"Aftab",surname:"Siddiqui",slug:"mohd-aftab-siddiqui",fullName:"Mohd Aftab Siddiqui",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/329795/images/system/329795.png",biography:"Dr. Mohd Aftab Siddiqui is an assistant professor in the Faculty of Pharmacy, Integral University, Lucknow, India, where he obtained a Ph.D. in Pharmacology in 2020. He also obtained a BPharm and MPharm from the same university in 2013 and 2015, respectively. His area of research is the pharmacological screening of herbal drugs/natural products in liver cancer and cardiac diseases. He is a member of many professional bodies and has guided many MPharm and PharmD research projects. Dr. Siddiqui has many national and international publications and one German patent to his credit.",institutionString:"Integral University",institution:null}]}},subseries:{item:{id:"38",type:"subseries",title:"Pollution",keywords:"Human Activity, Pollutants, Reduced Risks, Population Growth, Waste Disposal, Remediation, Clean Environment",scope:"
\r\n\tPollution is caused by a wide variety of human activities and occurs in diverse forms, for example biological, chemical, et cetera. In recent years, significant efforts have been made to ensure that the environment is clean, that rigorous rules are implemented, and old laws are updated to reduce the risks towards humans and ecosystems. However, rapid industrialization and the need for more cultivable sources or habitable lands, for an increasing population, as well as fewer alternatives for waste disposal, make the pollution control tasks more challenging. Therefore, this topic will focus on assessing and managing environmental pollution. It will cover various subjects, including risk assessment due to the pollution of ecosystems, transport and fate of pollutants, restoration or remediation of polluted matrices, and efforts towards sustainable solutions to minimize environmental pollution.
",coverUrl:"https://cdn.intechopen.com/series_topics/covers/38.jpg",hasOnlineFirst:!1,hasPublishedBooks:!0,annualVolume:11966,editor:{id:"110740",title:"Dr.",name:"Ismail M.M.",middleName:null,surname:"Rahman",slug:"ismail-m.m.-rahman",fullName:"Ismail M.M. Rahman",profilePictureURL:"https://mts.intechopen.com/storage/users/110740/images/2319_n.jpg",biography:"Ismail Md. Mofizur Rahman (Ismail M. M. Rahman) assumed his current responsibilities as an Associate Professor at the Institute of Environmental Radioactivity, Fukushima University, Japan, in Oct 2015. He also has an honorary appointment to serve as a Collaborative Professor at Kanazawa University, Japan, from Mar 2015 to the present. \nFormerly, Dr. Rahman was a faculty member of the University of Chittagong, Bangladesh, affiliated with the Department of Chemistry (Oct 2002 to Mar 2012) and the Department of Applied Chemistry and Chemical Engineering (Mar 2012 to Sep 2015). Dr. Rahman was also adjunctly attached with Kanazawa University, Japan (Visiting Research Professor, Dec 2014 to Mar 2015; JSPS Postdoctoral Research Fellow, Apr 2012 to Mar 2014), and Tokyo Institute of Technology, Japan (TokyoTech-UNESCO Research Fellow, Oct 2004–Sep 2005). \nHe received his Ph.D. degree in Environmental Analytical Chemistry from Kanazawa University, Japan (2011). He also achieved a Diploma in Environment from the Tokyo Institute of Technology, Japan (2005). Besides, he has an M.Sc. degree in Applied Chemistry and a B.Sc. degree in Chemistry, all from the University of Chittagong, Bangladesh. \nDr. Rahman’s research interest includes the study of the fate and behavior of environmental pollutants in the biosphere; design of low energy and low burden environmental improvement (remediation) technology; implementation of sustainable waste management practices for treatment, handling, reuse, and ultimate residual disposition of solid wastes; nature and type of interactions in organic liquid mixtures for process engineering design applications.",institutionString:null,institution:{name:"Fukushima University",institutionURL:null,country:{name:"Japan"}}},editorTwo:{id:"201020",title:"Dr.",name:"Zinnat Ara",middleName:null,surname:"Begum",slug:"zinnat-ara-begum",fullName:"Zinnat Ara Begum",profilePictureURL:"https://mts.intechopen.com/storage/users/201020/images/system/201020.jpeg",biography:"Zinnat A. Begum received her Ph.D. in Environmental Analytical Chemistry from Kanazawa University in 2012. She achieved her Master of Science (M.Sc.) degree with a major in Applied Chemistry and a Bachelor of Science (B.Sc.) in Chemistry, all from the University of Chittagong, Bangladesh. Her work affiliations include Fukushima University, Japan (Visiting Research Fellow, Institute of Environmental Radioactivity: Mar 2016 to present), Southern University Bangladesh (Assistant Professor, Department of Civil Engineering: Jan 2015 to present), and Kanazawa University, Japan (Postdoctoral Fellow, Institute of Science and Engineering: Oct 2012 to Mar 2014; Research fellow, Venture Business Laboratory, Advanced Science and Social Co-Creation Promotion Organization: Apr 2018 to Mar 2021). The research focus of Dr. Zinnat includes the effect of the relative stability of metal-chelator complexes in the environmental remediation process designs and the development of eco-friendly soil washing techniques using biodegradable chelators.",institutionString:null,institution:{name:"Fukushima University",institutionURL:null,country:{name:"Japan"}}},editorThree:null,series:{id:"25",title:"Environmental Sciences",doi:"10.5772/intechopen.100362",issn:"2754-6713"},editorialBoard:[{id:"252368",title:"Dr.",name:"Meng-Chuan",middleName:null,surname:"Ong",slug:"meng-chuan-ong",fullName:"Meng-Chuan Ong",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRVotQAG/Profile_Picture_2022-05-20T12:04:28.jpg",institutionString:null,institution:{name:"Universiti Malaysia Terengganu",institutionURL:null,country:{name:"Malaysia"}}},{id:"63465",title:"Prof.",name:"Mohamed Nageeb",middleName:null,surname:"Rashed",slug:"mohamed-nageeb-rashed",fullName:"Mohamed Nageeb Rashed",profilePictureURL:"https://mts.intechopen.com/storage/users/63465/images/system/63465.gif",institutionString:null,institution:{name:"Aswan University",institutionURL:null,country:{name:"Egypt"}}},{id:"187907",title:"Dr.",name:"Olga",middleName:null,surname:"Anne",slug:"olga-anne",fullName:"Olga Anne",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSBE5QAO/Profile_Picture_2022-04-07T09:42:13.png",institutionString:null,institution:{name:"Klaipeda State University of Applied Sciences",institutionURL:null,country:{name:"Lithuania"}}}]},onlineFirstChapters:{paginationCount:6,paginationItems:[{id:"83073",title:"Dental and Orofacial Trauma Impacts on Oral-Health-Related—Quality of Life in Children: Low- and Middle-Income Countries",doi:"10.5772/intechopen.105845",signatures:"Yolanda Malele-Kolisa, Nazia Khan, Mpho P. Molete, Maphefo D. Thekiso and Mzubanzi Mabongo",slug:"dental-and-orofacial-trauma-impacts-on-oral-health-related-quality-of-life-in-children-low-and-middl",totalDownloads:11,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Dental Trauma",coverURL:"https://cdn.intechopen.com/books/images_new/11567.jpg",subseries:{id:"2",title:"Prosthodontics and Implant Dentistry"}}},{id:"82938",title:"Trauma from Occlusion: Practical Management Guidelines",doi:"10.5772/intechopen.105960",signatures:"Prashanth Shetty, Shweta Hegde, Shubham Chelkar, Rahul Chaturvedi, Shruti Pochhi, Aakanksha Shrivastava, Dudala Lakshmi, Shreya Mukherjee, Pankaj Bajaj and Shahzada Asif Raza",slug:"trauma-from-occlusion-practical-management-guidelines",totalDownloads:14,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Dental Trauma",coverURL:"https://cdn.intechopen.com/books/images_new/11567.jpg",subseries:{id:"2",title:"Prosthodontics and Implant Dentistry"}}},{id:"82608",title:"Early Management of Dental Trauma in the Era of COVID-19",doi:"10.5772/intechopen.105992",signatures:"Khairul Bariah Chi Adam, Haszelini Hassan, Pram Kumar Subramaniam, Izzati Nabilah Ismail, Nor Adilah Harun and Naziyah Shaban Mustafa",slug:"early-management-of-dental-trauma-in-the-era-of-covid-19",totalDownloads:3,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Dental Trauma",coverURL:"https://cdn.intechopen.com/books/images_new/11567.jpg",subseries:{id:"2",title:"Prosthodontics and Implant Dentistry"}}},{id:"82767",title:"Teeth Avulsion",doi:"10.5772/intechopen.105846",signatures:"Manal Abdalla Eltahir, Randa Fath Elrahman Ibrahim and Hanan Alharbi",slug:"teeth-avulsion",totalDownloads:21,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Dental Trauma",coverURL:"https://cdn.intechopen.com/books/images_new/11567.jpg",subseries:{id:"2",title:"Prosthodontics and Implant Dentistry"}}},{id:"82288",title:"Dental Emergency and Conditions",doi:"10.5772/intechopen.105495",signatures:"Navneet Kaur",slug:"dental-emergency-and-conditions",totalDownloads:14,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Dental Trauma",coverURL:"https://cdn.intechopen.com/books/images_new/11567.jpg",subseries:{id:"2",title:"Prosthodontics and Implant Dentistry"}}},{id:"81961",title:"Antioxidants as an Adjuncts to Periodontal Therapy",doi:"10.5772/intechopen.105016",signatures:"Sura Dakhil Jassim and Ali Abbas Abdulkareem",slug:"antioxidants-as-an-adjuncts-to-periodontal-therapy",totalDownloads:4,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Dental Trauma",coverURL:"https://cdn.intechopen.com/books/images_new/11567.jpg",subseries:{id:"2",title:"Prosthodontics and Implant Dentistry"}}}]},publishedBooks:{paginationCount:1,paginationItems:[{type:"book",id:"10843",title:"Persistent Organic Pollutants (POPs)",subtitle:"Monitoring, Impact and Treatment",coverURL:"https://cdn.intechopen.com/books/images_new/10843.jpg",slug:"persistent-organic-pollutants-pops-monitoring-impact-and-treatment",publishedDate:"April 13th 2022",editedByType:"Edited by",bookSignature:"Mohamed Nageeb Rashed",hash:"f5b1589f0a990b6114fef2dadc735dd9",volumeInSeries:1,fullTitle:"Persistent Organic Pollutants (POPs) - Monitoring, Impact and Treatment",editors:[{id:"63465",title:"Prof.",name:"Mohamed Nageeb",middleName:null,surname:"Rashed",slug:"mohamed-nageeb-rashed",fullName:"Mohamed Nageeb Rashed",profilePictureURL:"https://mts.intechopen.com/storage/users/63465/images/system/63465.gif",institutionString:null,institution:{name:"Aswan University",institutionURL:null,country:{name:"Egypt"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},testimonialsList:[{id:"18",text:"It was great publishing with IntechOpen, the process was straightforward and I had support all along.",author:{id:"71579",name:"Berend",surname:"Olivier",institutionString:"Utrecht University",profilePictureURL:"https://mts.intechopen.com/storage/users/71579/images/system/71579.png",slug:"berend-olivier",institution:{id:"253",name:"Utrecht University",country:{id:null,name:"Netherlands"}}}},{id:"27",text:"The opportunity to work with a prestigious publisher allows for the possibility to collaborate with more research groups interested in animal nutrition, leading to the development of new feeding strategies and food valuation while being more sustainable with the environment, allowing more readers to learn about the subject.",author:{id:"175967",name:"Manuel",surname:"Gonzalez Ronquillo",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/175967/images/system/175967.png",slug:"manuel-gonzalez-ronquillo",institution:{id:"6221",name:"Universidad Autónoma del Estado de México",country:{id:null,name:"Mexico"}}}},{id:"8",text:"I work with IntechOpen for a number of reasons: their professionalism, their mission in support of Open Access publishing, and the quality of their peer-reviewed publications, but also because they believe in equality.",author:{id:"202192",name:"Catrin",surname:"Rutland",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",slug:"catrin-rutland",institution:{id:"134",name:"University of Nottingham",country:{id:null,name:"United Kingdom"}}}}]},submityourwork:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:11,numberOfPublishedChapters:90,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:108,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:33,numberOfPublishedChapters:332,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:14,numberOfPublishedChapters:145,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:11,numberOfPublishedChapters:141,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!0},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:124,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:11,numberOfPublishedChapters:112,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:22,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2753-894X",doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:12,numberOfOpenTopics:1,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!0},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:5,numberOfUpcomingTopics:0,issn:"2753-6580",doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],subseriesList:[{id:"3",title:"Bacterial Infectious Diseases",scope:"
\r\n\tThe era of antibiotics led us to the illusion that the problem of bacterial infection is over. However, bacterial flexibility and adaptation mechanisms allow them to survive and grow in extreme conditions. The best example is the formation of a sophisticated society of bacteria defined as a biofilm. Understanding the mechanism of bacterial biofilm formation has changed our perception of the development of bacterial infection but successfully eradicating biofilm remains a challenge. Considering the above, it is not surprising that bacteria remain a major public health threat despite the development of many groups of antibiotics. Additionally, increasing prevalence of acquired antibiotic resistance forces us to realize that we are far from controlling the development of bacterial infections. On the other hand, many infections are endogenous and result from an unbalanced relationship between the host and the microorganism. The increasing use of immunosuppressants, such as chemotherapy or organ transplantation, increases the incidence of patients highly susceptible to bacterial infections in the population.
\r\n
\r\n\tThis topic will focus on the current challenges and advantages in the diagnosis and treatment of bacterial infections. We will discuss the host-microbiota relationship, the treatment of chronic infections due to biofilm formation, and the development of new diagnostic tools to rapidly distinguish between colonization and probable infection.
",coverUrl:"https://cdn.intechopen.com/series_topics/covers/3.jpg",keywords:"Antibiotics, Biofilm, Antibiotic Resistance, Host-microbiota Relationship, Treatment, Diagnostic Tools"},{id:"4",title:"Fungal Infectious Diseases",scope:"Fungi are ubiquitous and there are almost no non-pathogenic fungi. Fungal infectious illness prevalence and prognosis are determined by the exposure between fungi and host, host immunological state, fungal virulence, and early and accurate diagnosis and treatment. \r\nPatients with both congenital and acquired immunodeficiency are more likely to be infected with opportunistic mycosis. Fungal infectious disease outbreaks are common during the post- disaster rebuilding era, which is characterised by high population density, migration, and poor health and medical conditions.\r\nSystemic or local fungal infection is mainly associated with the fungi directly inhaled or inoculated in the environment during the disaster. The most common fungal infection pathways are human to human (anthropophilic), animal to human (zoophilic), and environment to human (soilophile). Diseases are common as a result of widespread exposure to pathogenic fungus dispersed into the environment. \r\nFungi that are both common and emerging are intertwined. In Southeast Asia, for example, Talaromyces marneffei is an important pathogenic thermally dimorphic fungus that causes systemic mycosis. Widespread fungal infections with complicated and variable clinical manifestations, such as Candida auris infection resistant to several antifungal medicines, Covid-19 associated with Trichoderma, and terbinafine resistant dermatophytosis in India, are among the most serious disorders. \r\nInappropriate local or systemic use of glucocorticoids, as well as their immunosuppressive effects, may lead to changes in fungal infection spectrum and clinical characteristics. Hematogenous candidiasis is a worrisome issue that affects people all over the world, particularly ICU patients. CARD9 deficiency and fungal infection have been major issues in recent years. Invasive aspergillosis is associated with a significant death rate. Special attention should be given to endemic fungal infections, identification of important clinical fungal infections advanced in yeasts, filamentous fungal infections, skin mycobiome and fungal genomes, and immunity to fungal infections.\r\nIn addition, endemic fungal diseases or uncommon fungal infections caused by Mucor irregularis, dermatophytosis, Malassezia, cryptococcosis, chromoblastomycosis, coccidiosis, blastomycosis, histoplasmosis, sporotrichosis, and other fungi, should be monitored. \r\nThis topic includes the research progress on the etiology and pathogenesis of fungal infections, new methods of isolation and identification, rapid detection, drug sensitivity testing, new antifungal drugs, schemes and case series reports. It will provide significant opportunities and support for scientists, clinical doctors, mycologists, antifungal drug researchers, public health practitioners, and epidemiologists from all over the world to share new research, ideas and solutions to promote the development and progress of medical mycology.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/4.jpg",keywords:"Emerging Fungal Pathogens, Invasive Infections, Epidemiology, Cell Membrane, Fungal Virulence, Diagnosis, Treatment"},{id:"5",title:"Parasitic Infectious Diseases",scope:"Parasitic diseases have evolved alongside their human hosts. In many cases, these diseases have adapted so well that they have developed efficient resilience methods in the human host and can live in the host for years. Others, particularly some blood parasites, can cause very acute diseases and are responsible for millions of deaths yearly. Many parasitic diseases are classified as neglected tropical diseases because they have received minimal funding over recent years and, in many cases, are under-reported despite the critical role they play in morbidity and mortality among human and animal hosts. The current topic, Parasitic Infectious Diseases, in the Infectious Diseases Series aims to publish studies on the systematics, epidemiology, molecular biology, genomics, pathogenesis, genetics, and clinical significance of parasitic diseases from blood borne to intestinal parasites as well as zoonotic parasites. We hope to cover all aspects of parasitic diseases to provide current and relevant research data on these very important diseases. In the current atmosphere of the Coronavirus pandemic, communities around the world, particularly those in different underdeveloped areas, are faced with the growing challenges of the high burden of parasitic diseases. At the same time, they are faced with the Covid-19 pandemic leading to what some authors have called potential syndemics that might worsen the outcome of such infections. Therefore, it is important to conduct studies that examine parasitic infections in the context of the coronavirus pandemic for the benefit of all communities to help foster more informed decisions for the betterment of human and animal health.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/5.jpg",keywords:"Blood Borne Parasites, Intestinal Parasites, Protozoa, Helminths, Arthropods, Water Born Parasites, Epidemiology, Molecular Biology, Systematics, Genomics, Proteomics, Ecology"},{id:"6",title:"Viral Infectious Diseases",scope:"The Viral Infectious Diseases Book Series aims to provide a comprehensive overview of recent research trends and discoveries in various viral infectious diseases emerging around the globe. The emergence of any viral disease is hard to anticipate, which often contributes to death. A viral disease can be defined as an infectious disease that has recently appeared within a population or exists in nature with the rapid expansion of incident or geographic range. This series will focus on various crucial factors related to emerging viral infectious diseases, including epidemiology, pathogenesis, host immune response, clinical manifestations, diagnosis, treatment, and clinical recommendations for managing viral infectious diseases, highlighting the recent issues with future directions for effective therapeutic strategies.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/6.jpg",keywords:"Novel Viruses, Virus Transmission, Virus Evolution, Molecular Virology, Control and Prevention, Virus-host Interaction"}],annualVolumeBook:{},thematicCollection:[],selectedSeries:null,selectedSubseries:null},seriesLanding:{item:null},libraryRecommendation:{success:null,errors:{},institutions:[]},route:{name:"chapter.detail",path:"/chapters/56394",hash:"",query:{},params:{id:"56394"},fullPath:"/chapters/56394",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()